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Chapter 1

Introduction

27

Abdominal Aortic Aneurysms (AAA’s) are the end result of a mutifactorial
disease process affecting a high proportion of our elderly population. Ruptured
AAA’s are the tenth leading causes of death in elderly males and about half of all
patients with an AAA can expect to die of rupture if their aneurysm is not
surgically treated (Siegel and Cohan. 1994 and Schei et al., 2003). If left
untreated, aneurysms undergo progressive, merciless enlargement until rupture
occurs. They are often described as “silent killers” with rupture quite often being
the first presenting symptom. The natural history of an AAA is characterised by
progressive expansion and rupture. AAA’s are thought to be present in 4.7% of
men and 1.2% of women aged between 65-74 years. Most aortic aneurysms are
localised to the infra renal portion of the vessel (Ouriel, Greenberg and Clair,
2002).
The aorta is the largest artery in the body consisting of the ascending aorta,
the aortic arch the descending thoracic aorta, and the abdominal aorta (Chapter
2.0, figure 2.1). Rupture of an AAA is a catastrophic event, many die without even
reaching the operating table, and only approximately 50% of those undergoing
emergency open surgical repair survive beyond 30 days (The United Kingdom
small aneurysm trial participants). Hence, screening programmes are essential to
detect AAA’s and appropriate follow up programmes for such patients enabling
vascular surgeons to offer patients the opportunity to have their aneurysms
repaired electively when they are younger, fitter and asymptomatic, with an
associated improved survival rate.
Traditionally the procedure of choice was open surgical repair as described
by Dubost in the 1950’s. However, since Parodi reported the first successful case
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of endovascular repair of an AAA in 1991 the surgical management of aneurysms
has altered dramatically. Endovascular surgery is a less invasive, lower risk option
for repairing AAA’s. It has also made it possible for older and higher risk patients,
previously deemed unfit for open surgery to be considered for repair.
Cardiovascular disease is widely accepted as a leading cause of death in
the western world and is the most common cause of death in Ireland; in 2001 the
Irish Heart Foundation reported that cardiovascular disease accounted for over
40% of all deaths and 37% of deaths under 65 years in Ireland. In 2009 the Irish
heart foundation stated that despite a fall in cardiovascular deaths, it still remained
the number one killer in Ireland with just under 10,000 people dying each year.
Non invasive imaging techniques have become increasing popular and
have played an important role in the detection, diagnosis and management of such
conditions. Imaging modalities such as colour duplex ultrasound (CDU), have
become widely accepted and are a cost effective method of accurately diagnosing
cardiovascular disease when performed by a skilled operator.

The aim of this thesis is to investigate the role that CDU plays in the
detection, diagnosis and management of patients with AAA’s, with particular
relevance to those undergoing endovascular aneurysm repair (EVAR).

29

Objectives of this thesis
i Chapter one through five provides an overview of the normal arterial
anatomy and disease processes that affect the circulatory system, the
physics that underlies ultrasound and its use with particular reference to the
methodology pertaining to each of the individual studies that are outlined
below.

ii Chapter six examines the incidence of carotid artery disease (CAD) and
peripheral arterial disease (PAD) in the 389 patients currently on the
aneurysm surveillance programme using ultrasound based imaging
techniques. The aim of this part of the study is to determine if patients with
AAA’s are a reasonable focus group to screen for atherosclerotic
conditions in other vascular territories.

iii Chapter 7 compares the two imaging modalities of CDU and computed
tomography (CT) in assessment of the maximum aneurysm diameter in
126 patients under surveillance for AAA. It is an attempt to demonstrate
that CDU is a reliable surveillance tool prior to intervention
iv Chapter 8 compares CDU with CT in the post operative surveillance of
145 patients who have undergone EVAR. The aim of this study is to
evaluate the role of CDU in the postoperative surveillance of such patients
and determine whether CDU could supplant CT as the first line screening
tool following EVAR.
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v Chapter 9 evaluates the alterations in aneurysm sac size in 106 patients
following EVAR using CDU based imaging techniques. The aim of this
study is to determine the rate of residual aneurysm sac regression and
determine if there is a relationship between sac regression, pre existing
risk factors and the presence of a type 2 endoleak.
vi Chapter 10 attempts to determine the effect of AAA repair on arterial
stiffness using CDU as the sole method of investigation. This study
examines the affect of implanting an endovascular aortic graft on a patients
pulse wave velocity compared to patients who underwent the traditional
open surgical repair.
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Chapter 2

Arterial Anatomy
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2.1 Introduction
The anatomy of the normal abdominal aorta, peripheral arterial circulation and the
carotid and vertebral arteries are outlined in this chapter.

2.2 Structure of an Arterial Wall
Arteries have a similar structure throughout the body. An arterial wall is composed
of three layers.
Tunica Adventitia
Tunica Media
Tunica Intima
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Figure 2.0: The structure of an arterial wall
The tunica adventitia is the outermost layer consisting mainly of elastic lamina
enclosed by fibrous tissue. It is primarily fibro-cellular and provides the major
portion of the tensile strength of the vessel. The adventitia contains both the vasa
vasorum and the nerves which supply the vessel. The vasa vasorum is a network
of smaller blood vessels within the larger vessels whose function is to nourish the
walls of the larger vessels as well as acting as a conduit for eliminating waste
products.

The tunica media is the middle layer of the blood vessel. It is made up of smooth
muscle cells and elastic tissue; it is distinguished from the other two layers by its
colour and the transverse arrangement of its fibres. It contains bundles of elastic
fibres and collagen. The smooth muscle component is responsible for variations in
the tone of the vessel wall. The external elastic lamina separates the tunica
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adventitia from the tunica media and its function is to determine the elasticity of
the artery.

The tunica intima is the inner layer of the blood vessel which is extremely thin. It
consists of a single layer of endothelial cells separated from the internal elastic
lamina by a thin layer of mixed cells. These endothelial cells are in direct contact
with blood flow and have multiple functions such as preventing platelet
aggregation and thrombosis. They regulate the smooth muscle tone and they also
control the entry of lipoproteins into the vessel wall.

2.3 The Abdominal Aorta

2.3.1 General Overview
The aorta is the largest artery in the body. It becomes the abdominal aorta on
passing through the aortic hiatus of the diaphragm, in front of the lower border of
the body of the twelfth thoracic vertebra, descending in front of the vertebral
column and ending at the level of the fourth lumbar vertebra.
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Figure 2.1: The abdominal aorta

The aorta runs anterior to the spinal column and slightly to the left of the midline.
It bifurcates into the two common iliac arteries which in turn divide into the
internal and external iliac arteries. These vessels supply oxygenated blood to the
lower abdomen, pelvis and the legs.
As it lies upon the bodies of the vertebra, the curve which the aorta describes is
convex forward, the summit of the convexity corresponding to the third lumbar
vertebrae.
The abdominal aorta and its major arterial branches are highly elastic. During
systole, they expand rapidly to accommodate increased blood flow. The vessels

36

recoil during diastole and elastic fibres ensure that this contraction also serves to
drive blood through the arterial vessels.
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2.3.2 Branches of the Abdominal Aorta

These can be divided into visceral, parietal and terminal branches (table 2.1 and
figure 2.2). The visceral branches supply the organs in the abdomen, as well as the
kidneys and gonads. The parietal branches supply the diaphragm and the posterior
walls of the abdomen. The terminal branches supply the organs of the pelvis, the
pelvic wall and the paired common iliac arteries.

Visceral
Branches

Parietal Branches

Terminal
Branches

coeliac artery

inferior phrenic arteries

superior
mesenteric artery

lumbar arteries

right common
Iliac artery
left common Iliac
artery

inferior
mesenteric artery

median sacral artery

middle suprarenal
arteries
right and left
renal arteries
gonadal
arteries

Table 2.1: Classification of aortic branches
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Figure 2.2: The abdominal aorta and its branches

Of the visceral arteries the coeliac artery, the superior and the inferior mesenteric
arteries are unpaired. The suprarenal, renal, gonadal, inferior phrenic, lumbar and
all the terminal arteries are paired.
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The coeliac artery arises from the anterior aspect of the aorta below the aortic
hiatus of the diaphragm. It divides into three branches the left gastric artery, the
hepatic artery and the splenic artery. The left gastric artery distributes branches to
the oesophagus and the cardiac orifice of the stomach. The hepatic artery divides
into the right and left hepatic arteries which supply the corresponding lobes of the
liver. The splenic artery supplies blood to the spleen and follows a course superior
to the pancreas.
The superior mesenteric artery also arises from the anterior aspect of the aorta and
supplies the whole length of the small intestine with the exception of the proximal
duodenum. It also supplies the caecum, the ascending colon and the proximal two
thirds of the transverse colon.
The inferior mesenteric artery supplies blood to the transverse colon, the
descending sigmoid colon and the majority of the rectum. It arises from the
infrarenal aorta roughly 3-4cm above the iliac bifurcation.
The middle supra renal arteries arise from either side of the aorta and supply the
anteromedial portion of the suprarenal glands.
The renal arteries arise from either side of the aorta below the level of the superior
mesenteric artery. The right renal artery is longer than the left. Before reaching the
kidney each renal artery often divides into several branches which lie between the
renal vein and the urethra. It is possible for one or two accessory renal arteries to
exist, especially on the left side as they usually arise from the aorta and may come
off above or below the main artery. Instead of entering the kidney at the hilum,
they usually pierce the upper or the lower part of the organ.
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The gonadal arteries arise from the anterior aspect of the aorta approximately at
the level of the renal arteries. They pass obliquely over the urethra and the lower
part of the external iliac artery to reach the internal inguinal ring. Once they pass
through here they accompany the other constituents of the spermatic cord along
the inguinal canal to the scrotum in the male or in the female they pass inwards
between the two layers of the ovariopelvic ligament and the broad ligament of the
uterus to the ovary.
The lumbar arteries arise from the posterior wall of the aorta commonly existing
as four pairs of vessels. Muscular branches are supplied from each lumbar artery.
The middle sacral artery arises from the posterior aspect of the aorta just before it
bifurcates into the right and left common iliac arteries. It descends near the
midline in front of the fourth and the fifth lumbar vertebrae, the sacrum and the
coccyx to the glomus coccygeum. Branches pass to the posterior surface of the
rectum, at the last lumbar vertebrae it anastomoses with the lumbar branch of the
iliolumbar artery, in front of the sacrum it anastomoses with the lateral sacral
arteries and sends offsets into the anterior sacral foramina.
The aorta divides into the right and the left common iliac arteries at approximately
the level of the fourth lumbar vertebra (figure 2.2).

2.4 The Lower Limb Arterial System

2.4.1 General Overview
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The common iliac arteries (CIA) arise from the bifurcation of the aorta and in turn
divided into two branches at the brim of the pelvis. The external and internal iliac
arteries (IIA) as in figure 2.2. The IIA supplies the pelvic viscera and the
musculature via their visceral and parietal branches.
The external iliac artery (EIA) gives rise to the inferior epigastric artery and the
deep circumflex iliac artery, then passing inferolaterally along the medial border
of the psoas major muscle from the common iliac bifurcation to the inguinal
ligament, midway between the anterior superior spine of the ilum and the
symphysis pubis where it enters the thigh to become the common femoral artery
(CFA) as described in figure 2.2.
The CFA branches in to 2 major arteries (figure 2.2) the profunda femoris artery
(PFA) also known as the deep femoral artery and the superficial femoral artery
(SFA).
The PFA runs posterolaterally and supplies the musculature of the thigh. It does
not leave the thigh, communicating with the popliteal artery (PA) at the level of
the adductor canal through collateral vessels.
The SFA (figure 2.2) supplies the greater part of the lower extremity. It runs as a
single trunk from the upper thigh to the lower border of the popliteus muscle
(figure 2.3). It passes down the front and medial side of the thigh and ends at the
junction of the lower one third of the thigh where it passes through an opening in
the adductor magnus muscle to become the PA (figure 2.4). The PA lies within the
adductor canal coursing posteriorly into the popliteal fossa behind the knee.
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Figure 2.3: The arteries in the thigh
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Figure 2.4: The arteries below the knee
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The PA supplies blood to the knee joint and muscles of the calf through numerous
smaller branches. It branches into the anterior tibial artery (ATA) and the tibio
peroneal trunk (TPT) below the knee joint (figure 2.4).
The ATA arches over the upper edge of the tibio fibular interosseous membrane to
enter the anterior compartment of the lower leg (figure 2.4). It is positioned
anterolateraly in the calf between the tibia and the fibula, supplying the extensor
muscles of the foot. It crosses the ankle on the anterior aspect of the foot to
become the dorsalis pedis artery (DPA).
The tibio peroneal trunk (TPT) is a continuation of the popliteal artery after it
gives rise to the ATA. It bifurcates into the posterior tibial artery (PTA) and the
peroneal artery (PER) within a few centimetres of the origin of the ATA (figure
2.4).
The PTA (figure 2.4) supplies the flexor muscles on the medial aspect of the calf.
It lies behind the medial malleolus and has multiple small branches. The PTA
carries blood to the posterior compartment of the leg and the plantar surface of the
foot were it gives rise to the medial and lateral plantar artery. The PER artery runs
deeper than and more lateral than the PTA (figure 2.5). It lies in the deep posterior
compartment just medial to the fibula. The PER divides on the lateral aspect of the
foot to form the external maleolar artery, the lateral tarsal artery, and the external
plantar artery.
Collectively the ATA, PTA and PER artery are all known as the crural arteries or
the tibial vessels.
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Figure 2.5: The arteries in the foot
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2.5 The Extracranial Carotid Arteries
2.5.1 General Overview
The blood supply to the brain is via the two internal carotid arteries (ICA) and the
two vertebral arteries. The aortic arch gives rise to the brachiocephalic artery
which travels superiorly and bifurcates into the right common carotid artery
(CCA) and the right subclavian artery at the right sternoclavicular junction. The
left CCA arises directly from the aortic arch. The CCA’s divide into the ICA and
external carotid arteries (ECA) at the level of the upper border of the thyroid
cartilage.

Figure 2.6: The extracranial carotid arteries
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2.5.2 The Internal Carotid Artery
The majority of the anterior circulation to the brain and the eyes is supplied by the
right and left ICA’s (figure 2.7). The ICA has no extracranial branches and is
usually larger in calibre than the ECA. As the ICA passes intracranially it ascends
in a series of curves; this section is referred to as the carotid siphon. It is at this
point that the ICA gives off one of its most important branches, the ophthalmic
artery which supplies blood to the eye. Branches of the ophthalmic artery supply
all the structures in the orbit as well as some structures in the nose, face and
meninges.
The ICA ascends and finally divides into the middle cerebral artery and the
anterior cerebral artery (figure 2.8). The right and the left anterior cerebral arteries
are connected by a small vessel called the anterior communicating artery.
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Figure 2.7: The internal carotid artery

Figure 2.8: The intracranial carotid circulation
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2.5.3 The External Carotid Artery
The right and the left ECA’s supply the exterior of the head, the face and the
greater part of the neck (figure 2.9). It usually lies anterolateraly and is more often
than not of smaller calibre than the ICA. The ECA has numerous branches;
however it is usually only the first branch, the superior thyroid artery that is
visualised during a colour duplex ultrasound (CDU) scan.
Its multiple branches become important collateral pathways when an ICA or
vertebral artery occlusion occurs. The ECA branches that are of most importance
in the formation of collateral pathways are those that communicate with the
ophthalmic artery and those that interconnect between the muscular branches of
the occipital and vertebral arteries.

Figure 2.9: External carotid artery and its branches
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2.5.4 The Vertebral Arteries
The posterior circulation to the brain is via the right and the left vertebral arteries
(figure 2.10). These vessels originate from the subclavian artery and course within
the foramina transversarium of the upper cervical vertebrae entering the
subarachnoid pace at the side of the medulla oblongata at the level of the atlantooccipital interspace. They continue cephalad and anteriorly until they reach the
pontomedullary level were they join to form the single basilar artery (figure 2.11).
The basilar artery ascends towards the brain and divides into the posterior cerebral
artery and the posterior communicating artery (figure 2.8). The right and left
communicating arteries, the right and the left middle cerebral arteries, the right
and the left anterior cerebral arteries and the anterior communicating artery all
constitute a structure called the circle of Willis (figure 2.11), which may or may
not constitute a complete circle.
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Figure 2.10: The vertebral arteries

Figure 2.11: The circle of willis
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Chapter 3

Pathology and Physiology of Vascular Disease

53

3.1 Atherosclerosis
Atherosclerosis is a systemic disease affecting the entire arterial tree, it is
characterised by endothelial dysfunction, vascular inflammation and the build up
of lipids such a cholesterol, calcium and cellular debris within the intima of the
vessel wall (figure 3.0). This complex series of events results in the formation of
atherosclerotic plaque which may significantly reduced the patent lumen of any
vessel, thus creating abnormalities in blood flow through the vessel and a
decreased oxygen supply to the tissues supplied by that vessel.

Figure 3.0: Atherosclerosis of an arterial Wall
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Diminished blood flow to a particular tissue or organ manifests as a reduction in
its normal function. Thus a decrease in blood flow and oxygen to the heart may
result in a heart attack, if the blood flow to the brain is affected the patient may
suffer a stroke and a decrease in blood flow to the lower limbs may lead to
claudication or ultimately limb loss. Symptoms usually occur when the lesions
become advanced and complicated by haemorrhage into plaque, emboli or
thrombosis.
There are a number of risk factors that predispose to the pathogenesis of
atherosclerosis, although the general consensus appears to be that atherosclerosis
is governed by the interaction of genetic and environmental factors, which have an
effect on the arterial tree.
Atherosclerosis initially affects the intima of the artery where there is a build up of
fatty deposits in the intima as “foam cells”. These are monocytes, (white blood
cells) which absorb cholesterol. Early build up of plaque is often referred to as
fatty streaks (figure 3.1). The disease is contained within the wall and the
endothelium covering the plaque remains intact. As the plaque develops and
increases in thickness it maintains a homogenous appearance. The plaque
gradually develops into a complex structure (figure 3.2). This leads to a
breakdown in the endothelium covering the plaque, exposing the underlying tissue
of the vessel wall, leading to platelet aggregation and the formation of thrombus.
Atherosclerotic lesions tend to be localised and occur at common sites along the
arterial tree such as bifurcations of the common carotid artery (CCA) and the
common femoral artery (CFA) due to the turbulent flow that can occur at these
sites.
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Fatty Streak

Figure 3.1: Initial stages of atheroma

Narrowed
lumen of
the artery
Extensive
Plaque

Figure 3.2: Extensive plaque
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Figure 3.1 demonstrates the initial stages of atherosclerosis along an arterial wall.
This build up of atheroma does not limit the flow through the vessel. This
atheroma eventually develops into extensive plaque (figure 3.2) greatly reducing
the lumen of the vessel, inevitable resulting in decreased flow and increased
pressure through the vessel and may become a source of emboli.
3.1.1 The Causes and Effects of Atherosclerosis

Atherosclerosis is thought to be caused by damage to the endothelium of the
vessel wall, although the underlying mechanism may vary, it is the resulting
endothelial injury that is the common initiating factor in the development of the
disease.

Risk

factors

such

as

cigarette

smoking,

hypertension

and

hypercholesterolemia have been implicated in its cause. When the vessel lumen is
reduced by 50% or greater (figure 3.2) the flow through the vessel may become
compromised.

3.1.2 Risk Factors for Atherosclerosis
The most commonly recognised risk factors associated with the development of
atherosclerosis

are

tobacco

smoking,

diabetes,

hypertension,

hypercholesterolemia, low density lipoprotein, high homocysteine levels, family
history, obesity and gender. The majority of these risk factors are modifiable and
essential to reverse the effects of atherosclerosis or at least control the effects.
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3.2 Peripheral Arterial Disease

3.2.1 Introduction
The peripheral vascular system refers to the blood vessels in the body which are
located outside of the heart and the brain. Peripheral arterial disease (PAD) refers
to the restriction of blood flow to the legs and in rare cases the arms due to a build
up of plaque along the arteries of these limbs. PAD is often asymptomatic, under
recognised and undertreated when compared with other cardiovascular diseases
(Lovell et al., 2009). There are several possible causes of lower extremity arterial
disease such as atherosclerosis (by far the most common), thromboangiitis
obliterans (Buerger’s disease) vasculitis, arterial trauma, popliteal arterial
entrapment and cystic adventitial disease.
Patients presenting with PAD may suffer with a wide range of symptoms
depending on the severity of the disease. As with any condition the baseline
assessment for PAD is by history taking and physical examination. Ankle brachial
pressures (ABI’s) are then carried out to quantify the extent of disease present
prior to further investigation with colour Duplex ultrasound (CDU), magnetic
resonance imaging (MRI) or conventional angiography to further define the extent
and localisation of the disease.
PAD can take many forms; mild PAD may be initially asymptomatic progressing
to pain exacerbated by exercise, severe PAD manifests as rest pain, ischemic
ulcers and gangrene.
Treatment of PAD usually varies depending on its severity and extent. Mild PAD
may be treated with risk factor modification, exercise and pharmacological
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treatment. However, severe PAD may require surgical or radiological intervention
to relieve symptoms and prevent amputation.
Mortality rates for PAD may be as high as coronary artery disease and
cerebrovascular disease (CVD) and it is common for all three conditions to coexist together. The presence of symptomatic PAD confers a threefold risk of
cardiovascular death relative to the general population (McDermott. 2006).

3.2.2 Aetiology
The prevalence of PAD increases markedly with older age and in persons with
diabetes or a history of smoking; prevalence also is elevated in persons with
hyperlipidaemia, hypertension or chronic renal disease (McDermott. 2006).

3.2.3 Signs and Symptoms
In most cases the first sign of PAD is lower limb claudication, also referred to as
“intermittent claudication”. This is described as pain or discomfort in the leg,
exacerbated by exercise and relieved by rest. Pain develops when the exercising
muscle is unable to meet the requirements of increased metabolic activity due to
inadequate blood supply. The location of the pain usually predicts the location of
the arterial disease. Aorta iliac disease will usually cause pain in the buttock or
thigh region with femoral popliteal disease usually causing pain in the calf region.
As the disease progresses the distance that the patient can walk before they
experience pain (the claudication distance) becomes progressively shorter.
A large number of trophic changes may occur in the appearance of a patient’s limb
with severe arterial insuffiency. The skin becomes pale and shiny with loss of hair
and nails become brittle. The limb will be cold and capillary refill time prolonged.
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In advanced disease ulcers will occur in areas of pressure such as the heel
malleolus or the toes. Gangrene may also occur (figure 3.3). As tissue dies
because of an insufficient blood supply, gangrene classically begins in the tissue
bed furthest away from the heart, i.e. at the tips of the toes and over pressures
points.

Figure 3.3: A patient’s foot with gangrene

Critical limb ischemia is the term given to the presence of ischemic rest pain and
tissue loss, i.e. non healing ulcers and gangrene. Critical ischemia will progress to
major limb loss unless reversed. Rest pain, usually described by the patient as foot
pain in bed which is present at night, relieved by placing the foot in a dependent
position usually over the side of the bed. An ankle systolic pressure of less than
50mmHg or, a toe systolic pressure of less than 30mmHg or both will often be
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present. Critical limb ischemia may be acute but in the majority of cases its
chronic as a result of progressive disease. The development of critical limb
ischemia usually involves multiple sites of arterial obstruction or occlusion. Acute
lower limb ischemia may be caused by embolisation of thrombus from a more
proximal vessel. Thrombus (figure 3.4) may arise from any part of the arterial tree
commencing in the left atrium. This thrombus travels distally and occludes one or
more vessel in the lower limb. Presentation is always acute with the patient
presenting with a pale, cold, painful limb which may become paralysed as the
ischemia progresses.

Thrombus

Patent
Lumen of
AAA

Figure 3.4: A large core of thrombus within an AAA

61

3.2.4 Diagnosis
The baseline investigation for patients suffering from PAD is the ankle brachial
pressure index (ABI). This technique is non invasive and reproducible, providing a
rapid and quantitative assessment of the arterial disease of the entire limb above
the ankle. Exercise tests can stress the patient’s resting ABI to further quantifying
the disease.
Toe brachial indices (TBI’s) are a useful investigation, particularly in diabetics
whose pedal vessels are often spared the calcification that can affect the tibial
arteries causing them to be incompressible, thus rendering the standard ABI
reading to be falsely elevated. The clinical measurement protocol for the
performance of ABI and TBI’s is detailed in Chapter 5.0 section 5.1.4 and 5.1.7.

3.2.5 Treatment
The majority of patients with PAD can be treated conservatively with lifestyle
changes and medication. A systematic review of patient’s risk factors is necessary
for the appropriate management to be instigated. Treatment of PAD can ultimately
be divided into three categories depending on the severity and the extent of the
disease and its affect on each patient. These categories are risk factor modification
and lifestyle change, pharmacological intervention and invasive strategies.
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Risk factor Modification and Lifestyle Change

The development of PAD is associated with similar risk factors to other
atherosclerotic diseases such as coronary artery disease and carotid artery disease
(CAD).
Diabetic control: The risk of atherosclerotic disease is markedly increased in
patients with diabetes; the increased risk is independent of, and additive to other
cardiovascular risk factors (Marso and Hiatt. 2006). Atherosclerosis is responsible
for most of the death and disability in patients with diabetes, particularly type 2
diabetes (Marso and Hiatt. 2006). Diabetic atherosclerosis is more diffuse, more
severe and manifests itself at an earlier age. Atherosclerosis is more aggressive in
diabetic patients and often involves the tibial and micro vessels making it more
difficult to treat. The risk of amputation in diabetic patients is 15 to 46 times
higher than in non diabetics (Yesil et al., 2009). Aggressive glycaemic control is a
mandatory part of managing diabetics with PAD.
Smoking cessation: Cigarette smoking has been shown in the Framingham study
to increase the risk of PAD in both males and females, with heavy smokers
showing a fourfold risk of developing PAD. Smoking cessation is associated with
a rapid decline in the incidence of PAD. The risk for ex smokers 1 year after
quitting is approximately the same as that for non smokers (Groechenig. 2003).
Hypertension: Elevated blood pressure is a well established risk factor for
mortality, cardiovascular and cerebrovascular events. Approx half of the patients
with PAD have elevated blood pressure. Prolonged increased blood pressure is
associated with increased risk of heart attack and stroke (Henry et al., 2002)
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Cholesterol Lowering: Many randomised control trials have assessed the impact
of cholesterol lowering on cardiovascular events in people with PAD. In the
LEADER study, 1568 men with PAD were randomised to either bezafibrate
400mg daily or a placebo. Treatment with bezafibrate had a positive outcome on
the incidence of non fatal coronary events but did not reduce the incidence of total
fatal and non fatal cardiovascular events. The authors concluded that all PAD
patients with a total cholesterol level of greater than 3.5mmol/l should be treated
with a statin (Meade et al., 2002).
Weight reduction: Obesity, defined as a body mass index of greater than 30Kg/m2
has been associated with an increase risk of cardiovascular mortality.
Aggressive modification of the aforementioned risk factors will lower the need for
intervention and lower the risk of limb loss. It is well documented that smoking
cessation alone significantly reduces the likely hood of amputation and may
increase the patients walking distance and ankle brachial pressure measurement
(Dieter et al., 2002).
Lifestyle changes
Exercise: Any form of physical activity will maintain health, lower blood pressure
aid in weight reduction and promote a general sense of well being. For individuals
with diabetes and PAD, physical activity in the form of walking is recommended
because success in treatment of PAD may be measured in distance walked without
pain. Clinical trials have shown that supervised exercise programmes in patients
with symptomatic claudication, are effective in increasing walking time when
compared to standard care (Leng, Fowler and Ernst. 2000). Higher levels or longer
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duration of physical activity is related to longer survival and lower risk of death
from cardiovascular disease among PAD patients (Garg et al., 2007).
ii.

Pharmacological Intervention

Medical therapy for patients suffering with PAD is mandatory to reduce blood
pressure, cholesterol and plasma glucose as these cannot be achieved with lifestyle
changes alone. Antiplatelet therapy such as aspirin should be instigated to reduce
the risk of stroke, or vascular death. Statin therapy may be indicated in patients
with elevated low density lipoprotein (LDL) cholesterol. Antihypertensive therapy
should be prescribed in patients with elevated blood pressure to achieve a goal of
less than 140/90mmHg for individuals without diabetes and, 130/80 mmHg for
patients with diabetes and renal disease to minimise the risk of stroke, heart attack
and cardiovascular death.
iii. Invasive Strategies
In a minority of patients lifestyle changes and medication alone are not sufficient.
In these cases intervention is inevitable for limb salvage. Such intervention may
include angioplasty, stenting or surgical bypass of the diseased vessel.
Angioplasty is an endovascular procedure that may be used to dilate a stenosed or
occluded blood vessel. A catheter with a deflated balloon on its tip is passed over
a guide wire into the stenosed arterial segment (figure 3.5, step A). The balloon is
then inflated to open up the narrowed segment and the catheter is withdrawn as
demonstrated in figure 3.5 steps B and C.
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Figure 3.5: Balloon angioplasty of a narrowed artery

A stent may also be deployed at this stage to prevent restenosis of the treated
vessel. A stent may be described as a cylindrical wire mesh tube (figure 3.6, A).
The stent is deployed in the segment of the vessel that has undergone angioplasty
(figure 3.6, B); it will remain in this position maintaining the patency of the vessel
(figure 3.6, C). Figure 3.7 demonstrates how a patent stent appears within an
artery.

66

Figure 3.6: Arterial stenting technique

Stent within
and artery
CDU image

Figure 3.7: A CDU image of a stent deployed in an artery
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Lower limb reconstruction is achieved by surgically bypassing the diseased
portion of the artery with a segment of vein or a synthetic graft. Bypass surgery is
usually indicated when the stenosed or occluded artery is not amenable to
angioplasty or stenting. The graft is anastomosed proximal to the diseased
segment of artery (figure 3.8). Thus, it provides an alternative route for the blood
to flow around the blocked or narrowed segment of artery and supply blood to the
lower limb. Surgical intervention requires regular surveillance with ABI’s and
CDU in order to ensure patency of the graft.

Surgical Bypass

Diseased Artery

Figure 3.8: Surgical bypass of a diseased artery
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3.2.6 Lower Limb Amputation
In very rare cases limb loss occurs despite attempts at revascularisation. The risk of
a person with claudication progressing to critical ischemia resulting in amputation
is as low as 1% per year (Transatlantic inter society consensus document). In these
cases intervention usually occurs as a result of multiple diseased arteries in the
lower limbs (Leiner et al., 2003). Patients that present with critical limb ischemia
have a one year amputation rate of 30% and a mortality rate of 25% (Feiring et al.,
2010).The need for amputation is 5-10 times higher in diabetic patients than those
without diabetes (Norgren at al., 2007). However, a large portion of patients that
are diagnosed with PAD never need to undergo any form of intervention.
The main aims of amputation of a major limb are removal of diseased tissue,
obtaining adequate pain relief and achieving healing of the amputation at the
chosen level to facilitate construction of a stump which will allow the amputee to
mobilise on a prosthetic limb.
The majority of lower limb amputations are performed for vascular and infectious
complications of diabetes mellitus, 15-35% of these patients will lose a second leg
within 5 years (High et al., 1984).
Amputations are performed at the level at which healing is most likely to occur
and permit the most effective use of the limb after surgery. However, despite
successful amputation of a limb complications can occur late in the recovery phase
inhibiting the patient’s ability to use their prosthesis.
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3.3 Carotid Artery Disease
3.3.1 Introduction
Stroke is the third leading cause of death in the world. The world health
organisation in 2007 documented that 15 million people suffer a stroke worldwide
each year, 5 million die and another 5 million are left permanently disabled. It is
the most common life threatening neurological disease and the leading cause of
adult disability in Europe (Higashida and Meyers. 2006).
Europe averages approximately 650,000 strokes per year. In developed countries,
the incidence of stroke is declining which the world health organisation feels is
largely due to efforts to lower blood pressure and increase smoking cessation.
However, the overall rate of stroke remains high due to the ageing population.
Transient Ischemic attack or TIA’s as they are more commonly known have a
prevalence of 5 per 1000 of the population. Between 10-12% of this group of
patients will go on to develop a stroke within the first week of their TIA (Gulli,
Khan and Markus. 2009). A TIA is defined as the complete resolution of focal
cerebral ischemia symptoms within 24 hours (Zweibel, Fifth edition, 2005, page
107). After a TIA, the risk of stroke is 12-13% during the first year and increases
to 30-37% within 5 years (Henry et al., 2000). Patients who have suffered a TIA
have a 13 fold risk of stroke during the first year and a 7 fold risk over the first 7
years compared with people without TIA’s (Dennis et al., 1990).
The national institute of neurological disorders and stroke suggests that one third
of patients who suffer a TIA will go on to have an acute stroke in the future.
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3.3.2 Aetiology
A stroke may be due to cerebral ischemia or cerebral haemorrhage. Ischemia
occurs due to an arterial occlusion or stenosis and haemorrhage due to rupture of
an artery. Differentiation cannot be made on clinical exam alone cerebral imaging
such as computed tomography (CT) or magnetic resonance imaging (MRI) is
necessary in order to definitely establish a diagnosis. The current recognised
ischemic stroke mechanisms are embolism, decreased perfusion and thrombosis.
Embolism to the brain may be cardiac or arterial in origin.
Plaques present in the aortic arch can act as a source of atheroembolic embolism.
A transoesophageal echo will allow detection of these plaques, the presence of
which is an established risk factor for ischemic stroke being associated with a 2.5
to 9 fold increase in the stroke risk in case controlled studies (Tullio et al., 2009).
Treatments with oral anticoagulants, antiplatelet agents or surgery to remove the
plaque are all options. The presence of severe stenosis in the carotid arteries and
basilar artery may lead to stroke due to perfusion failure. Carotid artery stenosis is
generally thought to induce stroke by either compromising cerebral perfusion or
by embolic phenomena. Intracranial atherosclerosis accounts for 29% of all
ischemic events (Higashida and Meyers. 2006). Ninety percent of all extracranial
carotid lesions are due to atherosclerosis (Singh, O’Donnell and Gillespie. 2010).
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3.3.3 Signs and Symptoms
The main presenting signs and symptoms are focal and non focal symptoms which
may be transient or permanent, carotid bruits and anatomical abnormalities

i

Focal and Non focal symptoms

Focal symptoms only relate to one side of the body and are usually called
lateralising. They may be attributed to problems in only one of the hemispheres
relevant to the anterior circulation. Focal brain ischemia occurs when a blood clot
has occluded a cerebral vessel, thus reducing the blood flow to that particular
portion of the brain and increasing the chances of cell death in that area. Focal
symptoms include transient blindness in one eye (amaurosis fugax), speech
disturbances and loss of power to one arm or leg or even loss of power to one
complete side of the body.
Non focal symptoms are difficult to assign to one particular side of the brain. They
may be associated with the posterior circulation or the brain stem resulting from
vertobasilar disease. Non focal symptoms may be dizziness, ataxia, syncope,
confusion and bilateral vision loss.
ii

Carotid Bruit

A carotid bruit is a systolic sound heard over the carotid arteries during physical
examination of the patient, it occurs as a consequence of the turbulent flow within
the artery which can be due to either a stenosis or a tortuous carotid artery system.
It is very unreliable clinical sign.
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iii Altered Anatomy
Visible or palpable pulsitile swellings at various sites may indicate the presence of
an aneurysm or pseudo aneurysm which may give rise to cerebrovascular
symptoms if left untreated. The carotid bifurcation is a common site of carotid
artery aneurysms and carotid body tumours (figure 3.9) may occur typically within
the bifurcation splaying the vessels apart as it enlarges.

Carotid bifurcation
A CBT splaying the
carotid bifurcation

Figure 3.9: A carotid body tumour

Figure 3.9 illustrates a typical carotid body tumour that is lying between the
internal carotid artery (ICA) and the external carotid artery (ECA) at the carotid
bifurcation and splaying the vessels around the tumour.
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3.3.4

Clinical Assessment

An acute onset focal neurological deficit must be regarded as a stroke or TIA until
proven otherwise. A rapidly performed brain CT will exclude haemorrhage. It is
thought that ~50% of all ischemic, carotid territory TIA’s or stroke occurs as a
consequence of thrombo embolism or atheroembolic debris from extracranial
carotid lesions (Silvennoinen et al., 2007). Transient monocular blindness
sometimes referred to as amaurosis fugax is typically described by patients as a
transient shadow or curtain obscuring all or part of the visual field in one eye
(Cole, Norris and Walker. 2001). This may last only a few seconds or may persist
for several hours; it may be caused by an embolism into the ophthalmic artery
which is the first major branch of the intracranial portion of the ICA.
Embolisation from the ICA commonly leads to a temporary or permanent focal
neurological deficit in the middle cerebral artery territory. Emboli from the ICA
may enter the middle cerebral artery and less commonly enters the anterior
communicating artery. Patients that present with typical carotid artery territory
symptoms may benefit from intervention.
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3.3.5 Treatment of Carotid Artery Disease

i

Carotid Endarterectomy

The aim of carotid artery intervention is to prevent cerebrovascular events in the
ICA territory. Approximately 15-20% of stroke patients report a previous TIA, the
time window for prevention of a stroke is small with over 40% of TIA’s occurring
during the week preceding the stroke (Rothwell. 2008).
Multiple studies have shown that symptomatic patients with a >70% ICA stenosis
will benefit from a carotid endarterectomy (CEA) and thus reduce the risk of a
subsequent ipsilateral stroke.
The North American Symptomatic Carotid Endertrectomy Trial (NASCET) which
included data from 50 clinical centres around the United States and Canada
demonstrates the benefits of surgery in patients with an ICA stenosis of between
70-99% who have suffered a recent TIA or stroke. It randomised 2226 patients
with a symptomatic ICA stenosis to medical care or CEA. Patients had their TIA
or stroke within 4 months of enrolment and were categorised into the 30-69%
group and the 70-99% group. For patients in the greater than 70% stenosis group,
CEA reduced the risk of any ipsilateral stroke from 26% to 9% at 2 years (North
American Symptomatic Carotid Endertrectomy Trialists’ Collaborative Group.
1991).
The Asymptomatic Carotid Atherosclerosis Study (ACAS) demonstrated the
benefits of surgery for a stenosis greater than or equal to 60% with low rates or
preioperative complications. This trial randomised 1662 asymptomatic patients
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with a 60% or greater ICA stenosis to CEA and medical therapy or medical
therapy alone (Moore et al., 1998).
CEA reduced the estimated risk of ipsilateral stroke or death from 11% to 5.1%.
These findings led to a major increase in the number of CEA’s performed in
asymptomatic patients in the United States, in contrast the ACAS results had little
effect on the number of CEA’s performed in other countries such as the United
Kingdom, where it was felt that the benefit did not justify the cost. It was
estimated that 40 operations were needed to prevent 1 disabling or fatal stroke
after 5 years. (Rothwell and Goldstein. 2004).
The Asymptomatic Carotid Surgery Trial (ACST) published in 2004 was an
international multicentre randomised trial set up to compare the efficacy of CEA
performed in conjunction with medical therapy with that of medical therapy alone
in prolonging stroke free survival time in patients with asymptomatic ICA
stenosis. Patients were included in the study if they had either a unilateral or
bilateral ICA stenosis considered for surgery, who had experienced no symptoms
of TIA or stoke within the past 6 months, had no history of disabling stroke and
had no contraindication for CEA. The authors concluded that at 5 years the risk of
stroke or death in the CEA group was 6.4% when compared to 11.8% in the best
medical management group. They also demonstrated that asymptomatic patients
were less likely to have a fatal or disabling stroke, 3.5% in the CEA group when
compared to 6.1% in the best medical therapy group (Hallinday and Mansfield.
1994)
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The ACST study confirmed the findings of the ACAS trial. ACST confirms the
overall benefit from surgery in patients with asymptomatic ICA narrowing of 6099% with the most benefit noted in patients under the age of 75 years.

Digital subtraction angiography (DSA) has long been considered the gold standard
method of assessing carotid artery stenosis. CDU, MRI and CT are now all widely
accepted methods of assessing the extracranial carotid arteries with a lower risk to
the patient. Due to the risk of morbidity and mortality associated with the invasive
procedure of cerebral angiogram most centres have employed the use of the noninvasive method of CDU in the detection and grading of carotid artery stenosis.
CDU has a sensitivity of 98% and a specificity of 88% when compared with
angiography (Jahromi et al., 2004).When CDU is inconclusive an MRA or CT
angiogram maybe performed and DSA is now only used when there is discordance
between two imaging modalities.
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ECA post CEA

ICA post CEA
CCA

Figure 3.10: The carotid bifurcation after CEA
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ii.

Carotid artery stenting

With advantages such as being less invasive, no neck incision, no risk of cranial
nerve injury and a shorter hospital stay, carotid artery stenting was thought to play
a huge role in carotid artery surgery. However, a consensus has not yet been
established. A Cochrane review carried out in 2007 showed that there was no
significant difference in late stroke risk and they subsequently concluded that there
was no current data to support a move away from the traditional method of
surgery CEA.
In 2006, results of a randomised control trial for carotid stenting versus CEA in
symptomatic patients, the Stent-Supported Percutaneous Angioplasty of the
Carotid Artery versus Endarterectomy (SPACE) trial failed to demonstrate the
advantages of carotid artery stenting over CEA. This study of over 1200 patients
showed a higher rate of ipsilateral ischemic stroke and death at 30 days in patients
undergoing carotid artery stenting. The trial concluded that there was no evidence
to justify the widespread use of carotid artery stenting for the treatment of CAD.
The international carotid stenting study (ICSS) also compared carotid artery
stenting to CEA in symptomatic patients. The authors demonstrated that a higher
incidence of stroke and death with stenting when compared to CEA. These results
were consistent with those found in the SPACE trial. However they also
documented that carotid artery stenting was more costly than CEA, and concluded
that it should perhaps be reserved for a select group of patients for whom CEA
cannot be offered (Paraskevas. 2010).
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3.4 Abdominal Aortic Aneurysms
3.4.1 Introduction
Abdominal Aortic Aneurysms (AAA’s) are the end result of a mutifactorial
disease process affecting a high proportion of our elderly population. Ruptured
AAA’s are among the tenth leading causes of death in elderly males and about
half of all patients with an AAA can expect to die of rupture if their aneurysm is
not surgically treated (Siegel and Cohen. 1994). It is thought that between 4-11%
of the elderly population over the age of 60 has an AAA, they are rarely present in
persons under the age of 65 (Posacioglu et al., 2002). The general consensus from
the multiple screening studies that have been carried out is that AAA’s occur in 213% of males and 6% of females over 65 years of age and approximately 90% of
aneurysms discovered on screening programmes are less than 3.5cm. Only 3040% of aneurysms are noted on physical examination with detection dependent on
aneurysm size and limited by factors such as obesity. An AAA may be present in
85% of patients with femoral aneurysms and 62% of those with popliteal artery
aneurysms. However, only 14% of patients with an AAA will have a femoral or a
popliteal artery aneurysm (Chaikof et al., 2009).
The prevalence of AAA is increasing probably due to increased life expectancy.
AAA’s are often co-incidentally discovered on other examinations such as
ultrasound or CT being performed for other disease processes. They are clinically
silent and therefore rupture is often the first presentation. The mortality rate for
ruptured AAA’s is substantial, as many as 2 of 3 patients with ruptured AAA’s die
before reaching the hospital. Of the patients that reach hospital, as many as one
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fifth die before undergoing surgery and the overall in hospital mortality rate still
averages approximately 49% (Tan. 2010).
The discovery of an aneurysm at an early stage means that a patient can then be
entered into a surveillance programme and monitored closely for growth of the
AAA allowing consideration for repair of the aneurysm at the correct stage.
The term aneurysm is derived from the Greek word “aneurysma” meaning “a
widening”. With much variation in the literature as to the correct definition of an
aneurysm the following is perhaps the most widely accepted “An artery is
considered aneurysmal when its diameter equals or exceeds 1.5 times the normal
diameter of the artery in question”. The normal diameter of the aorta in the
majority of adults does not exceed 2cm and so it is considered aneurymsal at 3cm”
(Zweibel. 2005). Normal arterial diameter is dependent on factors such as age,
gender and body size so, by practical convention an aneurysm is defined as a
localised dilation of an artery at least 50% larger than the normal adjacent portion
of the same artery. (Rutherford, Fifth edition, page 1241). Diffuse enlargement of
several arterial sections along the arterial tree is referred to as “arteriomegaly”.
The majority of AAA (approximately 90%) occur below the origin of the renal
arteries and extend to the iliac bifurcation (Dobrin. 1989). Approximately 10% of
all aneurysms involve the renal arteries (Siegel and Cohen. 1994).
Surveillance of an AAA depends on its maximum transverse diameter or anterior
to posterior wall diameter and follow up periods may vary from centre to centre.
Recommended guidelines for surveillance of an infra renal AAA are summarised
in the following table.
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Maximum diameter of

Follow up period

AAA
2.6cm-2.9cm

5 yearly intervals

3.0cm-3.5cm

3 yearly intervals

3.5cm-4.4cm

1 yearly interval

4.5cm-5.4cm

6 monthly intervals

Table 3.1: Recommended surveillance for abdominal aortic aneurysms
(Chaikof et al., 2009)
Maximum AAA diameter remains the most widespread criterion to assess AAA
rupture risk, but a variety of alternative parameters have been proposed as more
sensitive predictors of rupture risk including AAA expansion rate, increased
intraluminal thrombus thickening, wall stiffness, wall tension and peak AAA wall
stress. In the majority of cases surgery is usually considered when an aneurysm
reaches 5.5cm in males and 5cm in females. Table 3.2 summarises the risk of
rupture of an AAA.
Size of AAA

Risk of rupture

<4.0cm

Minimal

4.0cm-5cm

0.5-5%

5.0cm-6cm

3-15%

6.0cm –7cm

10-20%

7.0cm- 8cm

20-40%

>8.0cm

30-50%

Table 3.2: Risk of rupture of abdominal aortic aneurysms
(Brewster et al., 2003)
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Larger aneurysm enlarge rapidly were as smaller ones tend to expand very little.
The majority of smaller aneurysms grow at a rate of 0.3cm – 0.5cm per year
(Lederle. 2003). Rapid enlargement of the AAA between consecutive 6 monthly
visits is also an indication for urgent repair of an AAA.
CDU has become the method of choice for AAA screening and surveillance. The
methodology of AAA measurement is a constant source of debate with some
advocating outer wall to outer wall, inner wall to inner wall or outer wall to inner
wall.
Outer wall to outer wall is what surgeons see when operating, so perhaps this is
the correct method. The most important factor is that all measurements are
consistent and reproducible from visit to visit. Measurements are always taken and
compared from visit to visit in a transverse plane. Measurements taken in an axial
plane are thought to be overestimated and therefore should be avoided. This is due
to the fact that lateral borders are sometimes not clearly seen and the presence of
mural thrombus often makes it difficult to pick out the walls of the aorta
accurately.
As AAA’s are predominantly silent and asymptomatic, screening of a high risk
population of elderly patients for detection of an AAA is necessary for effective
treatment. The U.S Preventative Task Force recommends one time screening for
males 65-75 years of age who have ever smoked at least 100 cigarettes in their life
time. The Multi Centre Aneurysm Screen Study (MASS) suggested that there was
a 32% reduction in AAA related deaths in a screened population of men. The
Aneurysm detection and Management Veteran Affairs Cooperative study group
(ADAM) compared the long term follow up of patients. Those followed with
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surveillance and surgical intervention when the aneurysm reached 5.5cm versus
the immediate surgical repair of an AAA <5.5cm. No significant difference was
discovered between the two groups in terms of long term follow up and mortality
and thus the study concluded that there was no long term benefit to repairing
asymptomatic aneurysms less than 5.5cm. The United Kingdom Small Aneurysm
Trial (UKSAT) followed its 10,000 participants for a period of 10 years and also
documented no long term benefit to electively repairing asymptomatic AAA’s
greater than 5.5cm. Chaikof et al in 2009 recommended that one time ultrasound
screening for an AAA for all men at or older than 65 years, or as early as 55 years
in males with a family history of AAA. They also recommended that AAA
screening should be carried out in females greater than 65 years who smoked and
had a family history of AAA.
3.4.2 Etiology

i

Risk Factors

Risk factors such as advanced age, greater height; coronary artery disease,
atherosclerosis, hypercholesterolemia, hypertension, smoking and gender are
associated with a greater risk of developing an AAA (ADAM).
Smoking has been found to be the most significant factor associated with increase
in aneurysm size, more commonly the number of years the person has smoked
compared to the number of cigarettes smoked per day. A smoker has a sevenfold
increased risk of developing an AAA than a non smoker. Family members are also
at a greater risk of developing an AAA with a 12% to 19% of those undergoing
aneurysm repair having a first degree relative with an AAA (Chaikof et al., 2009).

84

AAA’s rarely affect people younger than 40 years of age, with a six fold greater
incidence in males than females (Chaikof et al., 2009). Other less common causes
of AAA’s can be infection, arthritis, cystic medial necrosis, trauma, inherited
connective tissue disorders.
ii

Signs, Symptoms and Diagnosis

The majority are asymptomatic and are largely discovered coincidently on other
examinations such as a routine clinical exam, x-ray, ultrasounds and CT’s
performed for other disease processes.
AAA’s rarely produce any definite signs, if the patient is thin a pulsation or a
swelling in their mid abdomen may be palpated, this would not be evident in
larger patients. Detection of an aneurysm during a physical exam depends on
factors such as body habitus with only 76% of aneurysm being noted on physical
exam being greater than 5cm, 3cm-3.9cm aneurysms are only palpated in 29% of
patients (Chaikof et al., 2009).
The major complications are due to rupture, thrombosis or embolism of some
thrombus from the aneurysm to the lower limbs causing ischemia. Patients
presenting with severe abdominal or back pain, hypotension and a pulsatile
abdomen would be of high suspicion for a ruptured AAA.
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3.4.3 Treatment of Abdominal Aortic Aneurysms
Aneurysms of the abdominal aorta can take many shapes and forms however, can
generally be classified according to their location, size, shape and etiology. The
shape of an aneurysm may be described as fusiform or saccular. However the size,
shape and extent of the aneurysm may vary quite significantly from patient to
patient.

Figure 3.11: A saccular and a fusiform aneurysm of the abdominal aorta

The aetiology is the most important consideration. Although the causes of most
aneurysms are known some are non specific. The majority of abdominal
aneurysms are atherosclerotic however congenital aneurysms associated with
arteritis and connective tissue abnormalities can occur.
These factors are taken into account along with the patient’s physical condition
and age when deciding which treatment is best for that patient. It is widely
documented amongst the literature that patients should be considered for AAA
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repair when their aneurysm reaches 5.5cm or when there has been a rapid increase
in the size of the AAA (>0.5cm) between consecutive 6 monthly visits with very
little evidence to support the treatment of aneurysms less than 5.5cm (UKSAT).
Two methods of AAA repair are widely practiced - open surgical repair and
endovascular aneurysm repair (EVAR).
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3.5 Open Surgical Repair
3.5.1 Introduction
Surgical aneurysm repair or “open” aneurysm repair is the traditional method of
choice for repair for AAA’s. The first described treatment of an aneurysm was
reported by Antyllus in the 2nd century who recommended ligating the artery
above and below the aneurysm and incising the sac and its contents. This method
remained the basis of direct arterial operations for the next 1500 years
(Rutherford. 2000).
The current technique of open AAA repair, replacing the aneurysmal aorta with a
portion of another artery or vein was devised in the early 20th century by the 1912
Nobel Laureat Alexis Carrell who only ever performed this procedure on an
animal (Dente and Feliciano. 2005).
In 1951 Charles DuBost reported the first replacement of an infra renal AAA. The
use of these homografts was ceased due to the risk of rupture and degeneration
that was associated with them. In 1954 Blakemore and Voorhees published their
results in 16 patients who had an AAA repair with a Vinyon N graft with a 56%
survival rate. In 1958 Michael DeBakey reported the use of a knitted Dacron Graft
to repair infra renal AAA in a number of patients.
The principle behind any procedure to treat an AAA is to prevent rupture of the
aneurysm by its exclusion from systemic circulation. Open repair achieves this
with an interposition synthetic graft. To date open repair has been reported to be
the most durable method of AAA repair. Elective surgical repair has been reported
to have a mortality rate of less than 5% compared to the 90% mortality rate of
ruptured AAA’s (Johansen et al., 1991).
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3.5.2 Technique
Prior to open surgical repair of an AAA a patient usually undergoes a CT scan to
determine the shape of the aneurysm and its relationship to the renal and iliac
arteries. If the aneurysm involves the iliac arteries or if the iliac arteries have
occlusive disease present then a bifurcated graft may be used with the distal
anastomosis onto either the iliac or the femoral vessels.
The aneurysm is usually approached via a midline transperitoneal approach
(Figure 3.12 & figure 3.13), although a transverse incision or a left retroperitoneal
approach have also been described. The small bowel is then displaced to the right
side of the abdomen to expose the base of the mesentery. The posterior
peritoneum is then incised from the ligament of treitz to the aorta bifurcation. This
excision can be extended further if the aneurysm involves some of or all of the
iliac arteries. Clamps are then placed on the distal vessels and the proximal aorta
to arrest blood flow through the aneurysm and ensure that the risk of distal
embolisation is minimal (figure 3.12). The aneurysm sac is opened longitudinally
and any thrombus that is present is evacuated.
The graft is then sewn into place (figure 3.12). The aneurysm sac is closed over
the graft to prevent contact of the graft and the intestines reducing the risk of
subsequent aorto-enteric fistula.
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Figure 3.12: Diagrammatic representation of open surgical repair
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Figure 3.13: An AAA exposed prior to open surgical repair
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3.6 Endovascular Aneurysm Repair
3.6.1 Introduction
EVAR involves the transluminal placement of a graft within the aneurysm that
completely excludes the aneurysm from the systemic circulation (figure 3.14). The
graft is held in place by a self expandable metal frame which supports the graft
and provides a seal proximal and distal to the aortic aneurysm. Once the graft is
fixed within the AAA it permits flow to only go through the graft and therefore
excludes the aneurysm from systemic circulation however, in contrast to open
surgical repair the native aneurysm remains in place.
The first reported series of endografts used in high risk patients was in 1991 by
Parodi and colleagues. Since then the use of endovascular grafts to repair AAA’s
has increased dramatically such that is no longer a novel technique to vascular
surgeons.
In the majority of cases the stent is deployed just below the renal arteries and as
close to the iliac bifurcation as possible, previously this precluded the repair of
aneurysms that commenced at or above the level of the renal arteries by
endovascular means. There are now commercially available devices which can
repair AAA’s that involve the renal arteries.
As deployment of an endovascular stent avoids the need for a laparotomy, cross
clamping of the aorta, ischemia reperfusion injury and the obvious reduced blood
loss associated with opening an aneurysm, EVAR rapidly became the method of
choice for AAA repair for the vast majority of vascular surgeons. It has also been
proven by large multicentre trials such as the Dutch Randomised Endovascular
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Aneurysm Management trail (DREAM) and the Endovascular Aneurysm Repair 1
and 2 trials (EVAR 1 and 2 trials) that EVAR has a lower 30 day post operative
mortality when compared to the open surgical method.

Figure 3.14: Deployment of an endovascular stent
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It is also possible to carry out other procedure at the same time of EVAR such a
femoral to femoral crossover grafts for bypassing iliac artery occlusions (figure
3.15).

Figure 3.15: Deployment of an aorta uni-iliac graft and femoral to femoral
crossover graft
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Figure 3.16: An endovascular stent deployed within an AAA

Figure 3.16 demonstrates an endovascular graft within an AAA. This patient
initially underwent EVAR repair of their aneurysm however, was later converted
to open repair due to complication referred to as endotension which is discussed
later in this chapter.
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There are a number of advantages to EVAR, other than the reduced 30 day
mortality making it the primary method of choice for AAA repair. The most
documented being the use of a small incision in both groins instead of the large
abdominal incision needed for open surgical repair, no need for a laparotomy or
prolonged clamping of the aorta, a reduced hospital stay and a quicker overall
recovery time (Visser et al., 2006).
However, as with all surgeries there are also a number of disadvantages to this
new technique and EVAR has its own unique set of complications. The
commonest of these complications being termed “endoleaks”.
The term endoleak was first described by White and colleagues in 1996.
Endoleaks are defined as the persistence of flow outside the lumen of the
endoluminal graft but within an aneurysm sac or adjacent vascular segment being
treated by the graft (Rutherford. 2000). Thus, the aneurysm is not completely
excluded from systemic circulation and is still at a risk of rupture because there is
an incomplete sealing or exclusion of the aneurysm sac which is evident on an
imaging modality.
Although EVAR is associated with other complications such as, stent migration,
infection, limb thrombosis leading to embolisation, separation of limbs and
endotension, it is the complication of endoleak that is the most common and most
troublesome. Thus patients whom have had endovascular repair need to undergo
lifelong surveillance.
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3.6.2 Classification of Endoleaks
Endoleaks are typically classified into one of four categories:
i.Type 1
Type 1 endoleaks represent an inadequate seal of the graft ends and thus the blood
flow into the sac originates at one of the attachment sites.
Type 1 endoleaks can be further divided into Type 1a (flow originating from the
proximal sealing zone) and Type 1b (flow originating from the distal sealing
zone). Separation of the graft from the arterial wall causing flow into the
aneurysm sac ultimately means the aneurysm has not been excluded from the
systemic circulation and thus is at risk of rupture.
Type 1 endoleaks may occur as a consequence of unsuitable anatomy such as an
angulated neck proximally or tortuous iliac arteries distally. They require
immediate attention. Figure 3.17 and 3.18 demonstrate a Type 1a and Type 1b
endoleak. A CDU image of a Type 1b endoleak is illustrated in a figure 3.22.
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Extra stent flow
originating from
the proximal
attachment site

Figure 3.17: Diagrammatic representation of a type 1a endoleak. Extra stent
flow can be seen originating from the proximal attachment site

Extra stent flow
originating from
the distal
anastomosis site

Figure 3.18: Diagrammatic representation of a type 1b endoleak. Extra stent
flow can be seen originating from the distal anastomosis site
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ii. Type 2
Type 2 endoleaks (figure 3.19 & 3.23) represent persistent flow into the aneurysm
sac from collateral circulation such as lumbar arteries or a patent inferior
mesenteric artery.
Flow is retrograde and these endoleaks are not graft related so a complete seal
around the attachment sites is maintained. However, as with Type 1 endoleaks a
direct communication with the systemic circulation is present when a Type 2
endoleak exists.
Type 2 leaks are the most common type of endoleak to occur following
endovascular repair and have been reported to occur in up to 20% of patients
following EVAR (Jones et al., 2007).
In the majority of cases they do not require immediate intervention, quite often
close monitoring for a residual sac size with the presence of a patent Type 2
endoleak is appropriate management.
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Flow originating
from a patent
collateral vessel
which is feeding
the residual sac

Figure 3.19: Diagrammatic representation of a type 2 endoleak

Flow can be seen originating from a patent collateral vessel which is feeding the
residual sac. Figure 3.23 demonstrates the appearance of a Type 2 endoleak on a
CDU image.
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iii. Type 3
Type 3 endoleaks occur when there has been a structural failure in the graft such as
stent fracture, the development of holes within the stent walls or junction
separations between the components of the modular device. Like Type 1
endoleaks, Type 3 are high pressure leaks and require urgent correction, otherwise
they are likely to lead to aneurysm sac expansion and rupture. Type 3 endoleaks
are rare however they may be become more apparent over time as more
information is gathered. Figure 3.20 below demonstrates a type 3 endoleak; flow
into the aneurysm sac can be seen originating from the left iliac limb attachment
site.

Flow into the
aneurysm sac can be
seen originating
from the left iliac
limb attachment site

Figure 3.20: Diagrammatic representation of a type 3 endoleak
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iv.

Type 4

Type 4 endoleaks (figure 3.21) are related to the porosity of the graft within 30
days. Opacification of the aneurysm sac instantly after stent placement without an
apparent source of leakage is designated a type 4 endoleak. They occur during the
procedure and are transient, resolving after removal of anticoagulation (Bashir et
al., 2008)

Opacification
of the
aneurysm sac

Figure 3.21: Diagrammatic representation of a type 4 endoleak
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v. Type 5
Type 5 endoleaks are more commonly referred to as “endotension”. This may
cause a continued expansion of the graft without the presence of a documented
endoleak on any imaging modality. While the true nature of endotension has never
been documented, it may be due to the presence of a Type 1, 2 or 3 endoleak that
has not been detected on an imaging modality. It is the state of elevated pressure
within the aneurysm sac (Veith et al., 2002).
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EVAR stent walls
Flow into residual
aneurysm

Figure 3.22: A patent residual aneurysm sac on CDU as a result of a type 1b
endoleak

Patent IMA type 2 endoleak

Patent Stent
Figure 3.23: A type 2 endoleak on CDU. The residual aneurysm sac is being
fed by a patent IMA
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3.6.3 Endoleak Detection
Following EVAR, CT is considered by many to be the gold standard imaging
modality for the detection and classification of endoleaks. However, other imaging
modalities such as CDU are growing increasingly more popular for surveying
patients post EVAR for practical reasons.
It has been proven to be a practical, non-invasive and accurate method of
monitoring this particular group of patients over a long period of time. CT is a
static imaging system that requires the precision timing of contrast injections to
obtain optimal imaging results. It is for this reason that CT may not be sensitive
enough to detect the low flow that is present in many of the type two endoleaks
such as small patent lumbar arteries. CDU has the advantage of real time imaging
so the low volume flow present in these endoleaks can be detected more readily.
Both CT and CDU confirm the presence of an endoleak by detecting flow present
in the residual aneurysm sac. They both have the ability of measuring the residual
aneurysm sac over a period of time. CDU achieves this at a limited risk to the
patient. Aneurysms that have been successfully excluded from systemic
circulation should naturally decrease over a period of time or at least remain
stable. In the presence of an endoleak some residual aneurysms will increase over
a period of time, it is for this reason that the residual aneurysm size should be
monitored on a regular basis to ensure there is a decrease in size or at least no
change in size. Any aneurysm that increases significantly between follow up
exams should raise suspicion of an endoleak even if one is not present on an
imaging modality.
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3.6.4 Treatment of Endoleaks
Endoleaks are managed according to their classification either by observation,
further endovascular intervention, surgical ligation of the aneurysm neck or
conversion to open surgical repair of the aneurysm.
The presence of a type 1a or 1b endoleak may lead to further endovascular
procedures such as a cuff endograft for a type 1a leak (figure 3.17) or an extension
endograft for a distal type 1b endoleak (figure 3.22). An intersegment endograft
may be used for distraction of component parts of a modular graft. Surgical band
ligation of the proximal neck involves a laparotomy and open exposure to place an
external ligature around the proximal graft to achieve a seal. Conversion to open
repair is usually only indicated when further endovascular procedures have failed.
Type 2 endoleaks are more commonly observed. Some type 2 endoleaks seal
spontaneously over time. However, if there is a significant increase in the
aneurysm sac observed over time they may be treated by coil embolisation of the
feeding vessel. Laparoscopic clipping of the source vessel has also been described.
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3.6.5 Complications with Endovascular Aneurysm Repair
Other complications can occur with endovascular grafts, both immediately post
operatively and in the late follow up period. Kinking of the graft body or limb can
occur post operatively or in the follow up period. Consequences include lower
limb ischaemia due to decreased flow or complete thrombosis of one or both of
the iliac limbs. Some studies have actually documented the superiority of CDU
over other imaging techniques in the detection of limb occlusion (Berdejo et al.,
1997). Limb thrombosis may lead to dislocation of the limb of the endograft from
the native iliac vessel, kinking and thrombosis of the endograft are amenable to
endovascular correction thus avoiding the need to convert to open repair
(Rutherford, 5th edition, page 1289).
When complete shrinkage of the residual AAA is achieved, the endovascular graft
is subjected to stress at the limb junctions and the proximal and distal anastomosis
sites. This may ultimately lead to a type 3 endoleak in the late follow up period
however; further information on this will only become apparent as time goes on.
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Chapter 4

The Physics of Ultrasound
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4.0 Introduction
This chapter examines the background behind the physics involved in Doppler
ultrasound and the use of Doppler ultrasound to measure blood flow. It gives a
brief introduction to the physics of blood flow, arterial stiffness and pulse wave
velocity. Several texts were used to compile this chapter all of which are
documented in the reference section (Gibbs, Cole and Sassano. 2009. Hoskins,
Thrush and Whittingham. 2003 and Hussey. 1985).
4.1 Sound Waves
Sound is a mechanical disturbance in the air initiated by the vibration of the sound
source, which then travels through the air, impinges on and is received by the ear.
It consists of local disturbances in the air which propagates from the source to the
receiver. This type of phenomena is referred to as a wave.
A wave (figure 4.0) is a disturbance with a regularly repeating pattern which
travels from one point to another.
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Figure 4.0: A transverse wave

The simplest example of a wave is the one created on the surface of a pond when a
stone is thrown into the water. The stone cause’s some of the water to be displaced
and in turn there is a change in the height of the water. This change in height is
transferred to the adjoining region, and so the energy is transported across the
water from stone to shore.
This type of wave that travels across the surface of the pond is called a transverse
wave (figure 4.0). The movement of the water surface is at 90 degrees (transverse)
to the direction of travel of the wave.
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Figure 4.1: A longitudinal wave
The sound waves used to form a medical image are longitudinal waves (figure
4.1). The particles that are closest to the source of vibration are the first to vibrate.
The direction of vibration of the particles and the direction of motion of the wave
are the same; hence the wave is a longitudinal wave.
Within the medium the particles move backwards and forwards, as the particles in
adjacent regions move towards each other they develop a region of compression
(increased pressure) however, when the particles move away from each other a
region of rarefaction (reduced pressure occurs) as described in figure 4.2. There is
no movement of the medium itself, only the disturbance and the associated energy
is transported.
The most common sound waves are those that travel in air from sources of sound
such as from a bell to the human ear. The surface of the bell when struck vibrates
causing the air molecules adjacent to it to push and pull against each other setting
the neighbouring air molecules in motion and thus the disturbance travels through
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the air as a sound wave. When the sound wave reaches the human ear it causes the
ear drum to vibrate giving the sensation of sound. Thus, energy from the bell is
transported by the wave to the ear drum causing it to move.

Figure 4.2: Changes in pressure that occur in a medium through which a
sound wave is travelling

4.2 Properties of Sound Waves
4.2.1 Frequency
The number of complete cycles occurring at a point each second is called the
Frequency (

figure 4.2). The units of frequency are hertz (Hz). Frequency is

determined by the sound source and not the medium through which it is travelling.
Frequency ranges
Sound can be broken up into three major frequencies. The first one being the
audible sound range, this is the sound range that a human ear can hear, it varies
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with age but can be described as being between 20Hz-20000Hz. Ultrasound is a
high frequency sound wave which is not within the human hearing range, it has a
frequency greater than 20000Hz. The third category of sound ranges is infrasound
which includes all frequencies below 20Hz.
4.2.2 Wavelength
Wavelength (figure 4.2) is the length of one cycle of a wave; it is represented by
the symbol lambda (λ). The unit of measurement for the wavelength is the meter
(m). With an increase in the frequency the wavelength decreases. The wavelength
is inversely proportional to the frequency. Wavelength is determined by both
frequency and velocity and by both the sound source and the medium through
which it is travelling.
Equation 4.0
V = Velocity
F = Frequency
λ = Wavelength
4.2.3 Period
The period (equation 4.1) is the time taken for one wavelength to pass a particular
point. The period is equal to one divided by the frequency and its units of
measurement are time.
This relationship may be defined as:

Equation 4.1
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4.2.4 Amplitude
Amplitude is defined as the maximum amount of variation that occurs in an
oscillation, or the height of the wave (figure 4.2). It is determined only by sound
source and not the medium through which it is travelling. It is equal to the
maximum value of the oscillation minus the normal value.
4.2.5 Power and Intensity
Power is the rate at which work is done or energy is converted. The parameter
which measures the rate of energy transfer is the intensity, defined as the amount
of energy in joules, transported each second through each square meter of the
medium perpendicular to the direction in which the sound is travelling. The
intensity is the power in watts per square meter. The more intense the sound wave,
the more energy that is transported each second through each square meter. It is
determined by the source of the sound and not the medium through which it is
travelling. Equation 4.2 describes the relationship between intensity, power and
beam area.

Equation 4.2
4.3 Propagation of Sound Waves
The speed at which a sound wave travels is determined by the medium in which it
is travelling. The speed of sound has units of meters per second (ms-1). The
properties of a medium which determine the speed of sound are Density (ρ),
measured in kgm-3 and Stiffness denoted by the symbol Kappa (k), units of Pascal
(Pa).
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Dense materials are composed of large molecules which are difficult to move,
these molecules are closer together making it easier for oscillations of individual
particles to be transmitted to their neighbouring molecules. Gases have molecules
that are far apart when compared to liquids therefore it is more difficult for sound
to travel from one particle to another. Increasing stiffness therefore increases
transmission speed. The speed of sound in air is 333ms-1, in soft tissues (human
flesh) the speed of sound is 1540 ms -1; most medical devices are calibrated for
this speed.
Table 4.0 describes the relationship of the velocity of sound to the stiffness of the
medium through which it is travelling. The lowest speed occurs in gases such as
air, with increasing velocities in liquid such as blood and the highest velocities in
solids such as bone.

Speed of Sound (ms-1)

Material
Air

331

Lung

650

Mercury

1460

Fat

1460

Water

1520

Blood

1560

Muscle

1580

Bone

2700-4100
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Brass

4490

Quartz

5470

Aluminium

6400

Table 4.0: Relationship between velocity of sound and stiffness of a medium
It is important to note that with the exception of bone all body tissues behave like
liquids due to their high concentration of water. Therefore they all transmit sound
at a similar velocity, approximately 1540m/sec.
Low density and high stiffness lead to high speed sound waves, high density and
low stiffness lead to a reduced speed of sound. The speed of sound is expressed in
equation 4.3.

Speed of sound c

Equation 4.3

Propagation speed is the speed at which a sound wave moves through a particular
medium. It is determined by the density and the stiffness of the medium.

Equation 4.4
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In ultrasound the range equation (equation 4.5) is a method of measuring the
distance from the sound source to any reflector of interface within the
transmission medium. It relates reflector distance to echo arrival time. The
propagation speed of the transmission medium must be known and the time for the
ultrasound pulse to make a complete round trip from the transducer element to the
interface and back to the transducer element again.

The Range Equation:

Equation 4.5

D= the distance from the reflector
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4.4 The Interaction of Ultrasound with Tissue
4.4.1 Attenuation
Attenuation describes the reduction in intensity of the sound wave as it propagates.
Once a sound wave enters the body, the longer the path it has to travel the greater
the effect of attenuation. This decrease in the intensity of the wave is due to
multiple factors such as absorption, scattering, reflection and beam divergence.
Absorption of the sound by body tissue accounts for the largest losses. Scattering,
occurs when an ultrasound wave strikes a boundary between two media that have
surface irregularities of the order of magnitude of the wavelength or less, the
reflected wavelength is fragmented into random directions relative to the
boundary.
Both absorption and scattering are dependent on frequency and the overall
attenuation is also frequency dependent.
Every tissue type has its own attenuation coefficient (MHz -1). Tissues with high
attenuation coefficient absorb sound more efficiently than those with a low
attenuation coefficient. For example, blood has an attenuation coefficient of 0.2
MHz

-1

and bone has an attenuation coefficient of 10 MHz-1. Therefore

transmission in bone is at a much higher level than blood making it impossible for
the sound wave to be transmitted in bone within the diagnostic ultrasound range.
This is why bone causes regions of shadowing on an ultrasound image.
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4.4.2 Acoustic Impedance
Acoustic impedance (Z) of a material is a measure of the response of the particles
of a medium, to a wave of given pressure (equation 4.6). It is determined by the
density and the stiffness of the material. An echo is generated when a sound beam
crosses into a tissue which is composed of differing acoustic impedances. The
amplitude of the echo is dependent on the difference in the acoustic impedances of
the two tissues involved. Acoustic Impedance describes the relationship between
excessive pressure (P) and particle velocity (Uo).
Substances such as bone whose particles are densely packed have high acoustic
impedance so it will take excessive pressure for all the particles to be moved at the
same velocity. In contrast, the particles in air are loosely packed. Therefore, it
takes a much lower pressure for all the particles to be moved at the same velocity.
Therefore air has lower acoustic impedance than bone. Acoustic impedance
increases if either the density or the stiffness of the material increases, and it is not
dependent on the frequency of the applied signal.

Equation 4.6
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4.4.3 Reflection
When an ultrasound beam strikes a particular interface, it is the acoustic
impedance of the two mediums that determines whether reflection (figure 4.3)
occurs. Several things may happen to the beam depending on whether the beam
strikes the interface perpendicularly or at an angle.
If the sound wave strikes the interface at an angle perpendicular to the incident of
sound, the wave may be reflected or transmitted, or both. The reflected portion of
the beam returns to the transducer and is detected as an echo. The amplitude of the
returning echo depends on the intensity of the incident beam and the difference in
the two acoustic impedances of the mediums forming the interface.
If the tissue interface is oblique not perpendicular, the reflected sound wave will
travel along a different path. The greater the difference in the acoustic impedances
of the two mediums the greater the reflected energy and thus a larger echo is
received by the transducer. When there is only a small difference in the acoustic
impedances of the two mediums only a small amount of energy is reflected back.

Figure 4.3: Reflection and Refraction
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4.4.4 Refraction
Refraction (figure 4.3) of the sound wave occurs when the speeds of sound are
different on each side of the tissue interface. If the angle of incidence is not
perpendicular to the interface, then the path of the beam will be refracted.
Refraction of a beam up to 10% can lead to missregistration of the echoes. This
may lead to displaying some of the returned echoes as artefacts.
The degree of missregistration is dependent on the angle of the incident wave and
the difference in the speed of sound of the tissues.
Snell’s Law (4.7) describes the degree of refraction that occurs with oblique
incidence of an ultrasound beam at the boundary of two mediums with differing
propagation speeds.

Equation 4.7

= the speed of sound in the two mediums

If the propagation speed through medium two is greater than the propagation
speed through medium one, then the transmission angle will be greater than the
incidence angle and vice versa.
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4.4.5 Scattering
Scattering occurs at large interfaces, for examples between organs were there is a
change in acoustic impedances. When an ultrasound wave is incident on such
targets, it becomes scattered over a large range of angles (figure 4.4). The sound
beam is scattered or diffused by tiny reflectors such as red blood cells, this
scattered energy is radiated in all directions, and this phenomenon is referred to as
Rayleigh scattering. These backscattered echoes allow for the imaging of tissues.
The intensity of the backscattered echoes varies with the size of the scatter and the
frequency of the transducer. The backscattered echoes as in the case of red blood
cells may also be received by the transducer and then analysed.
In the case of Rayleigh scatter the returning sound intensity is not entirely
dependent on the angle of incidence. It is also dependent on the dimension of the
scatter, the number of scatters present and the frequency of the ultrasound. More
scattering will be noted at higher frequencies. Some of the echoes will be returned
to the transducer and displayed. However, the majority will be scattered nonuniformly in all directions and not recorded.

Figure 4.4: Rayleigh scattering of a wave
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4.5 Ultrasound Transducers
4.5.1 The Piezoelectric Effect
The Piezoelectric effect is the ability of a material to generate an electrical charge
in response to applied pressure. When a piezoelectric material is compressed a
potential difference is generated across opposite faces, one becomes positive and
the other becomes negative. Conversely, if an electric field is applied across the
crystal it changes its shape.
A transducer converts one form of energy into another. An ultrasound transducer
converts electrical energy into ultrasound energy and vice versa, using the
piezoelectric effect. When a voltage is applied to the ultrasound transducer a
mechanical wave is generated, when the wave returns to the transducer an
electrical voltage is generated. The transducer serves as both the emitter of sound
and the receiver of the returning sound waves.
Due to their mechanical nature sound waves require a medium for their
transmission. The mechanical wave produced by the transducer travels away from
the source causing displacement of the particles within the medium.
Ultrasound transducers are usually described by their type and operating
frequency which can range from as low as 2,000,000Hz (2MHz) to as high as
20,000,000Hz (20MHZ). They can operate in a continuous mode or in a pulsed
mode with the voltage being applied in a pulsed fashion.
An ultrasound transducer should be chosen to best suit the purpose it is intended
for; image resolution will not be as good with a transducer that operates at deeper
frequencies. For example a 15MHz transducer will give excellent resolution of
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superficial structure such as the cephalic vein but would not be suitable to image
deeper structures such as the aorta.
As a continuous alternating voltage is applied to the transducer element, the
element produces a continuous alternating pressure wave that propagates as a
sound wave. The frequency of the sound produced by the transducer is directly
related to the frequency of the voltage applied to the transducer element as well as
the thickness and propagation speed of the element itself.
Pulsed ultrasound is used in medical ultrasound imaging, the pulse repetition
frequency (PRF) is the number of pulses occurring in one second (figure 4.5), and
its units are hertz (Hz). The amount of time between each pulse is measured in
seconds and is referred to as the pulse repetition period (PRP). Pulse duration is
the time taken for one complete pulse to occur and is equal to the period
multiplied by the number of cycles in the pulse.

Equation 4.8

Equation 4.9
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Figure 4.5: Pulse repetition period

Equation 4.9 is derived from equation 4.8. Both equations describe the following
relationships. As the PRF increases, PRP decreases. As the period increases, pulse
duration decreases. As the number of cycles in the pulse increases, pulse duration
increases. And finally, as the frequency increases, pulse duration decreases.
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4.6 Ultrasound Transducer Construction
Ultrasound transducers are composed of several major components, the
piezoelectric crystal, the backing material, a matching layer, and a case to house
the components.

Figure 4.6: A single element ultrasound transducer

i.

The Crystal Element

The piezoelectric effect is responsible for the production of a pressure wave when
a piezoelectric material is deformed by an electric voltage. Most transducers are
composed of ceramic material such as lead zirconate titanate which following a
procedure called polarisation is made piezoelectric.
Piezoelectric materials are crystalline materials composed of dipolar molecules
which have a random arrangement within the material. These dipolar molecules
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have an inability to arrange themselves in an applied electrical field. However,
when the material is heated above the Curie temperature (365 degrees Celsius) in
the presence of an electrical field the molecules align within the field. When the
material is cooled below the Curie temperature the molecules will remain aligned
while an electric field is removed. The piezoelectric crystal can now be used in an
ultrasound transducer to transmit and detect sound.
For pulsed ultrasound the thickness of the transducer element as well as the
propagation speed of the material that the element is composed of determines the
operating frequency of that transducer. The operating frequencies of the ceramic
crystal will increase with the increasing propagation speed of the transducer
element.
ii. Damping Material
This layer is applied to the back of the crystal element to reduce the duration of
the pulse and thus the number of cycles in the pulse. This is necessary as the
transducer will continue “ringing” at its resonant frequency following excitation
by the pulse transmitter.
iii. Matching Layer
This is applied to the face of the crystal element and is composed of a material
which has an acoustic impedance value that is between the transducer element and
the tissue interface to which the transducer is being applied. This reduces the
reflection that occurs at the transducer skin interface due to the difference in their
acoustic impedances. The matching layer is further enhanced when acoustic gel is
applied to the transducer before applying the transducer to the patient. This gel
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acts as a coupling agent and eliminates the air interface that is present between the
transducer and the patient thus interfering with sound transmission.
4.6.1 Ultrasound Beam Profiles
The ultrasound beam is the area through which the sound energy emitted from the
ultrasound transducer travels. The beam is a three dimensional emission and is
symmetrical around its central axis. It can be divided into two regions (figure 4.7),
the near field (Fresnel Zone) and the far field (Fraunhofer Zone).
The near field is cylindrical in shape and will increase as the frequency of the
transducer increases and with an increasing transducer diameter. The area between
the near field and the far field is called the transition zone.
The far field is the region beyond a distance of one near field length away from
the transducer face. It is where the beam diverges and becomes cone shaped
(figure 4.7). The shape of the beam depends on factors such as the diameter of the
crystal, the frequency and the wavelength. The design of the transducer will also
be a factor in the shape of the beam. Increasing the frequency of the transducer
will create a longer near field and a shorter far field. A narrow crystal results in the
beam being narrow in the near field.
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Figure 4.7: Near and far zones of an ultrasound beam
4.6.2 Side Lobes
Side lobes describe the energy that radiates at various angles from the transducer
face (figure 4.8). They are not part of the main ultrasound beam, they are three
dimensional and there may be one or more of them. They return echoes from any
interface they encounter. These returning echoes will be incorrectly placed on the
image as the ultrasound machine assumes they are from the main beam. They
result from continued excitation of the piezoelectric crystal. The number of side
lobes can be reduced by energising the crystal in a pulsed pattern.
Grating lobes are at various angles to the main beam and also have the same effect
as side lobes (figure 4.9). Grating lobes are caused by the regular, periodic spacing
of the small array elements. Both can lead to artefact on the image.
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Figure 4.8: Side lobes of an ultrasound beam

Figure 4.9: Grating lobes of an ultrasound beam
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4.6.3 Beam Focusing
The diameter of the ultrasound beam at any given point determines the lateral
resolution of the transducer. The focal zone of the transducer is the distance
between the centre of the ultrasound beam at which the intensity remains within
25% of the peak intensity of the focus of the transducer (figure 4.10). The width of
the ultrasound beam is the dimension of the beam in the scan plane and it will vary
accordingly when focusing of the beam is being conducted. The width of the beam
will vary with depth and will have an effect on the spatial resolution of the
resulting image. In principle, the narrower the beam the better the resolution.
Focusing of the ultrasound beam will improve the quality of the image at that
particular point, causing the ultrasound beam to converge at a particular region
resulting in a narrower beam at the region of interest. Increasing the number of
focal zones will improve resolution; however, because the transducer is now
sending out multiple sets of echoes with a focus at each of the focal zones, this
takes more time and will result in a slower frame rate.
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Figure 4.10: Focal zone of an ultrasound beam
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Focal zone

Figure 4.11: A B-Mode Duplex image with one focal zone

Focal zone 1

Focal zone 2

Figure 4.12: A B-Mode Duplex image using two focal zone
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4.7 Image Resolution
Detailed resolution is composed of two components, axial resolution and lateral
resolution.
i. Axial Resolution
This is the resolution along the axis of the beam; it is dependent on the spatial
pulse length (figure 4.12) and can be defined as the minimum distance separating
two different reflectors along a longitudinal axis of sound travel thus separate
echoes are produced on the display. It is equal to half the spatial pulse length of
the ultrasound pulse emitted from the transducer. Axial resolution therefore
improves as it reduces.
Frequency and transducer design both affect the spatial pulse and therefore the
axial resolution. Ultrasound transducers with a higher frequency for imaging will
result in a shorter spatial length and improved axial resolution. The length of the
pulse also depends on the amount of dampening applied to the piezoelectric
crystal. Increasing the amount of dampening makes the pulse length shorter and
therefore the axial resolution will be improved.
ii. Lateral Resolution
Lateral resolution (figure 4.13) is the minimum distance separating two different
reflectors lying in a plane that is perpendicular to the direction of sound travel,
thus separate echoes are displayed. Lateral resolution is equal to beam diameter at
that point in the ultrasound beam and it improves as frequency increases. It is
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dependent on the beam width and is the resolution at right angles to the beam.
Lateral resolution is generally not as good as axial resolution. The width of the
beam determines the size of the echoes that are displayed on the screen. The
structures being imaged must be separated by a distance greater than the beam
width for them to be resolved into separate structures.
iii. Contrast Resolution
This is the ability of an ultrasound system to assign a different shade of grey to
returning echoes of varying amplitudes thus differentiating between body tissues
and displaying them on a monitor. Better contrast resolution will result in better
axial and lateral resolution. Transducer design, analogue to digital conversion and
the control settings of the machine such as gain, time gain compensation and
harmonic imaging, all affect the contrast resolution.

Figure 4.13: Axial and lateral resolution
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4.8 Ultrasound Imaging

4.8.1 Introduction
i. Amplitude Mode
The earliest and most simple form of presenting returning echoes on a display was
to use Amplitude mode (A-Mode). This is where a transducer was placed in the
direction of the area of interest and a pulse of ultrasound was directed into the
subject. The pulse of ultrasound travels through the medium at the speed of
propagation of sound in the medium. After a distance it encounters a reflecting
boundary. At the boundary the incident pulsed wave is portioned into the reflected
and transmitted components. The reflected components travel back towards the
probe at the speed of propagation of ultrasound in the medium. The reflected pulse
reaches the transducer as an echo and is detected by the transducer.
By measuring the time taken for the echo to return and knowing the speed of
propagation of ultrasound in that medium, the depth of the reflecting boundary
producing the echo may be calculated (equation 4.10).

Equation 4.10

A-Mode imaging is not of great importance today it is still however used today in
ophthalmology and to some extent in cardiology.
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ii. Brightness Mode
Brightness mode ultrasound (B-Mode) displays the returning echoes as a series of
dots with the position of each dot corresponding to its distance from the reflector
and the brightness of each dot corresponding to the amplitude of the returning
signal.
The transducer crystal emits a sound pulse, some of which is reflected back to the
transducer or transmitted further into the tissues. At each interface a dot with grey
scale brightness proportional to the strength of the signal is placed on the screen.
This process continues in real time along the length of the transducer with the
result being a B-Mode image. Currently ultrasound systems utilize one hundred or
more ultrasound beams to produce a single frame for a B-Mode image.
The development of B-Mode imaging greatly expanded the use of ultrasound in
medical imaging. B-Mode scanning techniques required the operator to move the
transducer across the area of interest resulting in a slice or a cross sectional image
of the patient at that point, this required a method of storing the echoes as well as
displaying them on a monitor.
There are two types of B-scan formats that may be used, static scanning and real
time imaging. Static scanning is not as commonly used in medical imaging today.
A real time ultrasound machine must have the ability to produce several images
per second in order for a moving image to be displayed on a monitor. Each
individual scan produced by the transducer is referred to as a frame and each
frame is composed of hundreds of scan lines, one scan line for each time the
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ultrasound transducer is pulsed. Line density is the number of vertical lines present
per field of view, the greater the number of lines the better the resolution of the
image. The pulse repetition rate or the frame rate is limited by the speed of
ultrasound in the tissue being imaged as a new pulse cannot be generated until the
first pulse has returned. Therefore when imaging deeper structures a slower frame
rate or pulse repetition rate is used.

4.8.2

Real Time Ultrasound Imaging

The two most common formats of displaying an ultrasound image are rectangular
and sector, depending on the type of transducer being used.
Real time ultrasound scanning can be performed in two ways mechanically and
electronically. During mechanical scanning one or more transducer elements are
mechanically moved to form a real time image. Electronic scanning involves the
activation of an array of transducers by electronic means, the transducers do not
move. In both methods the ultrasound beam is continually swept or scanned
through an area of interest. Electronic array scanning is more commonly used in
vascular ultrasound.
Electronic Array Scanning
Electronic muti array transducers have an array of rectangular piezoelectric
crystals etched side by side within the transducer housing. There around 128-256
elements across the face of these transducers which are individually connected
through an ultrasound port on the machine. Electronic array transducers emit a
series of small narrow beams along the transducer face which travel along
adjacent paths through the patient to generate a cross sectional image. By
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introducing a set of time delays to the individual elements the shape of the
ultrasound beam and direction can be electronically manipulated to focus and steer
the ultrasound beam. None of these transducers have moving parts; they simply
focus the ultrasound beam by introducing a time delay to a crystal when it emits
its pulse of energy. By varying the location and the sequence of each pulse it is
possible to focus more ultrasound signal at a given point of interest or depth and
thus improve the resolution of the image from this depth. This ability to achieve
focusing by applying the order in which the elements of the array are fired is
referred to as phasing.
The electronic array ultrasound transducers available for today’s applications can
be classified into one of three groups, linear array transducers, curvilinear or
sector array transducers and phased array transducers. Linear array transducers
and sector array transducers are widely used in vascular ultrasound.
i.

Linear Array

Linear array transducers (Figure 4.14) are commonly used to image the more
superficial structures and vessels. They are composed of between 128 – 256
piezoelectric crystals in a row which produce parallel scan lines and transmit
perpendicularly to the transducer face thus resulting in a rectangular field of view
(figure 4.15).
Linear transducers traditionally operate at frequencies above 4 MHz and usually
produce an image about the length of the transducer head. They can operate at
frequencies as high a 15MHz.
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Linear head

Figure 4.14: A Siemens linear array transducer

Rectangular field
of view of IJV

Rectangular field of
view of the CCA

Figure 4.15: A rectangular field of view produced by a linear array
transducer
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ii.

Curvilinear Array

These transducers are sometimes referred to as sector array transducers. They
traditionally operate at lower frequencies than linear array transducers and are
therefore good at imaging deeper structure within the body. They operate around
3.5MHz and provide a wide field of view (figure 4.16) due to the transducer head
being curved in shape (figure 4.17).

Curvi linear head

Figure 4.16: A Siemens curvi linear array transducer

Wide field of view
produced by a
curvilinear
transducer

142

Figure 4.17: A wide field of view produced by a sector array transducer
4.9 Doppler Ultrasound
4.9.1 Introduction
The Doppler Effect was first described by Christian Andreas Doppler in 1842; the
acoustical Doppler Effect was first demonstrated in 1845 by Buys Ballot using a
trumpeter riding on a steam locomotive. However, the use of Doppler in the
clinical investigations of peripheral vasculature was not accomplished until the
1960’s after the development of the first Doppler probe by Satomura in 1959.
Today Doppler ultrasound is routinely used as a non invasive test to examine and
evaluate the movement of blood flow through arteries and veins and thus giving us
the ability to diagnose multiple conditions such as arterial narrowing, heart valve
defects, deep venous thrombosis, varicose veins and arteriovenous malformations.
4.9.2 The Doppler Effect
The Doppler Effect is the occurrence of a shift in the observed frequency of a
sound or ultrasound wave when there is relative movement between the sound
source and the observer.
In medical imaging this occurs when the ultrasound beam that has been produced
by the transducer encounters a moving target rather that the stationary interface. It
is defined as a change in the perceived frequency of sound emitted by a moving
wave source, receiver or reflector.
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Doppler ultrasound is used in vascular imaging to identify changes in the
frequency or the velocity of moving reflectors, red blood cells. This frequency
shift is known as the Doppler Effect and applies to both light and sound waves.
The Doppler Effect is used in ultrasound to examine blood flow through a vessel.
It gives us information on the direction of flow within the vessel, the presence of
flow and the absence of flow within the vessel. The transducer is the emitter and
the receiver of the ultrasound beam. The returned echoes are detected by the
transducer and are processed by the ultrasound system to detect the frequency shift
when compared to the emitted signals. The frequency shift detected in the emitted
and the received signals depends on the magnitude and the direction of blood flow
within the vessel.
4.9.3 Doppler shift
The Doppler shift is defined as the reflected frequency minus the incident
frequency, thus we get the frequency of the moving red blood cells. This is called
the Doppler shifted frequency and can be positive or negative depending on
whether the blood flow is going towards or away from the transducer.
In vascular ultrasound the Doppler shift frequency provides the basis for
calculating the velocity of flow in the vessel under investigation. The Doppler
shifted frequency falls within the audible hearing range of the human ear and so
the pitch is heard by the Technologist.
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4.9.4 The Doppler Equation
The Doppler equation describes the relationship between the speed of the moving
target and the change in frequency that occurs when the sound beam encounters
the moving target.

Equation 4.11
f(d) = Doppler shifted frequency
f(o) = Transducer operating frequency
C = Velocity of sound1540mms-1
V = Velocity of the moving red blood cells
= The angle between sound beam and blood flow.
4.9.5 The Doppler Angle
When the Doppler beam is pointing towards the direction of blood flow a positive
Doppler shifted signal is detected however, once the Doppler beam is pointed
away from the direction of flow a negative beam is observed. The smaller the
angle between the Doppler beam and the blood vessel, the larger the Doppler
shifted frequency. No signal is produced at an angle of 90 degrees. For a constant
flow velocity (V), the maximum value of cos

and the maximum value of the

Doppler shifted signal is at an angle of zero degrees. This corresponds to a
Doppler beam which is at an angle parallel to the vessel. In practice we take
Doppler measurements at an angle of between 45-60 degrees to ensure reliable
Doppler shifted frequencies. Angles above 90 degrees are always avoided as
greater flow velocities and smaller angles produce larger Doppler shifted
frequencies.
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In clinical use sound approaches the moving targets somewhere between 0 and 90
degrees. Due to the variability of the angle between the ultrasound beam and the
direction of blood flow, angle correction must be applied using the Doppler angle.
The Doppler angle may be defined as the angle between the direction of flow and
the direction of sound propagation.

Figure 4.18: The Doppler effect
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4.10 Doppler Instruments
In clinical practice Doppler techniques can be either imaging or non-imaging. Non
imaging techniques include the traditional hand held continuous wave Doppler
units used in detection of peripheral pulses and in obstetrics (figure 4.20). Imaging
techniques widely include colour Doppler, power Doppler and spectral pulsed
wave Doppler and are always used in conduction with B-Mode image.
4.10.1 Continuous Wave Doppler
These are the simplest Doppler devices available. They are typically a hand held
unit with a pencil probe attached (figure 4.20). The pencil probe (transducer)
consists of two piezoelectric elements. One element acts as the emitter and one the
receiver (figure 4.19). The two elements are set at angles to each other so that the
emitted and received beams over lap (figure 4.19). The overlap region is known as
the active or sensitive area which is where the Doppler signal can be detected. The
detected signal is obtained by comparing the emitted and received signal.
Continuous wave devices are still widely used today and have many clinical
applications such as fetal heart monitoring and detection of peripheral pulses.
However, their main disadvantage is that any sound detected in the crossover
region can be heard by the operator. For example flow from more than one vessel
may be heard at the same time such as an artery and a vein, resulting in a mixed
arterial and venous signal being detected. The biggest advantage is that they are
inexpensive and easy to use.
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Figure 4.19: A continuous wave Doppler probe

Figure 4.20: A handheld continuous wave Doppler unit
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4.10.2 Duplex Systems
Duplex ultrasound systems are devices that have a dual capacity, usually B-Mode
imaging and a Doppler blood flow detector in the same unit. The idea is to obtain
a B-Mode image of a blood vessel (figure 4.21) then a line representing the path of
the ultrasound beam from the Doppler unit can be inscribed on the image, so that
the angle of incidence of the ultrasound beam relative to the flowing blood cells
can be measured directly (figure 4.24).
4.10.3 Colour Flow Doppler Imaging
Colour flow Doppler imaging enables us to quickly and effectively identify the
presence and direction of flow within a vessel as the colour quickly highlights
abnormalities within a vessel such as a narrowing.
Colour flow imaging is always used alongside B-mode imaging, it is operated
using a colour box (figure 4.22) which highlights an area of interest. This colour
box is superimposed onto the B-Mode image and its position and size can be
adjusted to give the operator a wider field of view. The colour box is made up of
hundreds of lines which are further subdivided into smaller sample volumes. For
each sampler volume the mean Doppler shifted velocity is calculated and is
assigned a colour depending on weather it is positive or negative which is then
mapped onto a colour scale consisting of two primary colours red for positive and
blue for negative.
This is the direction information and once it has been assessed the sample volume
is assigned a shade depending on the calculated velocity. Doppler angle is again of
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extreme importance. The appearance of the colour flow image is dependent on the
operator’s ability to maintain a sufficient angle between the beam and the vessel.

IJV
CCA

Figure 4.21: B-mode image of a common carotid artery and jugular vein

IJV
CCA

Figure 4.22: B-mode image of the common carotid artery and the jugular
vein with colour flow superimposed showing the different direction of blood
flow in both vessels in red and blue
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4.10.4 Formation of Colour Flow Images
Colour flow imaging is carried out by estimating and displaying the mean velocity
relative to the ultrasound beam direction of scatters and reflectors in a scanned
region. The echo signals from the returning echoes are displayed so the colour
hue, saturation or the brightness indicates the relative velocity. The colour flow
data is then superimposed onto the B-mode image from stationary structures to
create a composite image.
To produce colour flow images there are several methods that have been
described. Some operate on the signal produced after Doppler signal processing,
few process Doppler signals directly. For each method a series of pulsed echo
sequences are produced along a signal beam axis. Echo signals from each
succeeding transmit pulse are compared with signals from the previous pulse, and
phase shifts in the succeeding signals are estimated. When this is carried out for all
pulse echo sequences along the beam line a mean Doppler frequency shift is
calculated. The process is completed for all locations along the beam line and
estimated velocity is displayed using a colour scale.
Frame rate tends to be lower than that of normal B-mode images as data for each
acoustic line that forms a colour velocity image are acquired using multiple pulse
echo sequences. The direction of blood flow is coded by the colour display. Red
may indicate towards the transducer and blue may indicate flow away from the
transducer. The colour process displays motion relative to the ultrasound beam
direction for each beam line, forming a new image. Different parts of a vessel are
often interrogated using different beam directions, usually due to the orientation of
the vessel.
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4.10.5 Pulsed Spectral Doppler
Pulsed wave Doppler is a process where the transducer is excited with regular
short bursts of pulses rather than a continuous pulse. It uses signals that are much
longer than those used in other imaging systems in order to properly determine the
Doppler shift of the returning echoes. After being reflected form the tissue
interface, the ultrasound waves received by the transducer are converted to voltage
pulses which are sent to the receiver. The receiver compares the frequencies of the
pulses detected by the transducer with the original transmitted frequency and
determines the difference. The result being the Doppler shifted frequency which is
then sent to a loudspeaker for audible analysis as well as display.
To detect a signal from a given depth within the tissue a “range gate” is placed
within the sample area (figure 4.23). The system will only detect a signal from
within this range gate. The Doppler sample is therefore only detected from a
specific volume within the body known as the sample volume.

Sample volume
within the region
of interest

Figure 4.23: A sample volume from the region which the Doppler signal is
detected
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Duplex systems use Doppler ultrasound in conjunction with imaging to provide an
overall picture. It enables the precise location of the Doppler sample volume in the
centre of the vessel were the flow is fastest (figure 4.24).
It is also possible to choose the angle of insonation of the Doppler sample and the
vessel using angle correction, thus ensuring that the Doppler sample is obtained at
an angle as close to 60 degrees as possible. Ideally the vessel walls should be
imaged with the beam at right angles to the vessel wall, were as the optimal
measurements are obtained parallel to the vessel wall so a compromise has to be
made. Linear transducers have the ability to steer the Doppler beam allowing the
Doppler beam to set an angle to the imaging beam enabling both the imaging and
the Doppler recording to be made in a vessel that runs parallel to the skins surface.
Curvilinear transducers do not have this ability to steer the beam so compromise
has to be made by angling the transducer and not the beam.

Pulsed spectral
Doppler from
within the
sample volume
Figure 4.24: Pulsed spectral Doppler obtained from a specific sample volume
within the artery
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The Doppler sample obtained can be analysed into its frequencies using a process
called the Fourier transform. The range of frequencies obtained relates to the range
of velocities within the sampled blood flow. The brightness of the display at each
point indicates the amplitude of each of the component frequencies which in turn
is an indication of the backscatter power for each value of Doppler frequency
shift. If the angle of insonation is known then the vertical frequency can be
converted to a velocity scale.
4.10.6 Doppler spectral analysis
The Doppler signal is in the audible frequency range and clinical interpretation
can be made by listening to the signal. A complex signal may be composed of
many single frequency signals each with a particular amplitude and phase, when
added together they form the original signal. Spectral analysis is a way to separate
a complicated signal into its individual components. The majority of systems use a
Fast Fourier Transform to carry out the spectral analysis of a Doppler signal. The
Doppler signal is fed into the spectral analyser in small time segments and then
displayed along a line were the height represents the frequency and the brightness
represents the power. The intensity of the Doppler signals depends on the amount
of blood generating that signal, so the brightness represents the amount of flow at
the velocity corresponding to that Doppler frequency.
As the spectral signals from a segment are being displayed, a subsequent segment
is being analysed and thus a continuous display is produced. Duplex instruments
produce a B-mode image along with a Doppler spectral display (figure 4.25).
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Spectral display

Figure 4.25: The Doppler spectral display from a selected sample volume at
an accurate Doppler angle
4.10.7 Power Doppler Ultrasound
Also referred to as energy Doppler or amplitude Doppler, power Doppler is a
colour flow imaging technique that maps the magnitude or the power of the
backscattered Doppler signal rather than the shifted flow velocities. The strength
of the Doppler signal is calculated and superimposed onto a B-mode (figure 4.26).
It is a measure of the amplitude of the red blood cells in one area. It does not
display the velocity or the direction of the blood flow in the sampled area. It uses
single colour strength and maps increasing signal strengths to increased
luminosity. It has several advantages over colour flow in that it is more sensitive
to flow and detecting very low velocity flow. It is independent of angle and it is
not subject to imaging artefacts such as aliasing as it does not use a sampling
technique. The obvious disadvantages of power Doppler are its inability to
determine flow velocity and direction, it has poor temporal resolution and it is
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extremely sensitive to motion so the transducer needs to be very steady in order to
obtain high quality images.

Carotid bifurcation
imaged with
power doppler

Figure: 4.26: Imaging of the carotid bifurcation using power Doppler

4.10.8 Ultrasound Artifacts and Limitations
An ultrasound artifact is a structure in an image which does not correlate with the
tissue being scanned. They can exist in many forms including, structures present
on an image that are not actually present, objects that should be represented but
are not and structures that are miss registered.
Misinterpretation of results is possible when an operator is not aware of the
presence of an artefact. Only some of the more common artifacts that we come
across daily are described here.
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i. Reverberation
This is the production of false echoes due to repeated reflections between two
structures with a high acoustic impedance mismatch. This can occur for example
behind bowel gas when the sound reverberates between the gas surface and the
transducer and can be differentiated from real echoes due to lack of breathing
movement.
ii. Acoustic Shadowing
This is one of the biggest limitations of vascular ultrasound. It appears as an area
of low amplitude echoes behind an area of strongly attenuating tissue. It will occur
at interfaces with a large acoustic mismatch such as bone or in the internal carotid
artery due to the presence of calcified plaque obscuring a portion of the artery and
thus imitating its assessment. Figure 4.27 demonstrates the acoustic shadowing
caused by the vertebral bodies thus obscuring the assessment of the vertebral
artery or vein.

Acoustic
shadowing from
vertebral body
obscuring the
vertebral artery
Vertebral artery

Figure 4.27: Acoustic shadowing caused by vertebral body
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iii. Aliasing
Aliasing can occur with all pulsed Doppler instruments because they employ a
sampling method to build the Doppler shifted signals. It is incorrect estimation of
Doppler shifted signals. The displayed Doppler shifted signals wrap around the
Doppler velocity scale and the Doppler shifted signals change from the maximum
velocity in one direction to the maximum velocity in the other direction.
Colour velocity images are also subject to aliasing as the colour velocity image is
produced using pulsed Doppler techniques. Altering the colour baseline can shift
the allowable Doppler frequency range and thus reducing the aliasing.
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4.11 Blood Flow within the Human Body
4.11.1 Introduction
Like all other fluids, blood flow in the circulatory system has to obey the laws of
physics. In the human circulatory system arterial haemodynamics begins with the
heart. It consists of two pumps in series, one to pump blood through the lungs for
oxygen and carbon dioxide exchange and the other to pump the oxygenated blood
to all the tissues of the body.
Cardiac output (the volume of blood being pumped out of the heart) varies
however; the continuous flow to the peripheral vessels is maintained after
distention of the aorta and its branches following ventricular systole. The elastic
recoil of the wall of the larger arteries propels blood forward as the heart relaxes.
With the continued repeated contraction and relaxation of the heart, the blood
moves rapidly forward into the smaller arteries which in turn branch and become
progressively narrower as they approach the periphery.

4.11.2 Factors Affecting Blood Flow
i. Pressure
There must always be a pressure gradient present in order for blood to flow from
one region to another. The circulatory system consists of high pressure, high
energy arterial reservoir and a low energy, low pressure venous system. These two
systems are connected by vessels of varying size and are intimately related by the
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resistance vessels that make up the microcirculation, arterioles, capillaries and
venules.
Arterioles are the principle point of resistance to blood flow in the circulatory
system. Adjustment in the degree of contraction of the muscle walls of the
arterioles allows regulation of tissue blood flow and helps control the arterial
pressure.
In addition to the change in pressure that occurs across the arterioles there is also a
change in the type of flow. The blood flow changes from pulsatile to steady.
ii.

Energy

The main form or energy present in flowing blood is the pressure distending from
the vessel walls. This is a form of potential energy which is created by the
continued pumping action of the heart followed by the immediate contraction of
the aorta.
Other forms of energy such as hydrostatic pressure and gravitational pressure also
exist. Hydrostatic pressure is as a result of the weight of a column of blood when a
person is standing upright it increases the pressure on the vessel walls and
therefore the degree of distension. Gravitational potential energy is related to the
effect of gravity on a moving body. The higher the body part the greater the
gravitational energy. For example raising an arm above your head will raise the
gravitational energy.
Kinetic energy occurs due to the fact that flowing blood is a moving mass.
Increases in kinetic energy occur whenever flow is at a higher state such as during
exercise or at high velocity stenotic lesions.
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Equation 4.12
Potential energy - pressure and gravity
Kinetic energy - velocity
4.11.3 Energy Losses in the Circulatory System
As blood flows through the circulatory system there is a continual loss of energy
in the form of heat due to the friction that occurs between different layers of blood
flow, as well as the frictions that are caused by the vessel walls. Pressure and
energy levels naturally fall due to these frictions. The energy required to maintain
arterial pressure and blood flow is continually being restored by the pumping
action of the heart.

i

Viscous energy losses

These are energy losses due to the friction that occurs between the layers of blood
flow. Normal blood flow in a non diseased artery is referred to as laminar blood
flow (figure 4.28). The flow velocity in a normal non disease artery is identical
across the width of the artery. This is referred to as “Plug Flow” and is normally
seen in aorta or at vessel origins. A few centimetres down steam the blood flow
profile will change to laminar which can be described as successive cylindrical
layers.
With laminar flow each red blood cells move in one concentric layer (figure 4.28
A) in a highly organised manner with each layer travelling at a different velocity,
the layers adjacent to the vessel wall move at a slower speed to the layers in the
centre of the vessel (figure 4.28 B). This creates a “parabolic” or “cone shaped”
flow pattern. Laminar flow describes the viscous energy losses that occur between
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the layers of blood flow and that of the vessel wall resistance. When there is a
significant increase in velocity through an artery due to the presence of a stenosis
laminar flow breaks down and the blood flow is referred to as turbulent (figure
4.29). Turbulent flow is when the cells move randomly at all different speeds
however; they still maintain an overall forward flow. When turbulent flow is
present there is greater energy needed, this may be seen distal to a stenosis and an
increase in spectral broadening may occur due to the variety of velocities
involved. The blood flow within any vessel may not be moving at the same speed
at one particular point in time. Faster flow is normally observed closer to the
centre of the vessel, slower flow observed closer to the wall. This variation in the
speed of blood flow is referred to as the “blood flow profile”. The shape of the
profile will affect the appearance of the colour flow image and the Doppler
spectrum.

Figure 4.28: Laminar flow profiles within a non diseased artery
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Figure 4.29: Laminar and turbulent flow profiles
ii. Inertial Losses
Inertial losses occur as a result of changes in blood flow velocity or direction.
When there is a deviation from the laminar flow pattern resulting in disturbed flow
there is an inertial loss of energy. Disturbed flow can be a result of changes in
cardiac cycle, change in vessel diameter, a curve or bifurcation of a vessel.

Figure 4.30: Flow patterns observed at a carotid bifurcation
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Figure 4.30 describes the blood flow profiles that occur at the carotid bifurcation.
There is a change in blood flow profile form the parabolic profile seen in the
common carotid artery (CCA) to an asymmetric internal carotid artery (ICA) flow
pattern with higher velocities near the flow divider and flow separation opposite
the flow divider within the carotid bulb.
Figure 4.31 demonstrates the flow changes that occur at a curve. There is
distortion of the parabolic flow pattern caused by centrifugal forces, the highest
flow velocities are at the outside wall of the curve. This is commonly observed in
a tortuous ICA.

Figure 4.31: Flow profiles in a curved vessel

The final cause of inertial energy losses are the flow changes that occur within a
stenosis. The flow profile is always altered within an artery when there is a
narrowing or a stenosis present. There is a small amount of flow reversal that can
occur distal to vessel constriction. Flow velocity increases as blood moves through
a narrowing. As figure 4.28 demonstrates the wide area immediate to the
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narrowing, shows an area of flow reversal caused by the sudden changes in
pressure which occur when velocity increases through a narrowing.

Figure 4.32: Relationship of flow through a tube to cross sectional area

4.11.4 Poiseuille’s Law
Relationship of Blood Flow Velocity and Cross Sectional Area
The relationship between steady flow (Q) in a rigid tube of a given cross sectional
area A, and the velocity of the fluid V is described by:

Equation 4.13
Flow throughout the tube will remain constant so long as there are no outlets or
branches along it. The mean velocity of flow at any point along the tube will
depend on the cross sectional area at a given point. When the cross section area of
a tube changes and flow remains constant, then the velocity changes are related to
the changes in cross sectional area.

Equation 4.14
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This relationship is applied to flow through a rigid tube so it cannot be directly
applied to pulsitile flow through an artery however; it gives an indication to how
the velocity can change across a stenosed artery.
The velocity at any point in the circulatory system is dependent on the cross
sectional area but it is also dependent on the magnitude of blood flow(Q) which
depends on many factors such as pressure gradient and the properties of the fluid
and dimensions of the entire circulatory system.
Poiseuille’s law is an important law governing flow of fluid through cylindrical
tubes. In a cylindrical tube the mean linear velocity of laminar flow is directly
proportional to the energy difference between the ends of the tubes and the square
of the radius and is inversely proportional to the length of the tube and the
viscosity of the fluid.
When applied to the circulatory system, volume flow is of more interest than
velocity, volume flow is proportional to the forth power of the vessel radius,
because it is equal to the product of the mean linear velocity and the cross
sectional area of the tube. Poiseuille’s law is expressed as follows:

Equation 4.15

Q

= volume flow rate

r = Radius of the vessel

L

= Length of the vessel

n = viscosity of the fluid

Is the constant of proportionally
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P1-P2 = Pressure differential from the proximal to the distal end of the tube
Even small changes in the radius of the vessel will result in large changes in flow.
Flow varies directly with the pressure difference and the fourth power of the
radius of the vessel, and varies inversely as the length of the vessel and the
viscosity of the blood.
Poiseuille’s law proves that as the pressure differences increases the flow rate
increases, as the diameter of the tube increases the flow rate increases, as the
length of the tube increase the flow rate decreases and finally, as the viscosity of
the fluid increases the flow rate decreases.
The most import conclusion to be reached from Poiseuille’s equation is the
relationship between the radius of the vessel and flow, as the diameter increases
the flow rate increases, since the volume flow is proportional to the fourth power
of the radius; it is evident that very small changes in vessel diameter will result in
an increase in flow.
Since the length of the vessel and the viscosity (fluids resistance to flow) of the
blood flowing in the vessel remain constant, changes in blood flow occur mainly
due to changes in the radius of the vessel and the pressure gradient across the
vessel, this phenomenon is known as the Bernoulli Effect.
Turbulent flow can occur in a non diseased vessel due to vessel bifurcations and
tortuosity as we have stated. In order to quantify the amount of turbulence that
may develop in a non diseased vessel, the elements that may affect turbulence can
be related to each other by the Reynolds number.
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Equation 4.16
Reynolds number is unitless, as described in equation 4.14 we can derive several
relationships from this equation. As flow speed increases the Reynolds number
increases, as the vessel diameter increases the Reynolds number increases, as fluid
density increases, the Reynolds number increases and finally, as the viscosity of
the fluid increases, the Reynolds number decreases. A Reynolds number greater
than 2000 results in turbulent flow.
4.11.5

The Bernoulli Effect

The Bernoulli Effect demonstrates the changes in kinetic energy that occur as a
result of a stenosis, by converting pressure into velocity and back to pressure. In
the circulatory system changes in energy are made by measuring velocity and
pressure. When there is a stenosis present there is an increase in velocity at a
region of narrowing and thus the pressure decreases. Distal to the stenosis the
velocity decreases and the pressure increases.
The pressure never returns to the pre stenotic levels due to the fact that much of
the kinetic energy resulting from the increase in blood flow velocity within the
narrow portion of the vessel is dissipated in the turbulent jet that occurs after a
stenosis. The magnitude of the loss of energy is proportional to the degree of
stenosis. The Bernoulli Effect explains why there is a pressure drop distal to a
stenosis.
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4.11.6

Pressure Changes in Systemic Circulation

As a result of left ventricular contraction, the volume of blood in the arterial tree
increases rapidly, rising blood pressure to it systolic peak. However, when cardiac
contraction ceases, the outflow of blood through the peripheral resistance vessels
exceeds the volume of blood ejected by the heart and the pressure begins to fall.
This fall in blood pressure continues during diastole.
This pulsatile variation in blood volume and energy results in a pressure wave that
can be detected at any point along the arterial tree. The amplitude and the shape of
the wave depends on factors such as the stroke volume of the heart, the left
ventricular contraction, the stiffness of the arterial walls and the peripheral
resistance.
Thus, an increase in any of these factors will result in an increase in the pulse
amplitude.
The arterial pressure wave travels from the heart through the peripheral arteries.
The pulse wave’s velocity increases as the vessel walls become stiffer due to the
increasing muscle content and the ratio of wall thickness to vessel diameter.
Therefore, the speed of the propagation of the wave increases as it courses further
into the arterial tree. Pressure changes also occur as the pulse wave travels distally.
The mean systolic and diastolic pressure in the arterial tree falls between the aorta
and the peripheral resistance (figure 4.33). The amplitude of the pressure wave
and the systolic pressure actually increases as the wave travels distally. This is
referred to as systolic amplification and it occurs as the stiffness of the vessel
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walls increases as the wave travels distally and also due to the presence of
reflected waves by increasing peripheral resistance.

Figure 4.33: Normal pressure changes that occur in systemic circulation

Reflected waves occur at a site where vessel walls change in diameter, vessel
walls bifurcate or where vessel walls change in stiffness.

In extremities the

reflected waves are enhanced by the increase in peripheral resistance.
4.11.7

Velocity Changes in Systemic Circulation

In the extremity arteries of the peripheral arterial circulation there is forward flow
of blood noted during systole, but temporary flow reversal occurs during early
diastole, this is referred to as diastolic flow reversal. This may occur due to the
negative pressure gradient and peripheral resistance which causes a reflection
wave proximally. Late in diastole flow again returns to a forward direction as the
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reflected wave encounters the proximal resistance caused by the next oncoming
wave and therefore reverts. In general, diastolic flow reversal exists in the vessels
that supply the vascular beds with a high peripheral resistance such as the
extremities. Flow reversal decreases with vasodilation and increases with
vasoconstriction.

4.11.8

The Effect of Exercise on Arterial Flow

In a normal resting position, blood flow to the peripheries is sufficient to supply
the metabolic needs of the muscles. The skin and the peripheral nerves have the
highest metabolic needs at rest and so demand a large percentage of the blood
flow. Muscle at rest has a much lower metabolic need.
Exercises causes a large increase in cardiac output related to the increase in stroke
volume (the volume of blood pumped from one ventricle of the heart with each
heart beat) and heart rate as well as large increase in the volume of blood supplied
to the peripheral vascular bed and muscles. This flow increase is as a result of the
increased metabolic needs of the peripheral muscles secondary to exercise. Blood
flow increases as a result of the dilation of arterioles in response to the byproducts of increased metabolism.
The metabolic demands of exercise increase arterial flow to the muscular beds by
as much as five times the normal resting levels. When diseased arteries are
present, blood flow increase to the muscles is limited by the proximal resistance of
the arterial stenosis. A pressure drop also occurs across the stenosis, this pressure
drop can be measured at the level of the ankle.
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4.11.9

The Critical Stenosis

This is described as a narrowing of the arterial lumen resulting in a
haemodynamically significant reduction in volume, pressure and flow.
Blood flow within a stenosis will vary with the degree of reduction in the diameter
of the vessel. When a reduction is less than 70-80% the flow will remain relatively
unchanged, as the diameter of the vessel reduces the stenosis that is present will
limit the flow. Figure 4.34 shows that as the diameter of a vessel decreases the
velocity within the vessel will increase. It is for this reason that velocity changes
are considered a more sensitive method of detecting vessel lumen reduction. A
point will be reached on the graph were flow will drop to such a huge extent that
the velocity will be described as “Trickle Flow” within the vessel.

Figure 4.34: Altered flow velocities with a decrease in diameter reduction
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4.12 Arterial Stiffness
The pulsatile changes in blood volume and energy in each cardiac cycle is
manifested in a pressure wave that can be detected throughout the arterial system.
The amplitude and the shape of the arterial pressure wave depends on many
factors such as stroke volume, the time course of ventricular ejection, peripheral
resistance and the stiffness of the arterial walls. An increase in any of these factors
can cause an increase in the pulse amplitude i.e., the pulse pressure (a difference
between the systolic and the diastolic pressure).
Increase in the stiffness of the arteries tends to occur with many risk factors such
as age, diabetes, renal disease and other cardiovascular disease. The arterial
pressure wave is propagated along the arterial tree distally away from the heart.
The speed propagation of the wave (pulse wave velocity) increases with the
stiffness of the artery wall and with the wall thickness. Arteries become
progressively stiffer towards the periphery and therefore the speed of propagation
of the wave should increase as it moves peripherally.
Arterial stiffness can be assessed non-invasively by many indirect measurements
of pulse wave velocity (PWV) based on the time it takes the pulse wave to travel a
specific distance along the peripheral vasculature.
Critical points of these methods are the precise measurements of the pulse transit
times and the path length. PWV is being used more commonly now as a diagnostic
tool in the clinical setting to assess a patients cardiovascular risk. The relationship
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between the pulse wave and the elasticity of a thin walled elastic tube filled with
an incompressible fluid is expressed by Moen’s Kortweg equation (4.17).

Equation 4.17

ρb = Density of blood
E = elastic modulus
hv= thickness of the arterial wall
rvi = the internal radius of the artery

We take from this equation that the PWV is related to the square root of Young
modulus of elasticity (E) so measuring PVW is a method of measuring the
stiffness of the tube. Higher velocities are equal to higher values of arterial
stiffness. Blood density (ρ) should be constant and h and D may be estimated from
the B-mode image of the artery.
4.12.1 Factors affecting Pulse Wave Velocity
There are many factors and physiological parameters that affect pulse wave
velocity and can alter its end value such as age and cardiovascular health. It is well
known that arterial stiffness increases with age therefore, PWV will also increase
with age and cardiovascular disease. Some studies have shown that pulse wave
velocity can vary with respiration. The observed differences between inspiration
and expiration were less than 0.5m/sec. Typical common carotid pulse wave
velocity is between 6.8m/s and 8.3m/s. some studies have shown however that
eating prior to testing increases pulse wave velocity of the peripheral vessels.
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Chapter 5

Methodology
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5.1 Assessment of Lower Limb Arterial Disease
5.1.1 Introduction
The measurement of Ankle Brachial Indices (ABI’s) is a rapidly performed,
reproducible and quantitative method of assessing arterial blood flow to the lower
limbs. This is a non invasive investigation and is useful as a screening tool to
assess the presence and severity of peripheral arterial disease (PAD). In the
context of patients undergoing endovascular abdominal aortic aneurysm repair
(EVAR) ABI’s provide an objective measurement of the adequacy of lower limb
arterial inflow. This is an important aspect of EVAR surveillance as both the
introduction of a large delivery sheath to the ilio femoral vessels during stent
delivery or the presence of the graft itself may alter the haemodynamics of the
lower limb blood supply.

5.1.2 Patient Preparation
No specific preparation is necessary for this test. The patient was required to
remove their shoes, socks and any bulky clothing for the purpose of the test. The
test was then explained in full to the patient and any questions were answered.
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5.1.3 Ankle Brachial Index Equipment
All ABI measurements were carried out using a Vasogard Scimed Microlite
automated system (figure 5.0). Four blood pressure cuffs in total were used during
the test, one on each ankle and one on each arm (figure 5.2). An 8 MHz
continuous wave Doppler probe (figure 5.1) was used to insonate to the Doppler
waveform from the brachial artery (BA) in each arm, the posterior tibial artery
(PTA) and the dorsalis pedal artery (DPA) in each leg.

Figure 5.0: Scimed microlite automated ABI system
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Figure 5.1: 8 MHz continuous wave pencil probe

5.1.4 Performance of Ankle Brachial Indices
1.

Patients are examined while supine. Those patients who are unable to lie

supine are examined in the seated position with their legs elevated and this is
documented in the patient’s report.
2.

A pneumatic cuff is then carefully placed around each of the patient’s ankles

and each of the patient’s arms (figure 5.2). The end of an 8MHz continuous wave
Doppler probe is covered in ultrasound gel and the BA in the right arm is then
insonated.
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Figure 5.2: Placement of pneumatic cuffs for ABI measurement

3.

While the probe is held static and the technologist listen’s to the BA Doppler

signal, the pneumatic cuff is inflated until the signal is inaudible, indicating
occlusion of the artery.
4.

The cuff is then slowly deflated until the BA Doppler signal returns sharply.

The systolic pressure reading at this point is recorded and the remainder of the air
in the cuff is rapidly deflated.
5.

Steps 4 to 6 are repeated for the left arm.

6.

Using the 8 MHz continuous wave Doppler probe the Doppler signal in the

PTA in the right foot is insonated.
7.

The probe is adjusted until the best Doppler signal could be heard, at which

point the cuff is inflated until the PTA is occluded and the Doppler signal is
inaudible. The cuff is then slowly deflated until the signal sharply returns, this
systolic pressure is recorded.
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8.

The Doppler signal in the DPA in the right foot is then insonated. The cuff is

inflated until the artery is occluded and the DPA Doppler signal is inaudible. The
cuff is slowly deflated until the Doppler signal returns and the systolic pressure at
this point is recorded. The remainder of the air in the cuff is rapidly deflated.
9.

Steps 8 to 10 were repeated for the left leg.

5.1.5 Interpretation of Ankle Brachial Index Measurements
ABI’s are expressed as the ratio of blood pressure in the ankle to the blood
pressure in the arms (equation 5.1).

Equation 5.1

In a normal healthy resting individual, lying supine, the ankle systolic pressure
should be equal to or slightly greater that the brachial systolic pressure. However,
in all patients with PAD of the lower extremities, the systolic pressure of the lower
limbs will be less than the systolic pressure in the BA and the degree of this
reduction will correlate with the severity of the PAD present in that limb. Thus, a
normal ABI at rest should be greater than or equal to 1.0.
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Resting ABI

Severity of disease

>1.4

Incompressible arteries

>1.0

No arterial disease at rest

1.0-0.8

No significant arterial disease at
rest

0.8-0.5

Moderate disease at rest

<0.5

Severe disease at rest

<0.3

Critical ischemia at rest

Table 5.1: Interpretation of ankle brachial pressure index
(Cole, Norris and Walker. 2001)

Table 5.1 summarises the interpretation of ABI measurements currently used in
the MMUH vascular laboratory as recommended by the Society of Vascular
Technology of Great Britain and Ireland (SVT).
5.1.6 Limitations of Ankle Brachial Indices
Like all investigations ABI’s are not 100% sensitive of specific. The principle
limitation is in the assessment of patients with incompressible arteries, such as
those patients with diabetes or those with chronic renal failure. In these groups of
patients the ankle pressures obtained may be falsely elevated due to the inability of
the pneumatic cuff to occlude the rigid diseased arteries. In some cases the arteries
will not occlude even with an ankle pressure of >250mmHg. In these patients the
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measurement of the toe brachial pressure index (TBI) is a more accurate and
reliable method of assessing blood flow to the lower limbs as these smaller arteries
are less likely to suffer from calcification.
5.1.7 Toe Brachial Indices
Toe brachial indicies are performed using the same automated Vasogard Scimed
machine used for measuring ABI’s (figure 5.0). Four cuffs are used in total, one
on each of the patient’s arms and one on each of the patient’s great toes (figure
5.4). It is important to ensure that the patient’s feet are warm before carrying out
this test as the digital arteries are prone to vasoconstriction.
All toe pressures are performed by photoplethysmography (PPG) as follows.
1.

All patients should be preferably lying supine for this test. A toe cuff is

applied to each of the patient’s great toes and the PPG sensor (figure 5.3) attached
to the toe above the cuff (figure 5.4). The pressure in both great toes can be
recorded simultaneously.
2.

When a steady arterial waveform is displayed on the screen. The cuff is

inflated until the waveform is obliterated indicating occlusion of the digital artery
3.

The cuff is then slowly deflated until the waveform reappears. The arterial

waveform at the point of return is recorded.
4.

This BA pressures are measured as in method section 5.4 steps 1-5.
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Figure 5.3: A photoplethysmography sensor used for performing TBI’s

Figure 5.4: Blood pressure cuff and PPG sensor attached to a patients great
toe
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5.1.8 Interpretation of Toe Brachial Measurements
In the normal limb the baseline digital index should be greater than or equal to 0.6
(Cole, Norris and Walker. 2000). TBI are calculated as described in equation 5.2.
If PAD is present this value will drop accordingly. A systolic toe pressure
measurement of < 30mmHg indicates the presence of critical ischemia.

Equation 5.2
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5.2 Assessment of Carotid Artery Disease
5.2.1 Introduction
Colour Duplex ultrasound (CDU) of the carotid and vertebral arteries is a reliable
non-invasive method of screening for extracranial vascular disease. The accuracy
of carotid Duplex scanning in the assessment of the degree of internal carotid
artery (ICA) stenosis is approximately 90% if performed with proper technique
and interpreted by experienced clinicians with established and validated criteria
(Brown et al., 2004).
Carotid artery Duplex scanning combines B-mode imaging and CDU to give a
high resolution anatomical picture as well as accurate flow velocities through the
vessel, which allows the determination of the degree of narrowing to be accurately
calculated.
Multiple screening programmes use CDU successfully to diagnose extracranial
vascular disease quickly and effectively in the community thus, reducing the risk
of stroke in a high-risk population. Qureshi and colleagues in 2001 screened an
unselected patient population for carotid artery disease and discovered that
smoking, hypercholesterolemia, coronary artery disease (CAD) and age greater
than 65 years were associated with an ICA stenosis of >60% by standard Duplex
scanning. Jacobowitz et al., 2003 documented that 9.3% of patients screened for
CAD were found to have a unilateral or a bilateral carotid artery stenosis, the
absence of risk factors such as smoking, hypertension, cardiac disease and
hypercholesterolemia was associated with a 1.8% incidence of carotid artery
stenosis. When one risk factor was present this increased to 5.8%, rising to 13.5%
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if there were two present and 16.7% if three risk factors were identified. The
authors concluded that the presence of carotid artery stenosis increases
significantly in the presence of one or more risk factor and that carotid artery
screening is justified in a select group of patients where treatment of carotid artery
disease is fundamental to stroke prevention.
5.2.2 Patient Preparation
No specific preparation is necessary for this investigation. The patient is required
to lie supine on the examination table and loosen the clothing around their neck to
allow the technologist to gain access to the vessels to be interrogated (figure 5.5).

Figure 5.5: Patient positioning for carotid and vertebral artery Duplex
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5.2.3 Equipment
All carotid Duplex scans were performed using one of 3 high resolution
ultrasound machines was used a Siemens Sequoia 512 Ultrasound System, a
Siemens S2000 Ultrasound System (figure 5.6) or, a Phillips IU22 Ultrasound
System. All CDU scans were performed using a multi frequency linear array
transducer (figure 5.7).

Figure 5.6: A Siemens S2000 ultrasound system
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Figure 5.7: A 7MHz linear array probe
5.2.4 Procedure for Carotid and Vertebral Artery Duplex
1.

All patients are scanned in the supine position with their head rotated initially

to the left to allow assessment of the right carotid and vertebral arteries and then to
the right to scan the contralateral vessels.
2.

Beginning at the base of the right side of the neck with the transducer placed

transversely across the neck in an anterolateral approach the common carotid
artery (CCA) is initially assessed in B-mode in a transverse plane (figure 5.8).
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IJV
CCA

Figure 5.8: The CCA in a transverse plane in B-Mode
3.

The transducer is slowly advanced towards the earlobe making note of any

plaque, thrombus or any wall abnormality.
4.

The transducer is gradually moved towards the jaw bone until the bifurcation

appears as two round structures in the centre of the image, the internal jugular vein
(IJV) will also be imaged at this level (figure 5.9). One being the ICA and the
other being the external carotid artery (ECA). The ECA may be identified at this
stage by its branches. The ICA does not branch extracranially.

ECA

ICA

Figure 5.9: The carotid bifurcation in transverse plane in B-Mode

190

5.

A note is made of any plaque, thrombus or wall abnormality that is present.

6.

Steps 2-7 are then repeated this time using colour Doppler imaging.

7.

Returning to the base of the neck the transducer is placed in a longitudinal

orientation (figure 5.10) and slowly moved towards the ear lobe making note of
any plaque, dilations or any abnormalities.

Figure 5.10: The CCA in a longitudinal plane in B-Mode
8.

The bifurcation eventually becomes evident. It is important to identify two

vessels at the bifurcation (figure 5.11). Both vessels may not be imaged on the
same plane.
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CCA

Figure 5.11: The carotid bifurcation in longitudinal plane in B Mode
9.

Steps 1-4 are repeated in longitudinal orientation with the colour flow on

(figure 5.12).

Carotid
Bifurcation
with colour
flow

Figure 5.12: The carotid bifurcation in a longitudinal plane in colour flow
10. Returning to the base of the neck the CCA is assessed in a longitudinal plane,
with colour flow on and the Doppler sample volume placed in the centre of the
vessel (figure 5.13).
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Doppler sample
volume in the centre
of the vessel

Figure 5.13: Assessment of the CCA with the Doppler sample volume
placed in the centre of the vessel

11. The Doppler spectral waveform is recorded at several points in the CCA,
taking note to record the increase in velocity proximal to, at and distal to any
plaque.
12. The transducer is then moved to the bifurcation and the ECA is identified and
assessed with the Doppler sample volume (figure 5.14).

Doppler
assessment
of the ECA
Figure 5.14: Assessment of the external carotid artery
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13. The ICA is then identified and assessed with the Doppler sample volume.
The maximum peak diastolic velocity (PSV) and end diastolic velocity (EDV)
throughout the ICA are recorded (figure 5.15). Care is taken around plaques to
ensure the maximum velocities proximal to, at and distal to the plaque are gained
and recorded.

Doppler
assessment
of the ICA
Figure 5.15: Assessment of the internal carotid artery
14. Steps 1-13 above are all repeated with the patients head turned to their right
in order to assess the left carotid and vertebral arteries.
5.2.5 Interpretation of Carotid and Vertebral Artery Duplex
The relationship between the progressive increases in flow velocity which occurs
in accordance with the degree of stenosis is used as the basis for estimating the
degree of narrowing in the ICA.
The degree of ICA stenosis is based on the analysis of the maximum PSV and the
EDV obtained within the ICA and the relationship of the PSV in the ICA to the
PSV in the CCA. Plaque can be identified in both B-Mode and colour Doppler
imaging. However, as the degree of visible lumen depends on the view used, a
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stenosis can often be overestimated or underestimated if this is the sole method
employed. Therefore, flow velocities are a more accurate way of quantifying the
level of stenosis present.
When there is a greater than 50% stenosis present the flow velocities will rapidly
increase. Measurement of the PSV, EDV and the ratio of the PSV in the ICA to
the PSV in the distal CCA are the most commonly used measurement. Using these
measurements the velocity increase is classified into one of six stenosis categories.
The velocity criteria employed in the MMUH is recommended by the Society of
Vascular Technology (Oates CP et al., 2008).
Stenosis Category

Velocity Criteria

0-29%

PSV <100cm/sec in the presence
of plaque

30-49%

PSV >100cm/sec <125cm/sec in
the presence of plaque

50-69%

PSV >125cm/sec
EDV <140cm/sec

70-80%

PSV > 125cm/sec ICA/CCA ratio
of 4

80-90%

PSV >125cm/sec
EDV >140cm/sec

90-99%

PSV >125cm/sec
EDV >200cm/sec

Occlusion

No colour flow or Doppler signal

Table 5.2: Interpretation of internal carotid artery velocities
(Oates CP et al., 2008)
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A very high grade stenosis of the CCA or the ICA on one side may lead to
increased compensatory flow in the contralateral carotid arteries. This creates an
increase in flow velocities on the other side which may be wrongly interpreted as
representing a degree of disease more extensive than that which actually exists.
Thus a carotid artery stenosis can appear to reduce in severity on ultrasound
following a carotid endertrectomy (CEA) that has been performed on the opposite
side.
All Doppler waveforms should be obtained in a longitudinal plane with colour
Doppler on and with an angle of insonation as close to 60 degrees as possible. All
PSV and EDV values obtained with an angle greater than 60 degrees are
inaccurate and may lead to over or underestimation of a stenosis. When there is
plaque present a Doppler sample should be obtained proximal to the plaque,
within the area of stenosis and distal to the plaque. In all cases the highest PSV
and EDV are used to derive the percentage value of the stenosis.
Colour flow is used in all cases as it enables us to quickly and accurately identify
the area of narrowing and the region at which the highest velocities will be
obtained, this region is commonly referred to as the “jet” (figure 5.16). It also
enables us to diagnose an occlusion of the vessel quickly and accurately (figure
5.17).
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High grade
stenosis of
distal ICA

Figure 5.16: A high grade stenosis in the distal internal carotid artery

Occluded
ICA

Figure 5.17: A total occlusion of the internal carotid artery
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5.2.3.1 Vertebral Artery Analysis
All standard carotid Duplex scans should routinely involve examination of the
vertebral arteries. Figure 5.18 represents the vertebral artery in B-mode with the
shadowing from the cervical vertebrae obscuring portions of the image.

Shadowing of
vertebral
artery by
cervical
vertebral

Figure 5.18: Shadowing from the cervical vertebrae
Patency of the vertebral arteries and flow direction should be documented. Figure
5.19 demonstrates a widely patent vertebral artery and assessment of flow through
the portion of the artery imaged. However, assessment of stenotic lesions may be
difficult due to the shadowing from the cervical vertebrae which only permits
assessment of the segmental portions of the arteries see figure 5.19. Reversal of
flow in the vertebral arteries indicates a stenosis or occlusion of the proximal
subclavian arteries or the innominate artery. When there is only a partial occlusion
of these arteries there will be a drop in the systolic portion of the waveform.
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Doppler
sample from
vertebral
artery

Figure 5.19: Doppler spectral analysis of the vertebral artery
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5.3 Abdominal Aortic Aneurysm Surveillance
5.3.1 Introduction
Ultrasound has been used in the diagnosis of abdominal aortic aneurysms (AAA)
since the 1960’s. An AAA was first demonstrated on ultrasound by Donald and
Brown in 1961. Using, Amplitude-Mode (A-Mode) ultrasound they were able to
demonstrate a one dimensional view of the aneurysm. Multiple studies have long
since demonstrated the accuracy of ultrasound in determining the maximum AAA
diameter (Bernstein et al., 1976). The United Kingdom small aneurysm trial
(UKSAT) highlighted the use of Duplex ultrasound as a tool for the surveillance
for AAA’s.
All patients that have been diagnosed with an AAA in the MMUH vascular
laboratory are followed up routinely according to the standard follow up protocol
for AAA (Chaikof et al., 2009), Table 5.3.
5.3.2 Patient Preparation for Abdominal Aortic Duplex Scanning
All patients are required to fast for at least 6 hours prior to the examination to
minimise the effects of bowel gas on the imaging. Where possible all routine
surveillance scans are carried out in the morning as bowel gas is naturally less in
the morning. The patient is then asked to loosen or remove any constrictive
clothing from their abdomen and loosen the waist band on their trousers (figure
5.20).
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Figure 5.20: Patient positioning for abdominal scanning

5.3.3 Equipment used in Abdominal Aortic Duplex Scanning
All abdominal aorta scans are performed by a qualified vascular technologist on
one of two machines a Siemens Sequoia 512 ultrasound system (figure 5.6) or, a
Phillips IU22 ultrasound system both using a curvi linear array transducer (figure
5.21) operating at the optimum frequency (2-5MHz).
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Figure 5.21: A multi frequency curvi linear ultrasound transducer

5.3.4 Procedure for Duplex Ultrasound of Abdominal Aortic Aneurysms
1.

The patient lies supine on the bed with their hands either by their side or

placed behind their head.
2.

Ultrasound gel is applied to the patient’s abdomen and beginning in B-Mode

and transverse orientation the abdominal aorta is imaged from the diaphragm to
the level of the iliac bifurcation (figure 5.22).
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AAA measured
from outer wall
to outer wall

Figure 5.22: An AAA measured from outer wall to outer wall
3.

The presence of any aneurysmal dilatation or thrombus is noted and the

maximum diameter is recorded at multiple sites along the aorta (figure 5.22).
4.

All measurements are taken from the outer wall to the outer wall and the

maximum measurement obtained was recorded and used for comparison in the
next follow up scan.
5.

The iliac arteries are then imaged in a transverse plane in B-Mode from the

level of the iliac bifurcation to the common femoral arteries (CFA) where possible
(figure 5.23).
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Iliac arteries
imaged in
transverse plane

Figure 5.23: A transverse image of the iliac arteries in B-Mode

6.

The maximum anterior to posterior wall (AP) and maximum transverse

diameters are obtained at multiple sites along the artery and the maximum of the
two measurements is recorded.
7.

The aorta is then imaged in a longitudinal plane in B-Mode from the

diaphragm to the level of the iliac bifurcation.
8.

The location of the aneurysm to the renal arteries is examined, the extent and

the presence of thrombus is noted.
9.

The Iliac arteries were also imaged in B-Mode in a longitudinal plane and the

extent of an iliac artery aneurysm if present was noted.
10. Using colour flow and spectral Doppler, the aorta and the iliac arteries are
examined in a longitudinal plane for the presence of a stenosis.
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5.3.5 Interpretation of Abdominal Aortic Duplex Scanning
With much debate as to the exact definition of an aneurysm in the literature the
most widely accepted definition is “an artery is considered aneurysmal when its
diameter equals or exceeds 1.5 times the normal diameter of the artery in question.
The normal diameter of the aorta in the majority of adults does not exceed 2cm
and so it is considered aneurymsal at 3cm” (Zweibel. 2005).
Iliac artery aneurysms can occur in conjunction with an AAA or in isolation. As
well as determining the maximum diameter of the aorta when following up a
patient with an AAA it is also important to determine the aneurysm’s relationship
to the renal arteries. The majority of AAA’s occur more than 1.5cm below the
renal arteries terming them “infra renal”, however they can also occur at the level
of the renal arteries “juxta renal” or above the renal arteries “supra renal”.
Approximately 95% of all aneurysms of the abdominal aorta are localised to the
infra renal segment and are due to atherosclerosis of the aorta (Winterstein and
Baxter, Chapter 34, page 449, Essential Practices of Surgery).
Aneurysms of the aorta are termed “true aneurysms”; they are permanent dilations
and involve all three layers of the artery wall. They can be fusiform or saccular
and this should be documented on the report.
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Figure 5.24: Different forms of abdominal aortic aneurysms

The vascular laboratory in the MMUH routinely follows up all AAA’s according
to a standard protocol summarised in Table 5.3.

Aneurysm Size

Follow up period

2.5cm - 3.0cm

2 Years

3.0cm - 4.0cm

Yearly

4.0cm - 4.5cm

6 monthly

>4.5cm

3 monthly

Table 5.3: Protocol for surveillance of small AAA’s in the MMUH
(Chaikof et al., 2009)
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5.4 Colour Duplex Ultrasound Surveillance of Patients Post Endovascular
Aneurysm Repair
5.4.1 Introduction
The surveillance of patients post EVAR is essential due to a number of
complications that can occur. Endovascular grafts are a relatively new and
evolving technology and thus require lifelong surveillance to monitor for
unforeseen complications. CDU is a non invasive and reproducible method of
surveying this particular group of patients.
There are three main objectives in CDU assessment of patients following EVAR.
1.

Ensuring that the residual aneurysmal sac is not increasing in size

2.

Ensuring that there is no perigraft blood flow

3.

Ensuring that there is no evidence of a stenosis or occlusion in the graft,

leading to a reduction in flow to the extremities.
5.4.2 Patient Preparation
The patient is required to fast for at least six hours prior to the exam, with the
majority of all surveillance scans being carried out in the morning to minimise the
effect of bowel gas on imaging. The patient is asked to loosen or remove any
restrictive clothing from their abdomen and the waist to ensure the abdomen is
visible (figure 5.20).
The patient’s personal details are correlated with records before proceeding to the
exam room. A brief history is taken from the patient noting any new symptoms
since their last visit. It is extremely import to note any new onset of symptoms
such as claudication as this may indicate a new occlusion or stenosis of a graft
limb.
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5.4.3 Duplex Ultrasound Equipment
All CDU scans on EVAR patients are performed by the same accredited vascular
technologist using a Siemens Sequoia 512 ultrasound system with a wideband
curved linear array transducer (6C2, figure 5.21).
5.4.4 Procedure for CDU surveillance of patients post EVAR
1.

The patient is required to lie supine on the bed with their hands by their side

(figure 5.20).
2.

ABI’s are performed on all patients on both lower limbs prior to their

ultrasound exam following the protocol documented in section 5.1.4.
3.

Each exam commences with imaging of the residual aneurysm in a transverse

plane in B-mode from the diaphragm to the iliac bifurcation. Multiple
measurements are obtained of the residual aneurysm sac in the transverse plane
(figure 5.25).

Measurement
of residual
aneurysm

Figure 5.25: Measurement of the residual aneurysm
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4.

The maximum measurements of the residual aneurysm sac are recorded and

compared to the last scan report measurements to ensure that there has been no
significant increase in sac size.
5.

Careful note is made in B-mode of the stent walls to ensure that there is no

evidence of obvious defects or kinking of the metal exo-skeleton.
6.

The iliac arteries are imaged in B-mode throughout their entire length.

Multiple Transverse and AP measurements are obtained (figure 5.26) and the
maximum of the two measurements recorded for follow up purposes.

Iliac
arteries in
transverse
Figure 5.26: Transverse imaging of the residual aneurysm in B-Mode

7.

Careful attention is given to the iliac limbs of the stent in B-mode to ensure

there is no evidence of graft compression or separation of modular junctions or
kinking (figure 5.26).
8.

The stent and residual aneurysm sac are then assessed using colour flow and

spectral Doppler to rule out the presence of an endoleak. This required the use of
very sensitive colour flow scale settings to determine the presence of low velocity
leaks which may have been present within the residual aneurysm sac (figure 5.27).
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Iliac arteries
in transverse
with colour
flow

Figure 5.27: Assessment of the residual AAA with colour flow

9. The stent is then assessed, again beginning at the diaphragm and continuing to
the iliac bifurcation, careful attention is given to both the proximal and the distal
anastomosis sites to ensure that there was no evidence of high jet flow indicating a
Type 1 endoleak.
10. Low velocity flow within the old aneurysm sac demonstrating forward and
reversed flow indicates the presence of a Type 2 endoleak which may represent
patent lumbar arteries or a patent inferior mesenteric artery.
11. Careful note is given to the iliac bifurcation to ensure that there is no
evidence of a Type 1 of Type 3 endoleak at the iliac junction.
12. Finally, the iliac limbs are assessed using both colour flow and Doppler
ultrasound to ensure that both the limbs were patent and that there is no increase in
flow indicating that there may be a stenosis resulting from graft compression or
kinking.
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5.4.5 Interpretation
i

Residual Aneurysm Size

A successful EVAR results in complete exclusion of the aneurysm from the
systemic circulation. An aneurysm that has been successfully excluded should
naturally decrease in size or remain stable. The residual aneurysm sac size should
be compared to the previous exam to ensure that there is no growth in the
aneurysm as an increase in size may indicate the presence of an endoleak from the
graft or the phenomenon of endotension (Chapter 3, section 3.6.2).
Any patient with a significant increase in sac size between each visit should be
investigated thoroughly, if there is a documented endoleak on CDU they should be
referred for further imaging such as CT or angiography. Any examination that
does not completely visualise the entire residual sac should be documented as
limited or inconclusive and the scan should be repeated or an alternative imaging
modality should be recommended.
ii

Endoleaks

An endoleak is identified by detecting the presence of colour flow outside of the
stent walls, within the residual aneurysm sac. When an aneurysm has been
excluded from the systemic circulation the blood flow within the residual sac
tends to clot naturally over time and will appear echogenic on a B-Mode image. A
residual aneurysm that contains echolucent regions within the residual aneurysm
over time should raise suspicions for the presence of an endoleak. The Doppler
waveform obtained from an endoleak should be reproducible in all cases.
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Endoleaks can be classified in to four categories as explained previously in
Chapter 3.0.
5.5 Measurement of Pulse Wave Velocity Using CDU
5.5.1 Introduction
Pulse wave velocity (PWV) is universally regarded as the gold standard method of
determining arterial stiffness in individuals. The PWV of arteries naturally
increases with age and increased arterial stiffness is thought to be an indicator of
underlying cardiovascular disease (Blancher et al., 1999, Laurent et al., 2000).
PWV is a non invasive method of determining arterial stiffness. The traditional
method of measuring PWV utilises an ECG trace as a timing reference, sensors
are applied aver the carotid and the femoral arteries sequentially. The transit time
between the upstroke of the carotid arteries and the femoral arteries can then be
determined. It can however also be determined by the transit time between the
Doppler velocity signal in the common carotid and the common femoral arteries
(Jiang et al,. 2007).
There are many commercially avaible systems on the market today to measure
PWV however, a standard Vascular Ultrasound system can also be used. Jiang and
colleagues in 2007 compared the measurements made by a commercially avaible
PWV system and a standard vascular ultrasound system demonstrating no
significant statistical difference between the two systems.
Vascular ultrasound scanners are available in all vascular laboratories thus making
the measurement of PWV practical in a clinical setting without the acquisition of
additional equipment
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5.5.2 Patient Preparation
No specific preparation is required for this procedure. The patient is required to
remove the clothing from their chest area, loosen the clothing around their groin
and lie supine for 10 minutes prior to the exam to allow their blood pressure to
normalise.
5.5.3 Ultrasound Equipment
All PWV ultrasound scans were carried out using a Phillips IU22 Ultrasound
System utilizing a 7-10MHz linear array transducer by the same accreditated
vascular technologist in a temperature controlled room of 20 degrees. The ECG
was attached to the patient appropriately and adjusted until a steady waveform was
obtained.
5.5.4 Procedure
1.

The patient is required to lie supine and rest for 20 minutes prior to

commencement.
2.

Using a standard commercial tape measure the distance between the sternal

notch and the femoral arteries was measured. This is the path length (L).
3.

Ultrasound gel and the linear probe was applied to the right side of the

patient’s neck and the probe was adjusted until a clear image of the right CCA
proximal to the bifurcation was obtained in a longitudinal plane.
4.

The Doppler sample gate was placed in the right CCA approximately 2 cm

proximal to the bifurcation and the Doppler spectral waveform and the ECG trace
were then recorded simultaneously for several cycles.
5.

The time interval between the R waves of the ECG to the foot of the Doppler

waveform was determined using the onboard computer and callipers. The foot of
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the waveform was identified by the intersection of the upstroke of the wave with
the base line of the zero frequency (figure 5.28).

Figure 5.28: Measurement of time interval between the R-wave of an ECG
trace to the foot of the Doppler waveform in the right CCA
6.

The femoral arteries were then identified by applying ultrasound gel and the

linear probe to the patient’s groin area and the probe adjusted until a clear image
of the CFA 1-2cm proximal to the bifurcation was obtained in a longitudinal
plane.
7.

The sample gate was place in the right CFA and a Doppler spectral waveform

and the ECG trace were recorded for several cycles (figure 5.29).
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Figure 5.29: Measurement of time interval between the R-wave of the ECG
trace to the foot of the Doppler waveform in the right CFA

5.5.5 Interpretation
The PWV was calculated for each patient using the following formulae as
described previously by Jiang et al., 2007.

Equation 5.3
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Figure 5.30: Measurement of PWV using the R-wave of the ECG trace as a
timing reference
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Chapter 6

Colour Duplex Ultrasound as a Screening Tool for
Peripheral Arterial Disease and Carotid Artery
Disease in Patients with Abdominal Aortic
Aneurysms
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6.1 Introduction
Atherosclerosis is a systemic disease, with peripheral arterial disease (PAD),
carotid artery disease (CAD) and coronary artery disease often co-existing
together (Sukhija et al., 2004). A relationship between CAD, PAD and coronary
artery disease has long been established. Kallikazaros et al., in 1999 examined the
relationship between coronary artery disease and CAD; they concluded that CAD
was significantly related to the presence and severity of coronary artery disease.
And the presence of CAD in patients with chest pain reflects the presence of
coronary artery disease. Klop and colleagues in 1991 demonstrated that PAD and
CAD co exist, suggesting that patients presenting with symptoms of PAD should
also be screened for CAD. In patients with overt cardiovascular disease, the
presence of PAD is associated with an increased risk of myocardial infarction
(MI), ischemic stroke, and vascular death (Hiatt and Krantz. 2006). Occlusive
PAD of the lower extremities is a common but often overlooked condition. Its age
adjusted prevalence is 12% and the risk of developing PAD more than doubles
each decade after the age of 40 years (Hiatt and Krantz. 2006). Patients with PAD
also show a 2 to 6 fold increase in the incidence of cardiovascular death
(Cimminiello et al., 2010). Criqui et al in 2008 demonstrated that after a 5 year
follow up of 100 patients with PAD, 16 had died of cardiovascular causes, 4 of
cerebrovascular causes, 3 of other vascular causes and 7 of non vascular causes,
equating to 30% mortality at 5 years. Carotid artery intima medial thickness (IMT)
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has also been widely described as a marker of the presence of CAD (Kallikazaros
et al., 1999) and has been previously correlated with the severity of coronary
artery disease (Adams et al., 1995). The exact causes of the degenerative process
remain unclear. Patients with AAA’s commonly have manifestations of
atherosclerotic cardiovascular disease (Hultgren., et al 2007) yet there is little in
the literature to suggest that screening this select group of patients for other
vascular disorders is a worthwhile exercise.
Colour Duplex ultrasound (CDU) is a non invasive, safe, reliable and
inexpensive method of screening patients for CAD. The sensitivity of CDU for the
detection and grading of carotid artery lesions has been reported to be as high as
90% (Wain et al., 1998). However, despite the advantages of CDU, identifying
candidates for carotid endarterectomy (CEA) with mass screening costs more per
quality life adjusted year than is usually considered acceptable (Kurvers et al.,
2003). The identification of a group at high risk of having occult CAD to allow
more focused screening is paramount. Carotid artery disease is associated with a
risk of stroke that increases with the severity of the internal carotid artery (ICA)
disease that is present (Busuttil et al., 1996).
Asymptomatic carotid disease, defined as the presence of internal carotid
artery stenosis, carotid bifurcation stenosis or occlusive lesions in patients with no
signs or symptoms of cerebrovascular disease (Halliday et al., 1994) may progress
to symptomatic disease within a mean time of 3-4 years. Thus there is merit in
identifying and treating patients with an asymptomatic stenosis prior to it
becoming symptomatic. The difficulty lies in identifying a population to screen for
asymptomatic carotid disease. The frequency of stroke in asymptomatic patients
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with a haemodynamically significant ICA stenosis is 2-5% (Rancic et al., 2002).
The asymptomatic carotid surgery trial (ACST) demonstrated that at 5 years the
risk of stroke or death in patients that underwent CEA was found to be 6.4%
compared to the 11.8% in the patients treated medically. The ACST also
demonstrated that patients with an asymptomatic carotid artery stenosis who have
undergone CEA are less likely to have a disabling stroke (3.5% in the surgical
group compared to the 6.1% in the non surgical group).
Identifying patients with an asymptomatic carotid artery stenosis usually
occurs in one of 2 ways, either identification of a bruit during routine physical
exam, or during an ultrasound screening programme. The current known rate of
TIA or stroke in patients with asymptomatic carotid artery disease of 5-18% is
dependent on the severity of the stenosis present and the nature of the plaque
itself.
PAD of the lower limbs is thought to be a marker of cardiovascular ischemic
events. It is easily detected by the measurement of Ankle Brachial Indices (ABI’s)
yet it still remains widely unrecognised by clinicians and the general population
(Cimminiello et al., 2010). The ABI is a ratio of the ankle to brachial systolic
pressure with a value of less than 0.9 at rest indicating the presence of lower limb
arterial disease. ABI’s have an inter observer variability as low as 7%, a sensitivity
of 90% and specificity of 98% for detection of arterial lesions greater than 50% in
the lower limbs (Quriel et al., 1982). Despite this, PAD is still thought to be an
under diagnosed lifestyle limiting disease that can be an indicator of
atherosclerosis in other vascular territories such as the carotid and coronary
arteries (Dooby and Anand. 2005). Under diagnosis of PAD is largely due to the
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fact that patients suffering with this disease initially present with symptoms of
intermittent claudication. Early detection of PAD in some patients may be limited
due to their inability to walk as they may suffer from other illnesses. There is
evidence to suggest that PAD is a strong predictor of future cardiovascular
outcomes such as myocardial infarction (MI), stroke and death (Vogt et al., 1993).
Similar to CAD, identification of a high risk group to screen for occult
asymptomatic PAD is an important step in cardiovascular risk reduction in the
population.
The objective of this study was to determine the presence and severity of
asymptomatic CAD and PAD in patients with known AAA’s who are perhaps an
unscreened population for atherosclerotic disorders in other vascular territories in
order to determine if this would be a reasonable focus group to screen for occult
CAD and PAD.
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6.2 Patients and Methods
Following approval from the hospital ethics committee, a retrospective audit of all
patients attending the vascular laboratory of the Mater Misericordiae University
(MMUH) hospital between the 1st of January 2007 and the 31st of December 2009
was performed.
All patients that had a known AAA who had either a CDU or ABI’s to determine
the presence of CAD and PAD as part of their surveillance were included in the
study. The patients pre-existing risk factors were obtained from the patient’s
clinical notes. The risk factors variables that were examined in the study included
age, gender, diabetes mellitus, history of coronary artery disease, hypertension,
hypercholesterolemia, smoking status and family history of an AAA.
In this time frame 389 patients were identified on the aneurysm surveillance
programme in the MMUH with a mean (

age of 76 (

years. There

were 305 (78.4%) male patients and 84 (21.6%) female patients. The mean male
age was 75.4 (

years and the mean female age was 77(
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years.

6.2.1 Patient Demographics
The patient’s risk factors and demographics are summarised in figure 6.1 below.
Of the 389 patients included in the study demographics were not available in 27
(6.9%) patients due to deficiencies in the patient’s notes.

Figure 6.1: Patient demographics
Of the 26 (6.6%) patients with a known family history of AAA, the mean (
age was found to be 74 (
male with a mean (
mean (

age of 78 (

7) years. Twenty two (84.6%) of the 26 patients were
age of 74 (

7) years. Four (18.2%) were female with a

4.5) years.

223

6.2.2 Carotid Artery Disease
Of the 389 patients included in this study, 332 (85.4%) patients had a CDU scan
performed to determine the presence of CAD at the time of study completion. The
mean (

age of this group was found to be 76 ( 7.6) years.

Colour Duplex Ultrasound
All CDU scans were carried out by a qualified vascular technologist using one of
three machines, a Siemens Sequoia 512 ultrasound system, a Siemens S200
ultrasound system (Chapter 5.0, figure 5.6) or a Phillips IU22 ultrasound system
all using a multi frequency linear transducer (Chapter 5.0, figure 5.7).
All patients were scanned in the supine position in a darkened temperature
controlled room following the standard clinical measurement protocol for carotid
and vertebral artery Duplex as previously described in Chapter 5 section 5.2.4.
Carotid artery stenosis was graded according to the maximum peak systolic
velocity (PSV) and end diastolic velocity (EDV) and interpreted as previously
described in Chapter 5.0 section 5.2.5.
A haemodynamically significant stenosis was defined as a greater than 50%
internal carotid artery (ICA) stenosis. Patients with a carotid artery stenosis of less
than 50% were taken to have no significant CAD.
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6.2.3 Peripheral Arterial Disease
Of the 389 patients included in the study 289 (74.2 %) of patients had either ABI’s
or TBI’s performed at the time of study completion to determine the presence of
PAD at rest. The mean (

age of the 295 patients was found to be 76 (

8)

years.
Ankle Brachial Indices and Toe Brachial Indices
All ABI’s and TBI’s were performed in a temperature controlled room with the
patient lying supine using an automated Vasogard Microlite system (Chapter 5.0,
figure 5.0) following the standard clinical measurement protocol for measurement
of ABI’s and TBI’s as previously described in Chapter 5 section 5.1.4 and 5.1.7.
All results were interpreted as previously described in Chapter 5.0 section 5.1.5
and 5.1.8. TBI’s were only performed in patients who were known diabetics and
patients with falsely elevated ankle pressures (>220MMHg).
PAD was defined as having an ABI less than 0.9 at rest or a TBI of less than 0.6 at
rest. The severity of the PAD at rest was classified into mild, moderate and severe
as described in Table 6.1 and 6.2 (Vascular Laboratory Practice Part III, First
Edition, Cole, Walker and Norris).
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ABI

Severity of
PAD at rest

>0.9

Normal

0.8-0.9

Mild

0.5-0.8

Moderate

<0.5

Severe

Table 6.1: ABI classification of PAD

TBI

PAD
Classification

>0.6

Normal

0.5-0.6

Mild

0.3-0.5

Moderate

0.2 or 30mmHg

Severe

Table 6.2: TBI classification of PAD
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6.3 Results
6.3.1 Carotid Artery Disease
Of the 332 patients that had a CDU for the detection of CAD, 101 (30.4%)
patients had a significant carotid artery stenosis (>50%) in either the right or the
left ICA or both. The remaining 231 (69.5%) patients had no significant CAD
(<50%) on either side.
Of the 101 (30.4%) of patients with significant CAD, 56 (55.4%) patients had
bilateral disease and 45 (44.6%) patients had unilateral disease. The total of 202
ICA’s in these 101 patients were classified into one of 5 categories according to
the severity of the CAD present (figure 6.2).

Number of Patients
Patients screened for CAD

332

Significant CAD

101(30.4%)

(>50% ICA stenosis)
No significant CAD

231(69.5%)

(<50% ICA stenosis)

Table 6.3: Summary of 332 AAA patients screened for carotid artery disease
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Stenosis Category

Number of ICA’s

<50%

48 (23.7%)

50-69

83 (41.1%)

70-80

22 (10.9%)

80-90

10 (4.9%)

90-99

17 (8.4%)

Occluded

22 (10.9%)

Table 6.4: Distribution of the 202 ICA’s in 101 patients with significant CAD
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Figure 6.2: Bar chart illustrating distribution of patients with significant CAD

229

6.3.2 Peripheral Arterial Disease
Of the 289 patient included in this group 131 (45.3%) were found to have PAD at
rest. The remaining 158 (54.7%) patients had an ABI greater than 0.9 or a TBI
greater than 0.6 at rest and were therefore determined to have no PAD at rest
(figure 6.3).
Number of Patients

Total patients screened for PAD

289

Significant PAD at rest

131 (45.3%)

No significant PAD at rest

158 (54.7%)

Table 6.5: Summary of 289 AAA patients screened for PAD at rest
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Figure 6.3: Summary of 289 AAA patients screened for PAD at rest
Of the 131 patients with PAD at rest 60 (45.8%) were found to have unilateral
PAD and 71 (54.1%) were found to have bilateral disease (figure 6.4).

Figure 6.4: Breakdown of patients with significant PAD
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Unilateral

Mild

Moderate

Severe

Mixed

24 (40%)

33 (55%)

3 (5%)

0 (0%)

5 (7%)

31 (44%)

0 (0%)

34(48%)

PAD
Bilateral
PAD

Table 6.6: Division of patients with unilateral and bilateral disease
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Figure 6.5: Division of patients with unilateral PAD

Figure 6.6: Division of patients with bilateral PAD
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6.3.3 PAD and CAD
Of the 389 patients on the current aneurysm surveillance programme 289 patients
had both a CDU scan for detection of carotid artery disease and ABI for the
detection of PAD. 59 (20.4%) patients had both significant PAD and CAD. The
mean (

SD) age in this group was found to be 76 (

8). Eleven (18.6%) of the

59 patients were female and 48 (81.4%) were male.

6.3.4 Summary
Group

Number of

Number of

Mean

Patients

patients with

Age

screened

significant
disease

CAD

332

101 (30.4%)

76 ± 7.6

PAD

289

131 (45.3%)

76 ±8

CAD and PAD

289

59 (20.4%)

76 ±8

Table 6.7: Summary of the incidence of CAD and PAD in patients with
AAA’s
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Evaluation of Risk Factors by Group

Figure 6.7: Patient demographics by subgroup
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Group Mean
Age

Smoker
(%)

Diabetic Hypertension Hypercholesterolemia Coronary Family Aspirin Lipitor Plavix Warfarin
(%)
disease
History (%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

41.6

15.4

49.6

49.6

49.6

6.6

60.1

25.9

14.1

7.2

Entire

76±8

CAD
alone

76±7.6

52.5

14.9

40.5

32.8

51.5

1.9

77.2

31.7

13.9

3.9

PAD
alone

76±8

48

21.4

55.7

61.4

57.3

5.3

69.5

32.8

13.7

7.3

CAD
and
PAD

76±8

16.7

51.7

35

55

5

61.7

20

13.3

5

50

Table 6.8: Patient demographics by subgroup
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6.4 Discussion
It is widely accepted that patient’s atherosclerotic conditions such as PAD, CAD
and coronary artery disease co exist. However, there is little in the literature to
suggest that patients with AAA’s should be screened for other asymptomatic
vascular disorders. This study assessed the prevalence of CAD and PAD in a
population of patients with known abdominal aortic aneurysmal disease in order to
determine if screening this group of patients for other vascular disorders might be
advisable.
When compared to other published series this study demonstrates a much
higher incidence of significant CAD (30.4%) than the 6% in the cardiovascular
health study and the 8% in the Framingham study. The United States preventative
task force (USPTF) estimates of the prevalence of carotid artery stenosis in
general population based studies ranges from 0.5%-0.8%. Weerd in 2010
performed an individual participant data meta analysis of 23,706 participants of 4
population based studies and concluded that the presence of severe carotid artery
stenosis in the general population ranged from 0% to 3.1%. However, Pilcher and
colleagues in 2000 examined the prevalence of asymptomatic carotid artery
stenosis in 200 patients with known PAD. They determined that 50 patients (25%)
had an ICA stenosis of greater than 50% similar to the 101 (30.4%) patients that
demonstrated a greater than 50% stenosis in this study. Fassiadis and colleagues in
2008 examined the prevalence of CAD in patients undergoing coronary
angioplasty. They examined 117 patients with a male to female ratio of 3.2:1 and
demonstrated a much lower prevalence of CAD (12.8%). Kiernan in 2009 also
demonstrated a lower incidence of CAD (7.7%) when screening patients
undergoing coronary artery bypass grafting. They examined multiple various risk
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factors that might be associated with a severe carotid artery stenosis and
concluded that the presence of PAD and a carotid bruit predicts the likelihood of a
greater than 70% carotid artery stenosis.
A total of 289 (74.3%) were screened for PAD of which 131 (45.3%)
demonstrated an ABI of less than 0.9. These findings are similar to that of Sukhija
et al, 2004 who examined the presence of coronary artery disease, PAD and
cerebrovascular disease in 110 men with an AAA. Despite their small sample size
and limiting their study to males they demonstrated a 46% prevalence of PAD and
a 27% prevalence of cerebrovascular disease compared to the 45.8% and 30.4%
presented here. They also documented a similar combined PAD and
cerebrovascular disease prevalence of 24%, compared to the 20.4% obtained in
this study. Of note the mean age (
younger at 66 (

SD) of patients in their study was much

10) years compared to the higher mean age of 76 (

years in

this study.
In 2003 Kakisis et al documented that a reduced ABI was a significant
predictor of cardiovascular mortality in patients. An ABI of less than 0.9 showed a
2.8 fold increase in the risk of a patient having cardiovascular disease compared to
patients that had an ABI of greater than 0.9. They also discovered that a carotid
artery stenosis greater than 50% was a strong predictor of cardiovascular mortality
with a 3.6 fold increase in the chance of cardiovascular death. The exact role of
atherosclerosis in the pathogenesis of the growth of an AAA is widely disputed.
However, it is clear that patients with a known AAA are at a greater risk of
developing other atherosclerotic occlusive disease.
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To screen the general population for asymptomatic CAD is an expensive and
time consuming task however; vascular surgeons have been known to perform
CEA in asymptomatic patients with a low morbidity and mortality rate of 0-3%
(Moore et al., 1995). The ASCT trial reported a risk of stroke or death within 30
days post CEA of 3.1%.
When examining the risk factors present in each group a higher incidence of
diabetes was found in the group of patients with significant PAD (21.4%)
compared to the 15.4% in the CAD group and the 14.9% in the group as a whole.
Hypercholesterolemia was also more prevalent in the PAD group at 61%
compared to the 32% in the CAD group and the 49.6% in the entire group. Family
history of AAA was more prevalent in the PAD group (5.3%) compared to the
1.9% in the CAD group. The mean age of patients on the AAA surveillance
programme with a known family history of AAA was lower at 74 (
compared to the overall mean age of 76 (
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8) years.

7) years

6.5 Conclusion
The incidence of CAD and PAD in this study is higher than previously found in
other screening studies performed on patients with selective atherosclerotic
disorders. This study suggests that patients with abdominal aortic aneurysmal
disease are at a higher risk of atherosclerotic disorders in other vascular territories
and therefore this is a group which should be targeted for screening.
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Chapter 7

Comparison of Colour Duplex Ultrasound with
Computed Tomography as a Determinant of
Maximum Abdominal Aortic Aneurysmal diameter
prior to intervention
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7.1 Introduction
Annual abdominal aortic aneurysm (AAA) expansion and rupture rates correlate
significantly with maximum aneurysm diameter (Lederle et al., 1995 and Sprouse
et al., 2003). Hence, the decision to repair an asymptomatic AAA is usually based
on an evaluation of its maximum diameter as obtained by a selected imaging
modality. In the majority of cases the modality of choice to determine the
maximum diameter prior to intervention is computed tomography (CT).
CT provides a detailed anatomical image of the organ of interest; it has
capabilities such as 3 dimensional imaging which immediately enhances surgical
planning prior to EVAR and thin slicing of images which facilitate the correct
diagnosis of anatomical abnormalities. AAA size is most accurate when measured
using 3D reconstruction of CT images and by measuring the maximal aortic
diameter perpendicular to the central line of flow (Chaikof et al., 2002). CT is
considered to be more reproducible than CDU, with more than 90% of remeasurements being within 2mm of the initial figure (Chaikof et al., 2009).
Indications for intervention in asymptomatic AAA are a maximum transverse wall
or anterior to posterior (AP) diameter of greater than 5.5cm or an expansion of
0.5cm or greater in a 6 month period (Hollier et al., 1992). The United Kingdom
Small Aneurysm study concluded that surgical repair of an AAA in the early
stages of dilation was of no benefit to mortality or outcome (Manning et al., 2002)
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Contrast enhanced CT imaging has been reported to have a sensitivity of 90% and
specificity of 91% when imaging symptomatic AAA’s (Chaikof et al., 2009).

Despite its advantages CT is both expensive and associated with certain risks to
the patient in terms of radiation exposure and intravenous contrast administration.
The need for multiple scans for AAA surveillance increases this risk. The majority
of intravenous contrast agents currently in use are iodine based and adverse
reactions such as contrast nephropathy (renal damage after intravascular injection
of the contrast agent) or the rare occurrence of anaphylaxis can have a detrimental
effect on the patients health.
Colour Duplex Ultrasound (CDU) is widely accepted as a safe modality for
the surveillance of patients with small AAA’s (United Kingdom Small Aneurysm
Trial participants). It is a non invasive imaging modality that has a sensitivity of
95% and a specificity approaching 100% when performed in a setting with
adequate quality assurance (The U.S. Preventative Service Task Force, 2005).
CDU is less expensive than CT and is also widely available with no exposure to
radiation or intravenous contrast. The investigation can also be conducted as a
portable examination, allowing the scanner to travel to the patient, rather than the
patient travel to the scanner, if necessary.
Evidence from large clinical trials such as the United Kingdom Small
Aneurysm trial (UKSAT participants) and The Multi Centre Aneurysm Screening
Study (MASS) demonstrated the safety and cost efficacy of CDU in the
surveillance of small AAA. Lindholt and colleagues reported that ultrasound
screening is not only cost effective but is also reduces AAA related deaths. The
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principal disadvantages of CDU are that it is operator dependent and the presence
of excessive bowl gas or the patient’s body habitus may affect the quality and
resolution of images making it difficult for the technologist to accurately identify
the defining walls.
This study sought to compare the two imaging modalities of CDU and CT
in assessment of the maximum aneurysm diameter in patients under surveillance
for AAA.

7.2 Patients and Methods
Following approval from the hospital ethics committee, all patients attending the
vascular laboratory of the Mater Misericordiae University Hospital (MMUH)
between the 1st of January 2007 and the 31st of December 2009 were recruited if
they had both a CDU and a CT scan for assessment of their AAA within 90 days
of each other.
During the study period 389 patients attended the vascular laboratory for
aortic aneurysm surveillance. Of these, 126 (32.4%) had both a CDU scan and a
CT scan within 90 days of each other. The remaining 263 (67.6%) patients were
excluded as they did not have comparable scans within the 90 day period. In all
cases this was because these aneurysms fell below the standard threshold for
intervention of 5.5cm and thus a CT was not warranted. Of the 126 patients
included, 3 (2.4%) patients had two CDU and CT scans within the required time
frame and 1 (0.8%) patient had 3 CDU and CT scans within the required time
frame, giving a total of 130 pairs of tests available for comparison.
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Ninety nine patients (78.6%) were male and twenty seven (21.4%) were
female with an overall mean age of 76.1 (
76.1 (

years. The mean male age was

and the mean female age was 76.2 (

there was no statistical

difference found between the two (p= 0.98).

7.2.1 Colour Duplex Ultrasound Imaging
All CDU scans were performed by a qualified Vascular Technologist proficient in
abdominal imaging using one of 3 machines, a Siemens Sequoia 512, a Siemens
S200 (Chapter 5, figure 5.6) or a Phillips IU22. All CDU scans were performed
using a wideband curvi linear transducer (Chapter 5, figure 5.21) capable of
harmonic imaging. All patients were scanned in the supine position in a darkened
temperature controlled room following the standard clinical measurement protocol
for surveillance of patients with an AAA as previously described in chapter 5,
section 5.3.4.
The maximum anterior to posterior (AP) wall diameter and the maximum
transverse wall diameter was recorded and documented for each patient with the
greater of the two measurements taken as the maximum aneurysm diameter and
used for comparison in this study.
7.2.2 Computed Tomography
All CT scans were carried out in the Radiology department of the MMUH
following their standard protocol for abdominal imaging. The maximum aneurysm
diameter documented on the final report was used for comparison in this study.
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7.3 Statistical Analysis
Statistical analysis included calculation of the Pearson correlation coefficient and
Students paired t- tests. A p value of less than 0.05 was considered significant. All
calculations for Pearson coefficient correlation and paired t-tests were performed
using Windows Microsoft Excel 2007.
Correlation between the CDU and CT was performed using the Pearson’s
coefficient correlation analysis. This method measures the strength of the
relationship between the two measurements not the agreement. The value obtained
may be anywhere between -1 and +1. It is used as a measure of strength of linear
dependence between two variables and may be interpreted as presented in table
7.1.

Pearson’s Coefficient

Level of Correlation

Correlation Value
0-0.09

None

0.1-0.3

Small

0.3-0.5

Medium

0.5-1.0

Large

Table 7.1: Interpretation of Pearson correlation coefficient
(Cohen. 1998)
As correlation alone does not consider the absolute agreement between the two
measurements, limits of agreement (LOA) was performed with the method described
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by Bland and Altman (Bland and Altman., 1986). LOA comprises of two values, a
positive (LOA-P) and a negative (LOA-N), that define the range in which 95% of the
differences between the methods of measurements fall (Sprouse et al., 2003). In this
study the LOA was calculated using MedCalc statistical software and was calculated
as the mean difference ± 1.96 times the standard deviation of the differences. The
accepted value for LOA is between -0.5 and 0.5cm, which are the values between
which 95% of the measured differenced are expected to fall.
The Pearson’s correlation coefficient, paired t-test and LOA were calculated
for the group of patients as a whole. Patients were then divided into three
subgroups small, medium and large aneurysms (figure 7.1) based on the study
reported by Sprouse et al in 2003.
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Figure 7.1: Aneurysm subgroup population

248

7.4 Results
7.4.1 Pearson Coefficient Correlation
i.

Entire Group

Mean (

SD) AAA diameter on CDU was 5.4

(

cm and on CT was 5.4

The Pearson Coefficient correlation (r) for the entire group and was

found to be 0.95, demonstrating a large degree of correlation between the two
modalities (figure. 7.2). There is no statistical difference (p = 0.1) between the
mean CT and mean CDU aneurysm diameter when the paired t test was
performed.
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Figure 7.2: Correlation chart for the complete group (n=130) indicating a
large degree of correlation between CDU and CT (r = 0.95)
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ii.

Small Aneurysms (AAA <5.0cm)

Twenty nine (23.0%) pairs of scans fell into this group. Mean (
diameter on CDU was 4.2 (

and 4.2 (

AAA

on CT, which was not

statistically different (p = 0.4). The Pearson’s Coefficient Correlation (r) was
found to be 0.94 indicating a large degree of correlation between CDU and CT
when imaging aneurysms less than 5.0cm.

Figure 7.3: Correlation chart for the small aneurysm group (n=29) indicating
a large degree of correlation between CDU and CT when imaging aneurysms
<5.0cm (r = 0.94)
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iii. Medium Aneurysms (AAA 5.0>-<6.5cm)
Eighty eight (69.8%) pairs of scans fell into this category. Mean (
on CDU was 5.5

cm and on CT was 5.0 (

SD) AAA size
there was no

statistical difference between the measurements (p = 0. 2) when the paired t test
was performed. Pearson’s coefficient correlation (r) for this group was 0.69,
indicating a large degree of correlation between CDU and CT for medium size
aneurysms.

Figure 7.4: Correlation chart for the medium aneurysm group (n=88),
Indicating a large degree of correlation between CDU and CT (r = 0.69)
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iv. Large Aneurysms (>6.5cm)
Thirteen (10.3%) pairs of scans for comparison fell into this group. Mean (
AAA diameter on CDU was 7.4 (

) cm and 7.5 (

SD)

) cm on CT. There

was no statistical difference between the two measurements (p = 0.1). Pearson
Coefficient Correlation (r) was found to be 0.96, indicating a large degree of
correlation between the two modalities for larger aneurysms.

Figure 7.5: Correlation chart for the large aneurysm group (n=13) indicating
a large degree of correlation between CDU and CT (r = 0.96)
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7.4.2 Limits of Agreement
i.

Limits of Agreement for the Entire Group

Figure 7.6:Bland and Altman plot for the entire group
Figure 7.6 is the Bland and Altman plot for the measurement of AAA’s by CDU
and CT for the entire group (n =130). The mean differences between the two
measurements are plotted against the mean aneurysmal diameter. The limits of
agreement were found to be -0.62 – 0.54, indicating, a 95% confidence level that
the error between the two techniques is within this range. However the LOA are
outside to accepted range of between -0.5 and 0.5.
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ii.

Small Aneurysms

Figure 7.7:Bland and Altman plot for the small aneurysm group
Figure 7.7 is the Bland and Altman for the measurement of small aneurysm by
CDU and CT (n=29). The mean differences between the two measurements are
plotted against the mean aneurysmal diameter. The limits of agreement were
found to be between -0.46 – 0.47 which represents the range within 95% of the
differences fall and were calculated as the mean

1.96 times the standard

deviation of the differences. Indicating, a 95% confidence level that the error
between the two techniques is within this range. These are acceptable LOA as they
fall within the acceptable range of between -0.5 and 0.5.
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iii. Medium aneurysms

Figure 7.8:Bland and Altman plot for the medium aneurysm group

Figure 7.8 is the Bland and Altman plot for the measurement of medium
aneurysms by CDU and CT (n=88). The mean differences between the
measurements are plotted against the mean aneurysmal diameter. The limits of
agreement (-0.68 – 0.59) represents the range within 95% of the differences fall
and were calculated as the mean

1.96 times the standard deviation of the

differences, indicating, a 95% confidence level that the error between the two
techniques is within this range. However the LOA are outside the accepted range
of between -0.5 and 0.5.

256

iv. Large Aneurysms

Figure 7.9:Bland and Altman plot for the large aneurysm group
Figure 7.9 is the Bland and Altman plot for the measurement of large aneurysms
by CDU and CT (n=13). The mean differences between the measurements are
plotted against the mean aneurysmal diameter. The limits of agreement (-0.55 –
0.35) represents the range within 95% of the differences fall and were calculated
as the mean

1.96 times the standard deviation of the differences. Indicating, a

95% confidence level that the error between the two techniques is within this
range.
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7.5 Discussion
This study evaluated the accuracy of CDU in assessing maximum AAA diameter
prior to intervention compared to the gold standard method of CT. CDU
demonstrated a large overall degree of correlation (r = 0.95) when compared to
CT for measuring the maximum AAA diameter. A large degree of correlation was
also achieved in all in all three subgroups (small, medium and large aneurysms)
verifying that measurement of aneurysm size prior to surgery can be accurately
measured by either imaging modality.
LOA in the entire group was found to be (-0.62 to 0.54), in the small
aneurysm group (-0.46 to 0.47) in the medium aneurysm group (-0.68 to 0.59) and
in the large aneurysm group was found to be (-0.55 to 0.35). These results indicate
a 95% confidence level that any error between the two techniques will be within
these ranges. In general the narrower the LOA, the smaller the expected error
between the two measurements. The accepted value for the LOA was defined as
between -0.5 and 0.5, which are the values between which 95% of the measured
differences are expected to fall. Despite achieving excellent correlation and small
limits of agreement between the two imaging modalities in all groups, the small
aneurysm group (<5cm) were found to have better agreement with 95% of the
differences in the two measurements falling between -0.46 and 0.47.
The patient demographics of this series differ significantly from those of
Huber et al., 2001 who reported a 6:1 male to female ratio, compared to 3.6:1 ratio
of male to female obtained in this study. The mean age of patients in this study
was 76.1 (

years whereas those in Huber’s series were slightly younger with
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a mean age of 72 years. This increase in mean age may be due to the increase in
the number of endovascular repairs being carried out now on patients that would
have otherwise been unfit for open AAA repair or may simply be explained by an
increase in life expectancy since Huber’s study was published in 2001.
Discordance in measurements between various imaging modalities when
measuring the maximal AAA diameter have been reported previously. Several
authors have reported that maximal AAA diameter on CT is smaller than that
obtained on Duplex (d’Audiffret et al 2001 and Lederle et al 1995), while Meier
documented that AAA diameter with ultrasound is usually larger than CT (Meier
et al 2003). In a study by Manning the mean CT measurement was significantly
larger than of ultrasound with Lederle (1995) and Sprouse (2003) reporting that
ultrasound measurements are consistently smaller than that found on CT.
Measurement of maximal aneurysm diameter on CT is considered the most
accurate method (Veith et al., 2004). The reporting standards for endovascular
aneurysm repair from the Society of Vascular Surgery recommended that AAA
size be measured in three dimensional reconstructions. However, amongst
asymptomatic patients ultrasound detects the presence of an aneurysm accurately,
reproducibly and at a low cost with a sensitivity and specificity approaching
100%, with 1-3% of ultrasound scans being inconclusive due to the patient’s body
habitus or the presence of bowel gas. CT has, in the past been more reproducible
than ultrasound however the other advantages of ultrasound make it the method of
choice for surveillance, with CT being the primary modality of choice for pre
operative assessment.
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The discordance between imaging modalities has been explained by the variation
in techniques used to determine maximum aneurysm diameter, together with the
presence of interobserver error. The United Kingdom Small Aneurysm Trial
(UKSAT participants) used the maximal anterior to posterior wall measurements
as obtained by ultrasound and recommended that surgical repair should take place
on aneurysms greater than 5.5cm in AP measurements. This study employed the
method similar to that used in the Multi Centre Aneurysm Screening Study
(MASS) which measured both the maximal AP and transverse diameter, with the
higher of the two measurements being reported as the AAA size.
The high degree of correlation achieved in this study may be explained by the
improved grey scale resolution and harmonic imaging achieved by currently
available ultrasound machines. Sprouse demonstrated an overall high correlation
of 0.70 compared to the overall correlation of 0.95 found in this study. They also
found that despite obtaining a good degree of correlation their LOA was clinically
unacceptable at (-0.45 to 2.36cm) compared to the (-0.62-0.54) achieved in this
study. Their subgroup analysis also demonstrated poor LOA in all cases.
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7.6. Conclusion
AAA’s less than 5cm in diameter can be accurately measured using CDU. On the
basis of these results it is reasonable to suggest that CDU is the surveillance tool
of choice for small AAAs, but cannot hope to supplant CT as the definitive
planning tool prior to Aortic intervention.
Having demonstrated the reliability of CDU as a surveillance tool prior to
intervention, the next logical investigation was to identify its role in postoperative
surveillance of patients who had undergone endovascular aneurysm repair.
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Chapter 8

A Comparison of Colour Duplex Ultrasound with
Computed Tomography in the Post Operative
Surveillance of Patients Following Endovascular
Aneurysm Repair
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8.1 Introduction
Successful endovascular aneurysm repair (EVAR) has been defined previously as
the exclusion of the aneurysm from circulation with absence of endoleak, limb
occlusion, graft migration, late rupture or the need for secondary intervention
(Sternberg et al., 2003).
Randomised control trials such as the United Kingdom Endovascular
Aneurysm Repair Trials (EVAR -1 trial) and the Dutch Randomised Endovascular
Aneurysm Repair trial (DREAM trial) have both established the superiority of
EVAR in the management of abdominal aortic aneurysmal disease. In the short
term, benefits such as decreased mortality, reduced blood loss, shorter hospital
stay and improved quality of life post procedure have all been documented
(EVAR -1 trial and DREAM trial). Long term follow up data and concerns
regarding EVAR specific complications such as, the durability of stent grafts,
endotension and the presence of endoleaks have necessitated lifelong surveillance
programmes in order to ensure continued exclusion of the aneurysm from the
circulation.
Contrast enhanced computed tomography (CT) is currently the standard
imaging modality for EVAR surveillance (Chaer et al., 2009). Concerns exist
regarding the use of CT as the primary surveillance modality due to the
administration of high doses of ionising radiation and the nephrotoxicity of the
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contrast used (Sandford et al., 2006). In addition the increased demand for CT
scanning by virtually all hospital disciplines means the avaibility of scanning time
is becoming an issue. As the number of patients in the EVAR surveillance
programme in the Mater Misericordiae University Hospital (MMUH) has
increased, the ongoing need for CT scanning has risen exponentially (figure 8.1 &
figure 8.2). The identification of a safer, non invasive and less harmful method of
adequately imaging the aorta with a high sensitivity and specificity following
EVAR is desirable.
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Figure 8.1: Increase in the number of CT scans required as the number of
EVAR’s increase
Figure 8.1 summarises the increased in the number of CT’s required per year as
the number of EVAR procedures increases, assuming that each patient has a CT
post surgery at 6 months and 1 year and annually thereafter.
Colour Duplex Ultrasound (CDU) is an inexpensive, harmless, non-invasive
and widely available imaging modality which is the investigation of choice for the
ongoing surveillance of AAA’s prior to undergoing intervention (UKSAT and
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MASS trial). CDU allows the measurement of aneurysm sac size over time and
the detection of blood flow within the residual aneurysm and thus should be
capable of supplanting CT as the primary surveillance tool in patients that have
undergone EVAR. CDU is more operator dependent than CT (Chaer et al., 2009)
and there is a perception that CDU scanning lacks reliability and reproducible
results (Arko et al., 2004).
There is much controversy in the literature with regard to the use of CDU as
the method of choice for post operative EVAR surveillance. Several studies have
established the ability of CDU to detect endoleaks and have documented good
correlation with CT in measuring the residual aneurysm diameter following repair
(Chaer et al., 2009). However Sandford concluded that although CDU was a
valuable method for follow up after EVAR, it was not as sensitive as CT in the
detection of endoleaks. Raman found that CDU had a high degree of correlation
with CT in aneurysm diameter measurement following EVAR but a low
sensitivity and positive predictive value in endoleak detection and concluded that
CDU could not effectively replace CT as a post operative surveillance modality.
Chaer and Beeman suggested that CDU surveillance alone following EVAR is
safe and can be initiated early after treatment in patients with shrinking and stable
aneurysms (Chaer et al., 2009 and Beeman et al., 2009).
Following the successful validation of CDU as a method of assessing patients
prior to undergoing EVAR as outlined in Chapters 6 and 7, the aim of this study
was to evaluate the role of CDU in the postoperative surveillance of such patients,
comparing it to the standard surveillance modality of CT, to determine if CDU
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could supplant CT as the first line surveillance tool following EVAR thus altering
the existing post operative follow up algorithm (figure 8.3).
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8.2 Patients and Methods
Following approval from the hospital ethics committee, all patients who
underwent EVAR of their AAA in the MMUH between the first of June 2003 and
the first of July 2010 (n=145) were retrospectively reviewed.
Figure 8.2 summarise the increase in the number of EVAR carried out over this
time frame.

Figure 8.2: Increase in the number of EVARs per year
Following graft implantation all patients underwent regular post operative
surveillance (figure 8.3). This included a CDU scan of the aorta, ankle brachial
indices (ABI’s), a CT scan and an abdominal plain film within 7 days of surgery.
After discharge from the hospital, all patients had both a CDU scan and ABI at 1
month and then a CDU scan, ABI’s and a CT scan, at 6 months, 12 months and
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annually thereafter if there was no documented endoleak on either CDU or CT
(figure 8.3).

Figure 8.3: Current follow up algorithm

Patients with a documented endoleak post implantation of their graft underwent
more rigorous follow up to closely monitor for an increase in the residual
aneurysm sac size.
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The CDU scans and CT scans of all 145 patients were retrospectively reviewed.
All scans carried out more than 90 days apart from each other were excluded from
the study.
There were 122 (84.1%) male and 23 (15.8%) female patients with a mean (
age of 77.1 (

SD)

years. The age range was 53-93 years. There was no statistical

difference found between the mean male age 76.6 (
female age of 79.3 (

years and the mean

years (p=0.99).

Figure 8.4: Patient demographics and co morbidities
Complete patient demographics and risk factors were available in 141 (97.3%)
patients (figure 8.4). The remaining 4 (2.8%) patients risk factors were not
available due to deficiencies in the clinical notes.

270

A total number of 715 scans were performed on the 145 patients that were
reviewed, of which 426 (59.6%) were CDU scans and 289 (40.4%) were CT
scans. The mean (
mean (

number of CDU scans per person was 2.9

number of CT scans per person was 1.9 (

the

scans.

Of the total 715 tests performed there were 484 (67.9%) scans avaible for
comparison (242 pairs) in 114 (78.6%) of the 145 patients reviewed.
The CDU and CT scans of the remaining 31 (21.4%) patients were not available
for comparison due to reasons such as inconsistent timing of imaging modalities
(scans performed greater than 90 days apart were excluded), failure to attend and
CT being contraindicated due to i.v. contrast allergy.
Of the 426 CDU scans carried out 26 (6.1%) scans were reported as limited, due to
the presence of excess bowel gas and body habitus limiting the capabilities of
CDU in determining the residual aneurysm sac size and detection of an endoleak.
The maximum residual aneurysm size was documented on the remaining 400
(93.9%) CDU scans.
Of the 289 CT’s performed 107 (37%) CT reports did not document the maximum
residual aneurysm size. The maximum residual aneurysm size was documented on
the remaining 182 (63%) of CT scan reports.
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8.2.1 Colour Duplex Ultrasound Scanning
All CDU scans were performed in the Vascular Laboratory of the MMUH by the
same Accredited Vascular Technologist using a Siemens Sequoia 512 Ultrasound
system (Chapter 5.0, figure 5.6). A wideband curvi linear transducer (Chapter 5.0,
figure 5.21), the 6C2 was used to perform all grey scale and Colour Doppler
images. All patients were required to fast for at least 6 hours and were scanned in
the supine position in a darkened temperature controlled room according to the
standard clinical measurement protocol as outline previously in Chapter 5.0
section 5.4.4. In all cases the vascular technologist was blind to the CT results
until after the CDU scan was reported.
8.2.2 Ankle Brachial Indices
All ABI’s were performed in the vascular laboratory of the MMUH by the same
accreditated vascular technologist using an Automated Viasys, VasoGuard
peripheral arterial system (Chapter 5, figure 5.0). ABI’s were performed to assess
the flow to the lower extremities and to rule out graft compression or stenosis in
the iliac stents from kinking.
All ABI’s were performed in the supine position in a temperature controlled room
according to the standard clinical measurement protocol as outline previously in
Chapter 5 section 5.1.4.
8.2.3 Computed Tomography
All CT scans were carried out in the radiology department of the MMUH
following their standard protocol. The maximum residual aneurysm measurement
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and the presence or absence of an endoleak as reported on the final report was
used for comparison.
8.3 Statistical Analysis
Both modalities were compared for accuracy in determining the residual aneurysm
sac size and detection and classification of endoleaks post EVAR. The sensitivity,
specificity, positive predictive value and negative predictive value were calculated
for all patients taking CT as the gold standard. The patient was considered a false
negative if CDU missed an endoleak that CT detected, a false positive if CDU
detected an endoleak that CT did not; a true positive if the endoleak was detected
by both CDU and CT and a true negative if CDU and CT documented no
endoleak.
The Pearson Coefficient Correlation was performed to assess the strength of the
relationship between CDU and CT in the measurement of the residual aneurysm
sac size post repair. A paired t test was performed also and a p value of less than
0.05 was considered statistically significant. All calculations for Pearson
coefficient correlation and paired t tests were performed using Windows Microsoft
Excel 2007.
A limit of agreement (LOA) was performed with the method described by Bland
and Altman (Bland and Altman., 1986). LOA comprises of 2 values a positive
(LOA-P) and a negative (LOA-N) that define the range in which 95% of the
differences between the methods of measurements fall (Sprouse et al., 2003). In
this study the LOA was calculated using MedCalc statistical software from the
means and differences of the two measurements.
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8.4 Results
8.4.1 Detection and classification of endoleaks and graft complications

Of the 484 scans available for comparison (242 pairs) an endoleak was documented
on 87 (36%) CDU scans and 25 (10.3%) CT scans.

i.

Type 1 endoleaks

There were 5 (2.1%) type 1 endoleaks noted on CDU, 3 (1.2%) were detected on
CT. There were no type 1 endoleaks noted on CT that were missed on CDU.
Of the two patients who had a type 1 endoleak on CDU and not on CT, one was an
anatomical abnormality which was misinterpreted on the CDU scan. The second
patient was documented as a type 2 endoleak on CT.
Four out of the five patients who had a type 1 endoleak detected on CDU
underwent further intervention.
ii.

Type 2 endoleaks

Of the 242 pairs of scans available for comparison within the 90 day time frame,
type 2 endoleaks were detected on CDU in 82 (33.9%) scans and on CT in 22
(9.0%) cases.
In no case was a type 2 endoleak detected on CT and not detected on CDU. Three
patients with a documented type 2 endoleak on both imaging modalities
underwent further intervention.
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iii. Type 3 endoleaks
There were no type 3 endoleaks detected in this series on either CT or CDU.
iv. Type 4 endoleaks
There were no type 4 endoleaks detected in this series on either CT or CDU.
v.

Endotension

One patient underwent further intervention for “endotension”. Both imaging
modalities documented a significant increase in residual aneurysm sac size. CDU
documented the presence of a type 2 endoleak originating from a lumbar artery; no
patent vessel was noted on CT or selective angiography. The patient underwent an
elective laparotomy were the aneurysm sac was opened but no patent feeding
vessel was identified and the sac was plicated over the endograft.
vi. Limb occlusion
Of the 145 patients in the study 2 patients underwent secondary intervention for
limb occlusion. In both cases the limb occlusion was documented on CDU first,
both patients then underwent a CT scan which confirmed the diagnosis and
underwent further surgery.
vii. Late Rupture
One (0.7%) patient experienced rupture at a late stage in the follow up and
underwent emergency conversion to an open repair. The patient had no endoleak
on either imaging modality at any stage during follow up and had a no significant
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increase in residual aneurysm sac size over time. The reason for rupture is
unknown as the patient underwent emergency surgery at another institution.

viii. Secondary Intervention
Eleven (7.5%) of the 145 patients in total underwent secondary intervention. Four
patients had further intervention for a type 1 endoleak, 3 for a type 2 endoleak, 2
for limb occlusion, 1 for endotension and 1 patient suffered late rupture.

8.4.2: Sensitivity, specificity, positive predictive value and negative predictive
value
CDU was found to have a sensitivity of 100% and a specificity of 85% in the
detection of endoleaks. The positive predictive value was 28% and negative
predictive value 100%.
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8.4.3 Residual Aneurysm Measurement
Of the 242 pairs of scans available for comparison, the residual AAA size on CDU
was not documented on 15 (6.1%) scans due to limited imaging. The residual
AAA diameter was not documented on 91 (37%) of the 242 CT scan reports.
This gave us a total of 142 (58%) pairs of scans where both the CDU scan and the
CT scan could be compared for accuracy in determining the residual AAA
diameter post EVAR.
Of the 142 pairs of scans for comparison the mean (
diameter on CDU was 5.5 (

and on CT was 5.6 (

residual AAA
there was no

statistical difference noted between the two measurements (p=0.99). The Pearson
Coefficient correlation was found to be 0.96 indicating a high degree of
correlation (Chapter 7.0, Table 7.1) between CDU and CT when measuring
residual aneurysm size post EVAR (figure 8.5).
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Figure 8.5: Scatter plot showing correlation (r) of residual aneurysm sac size
by CDU and CT (n=142) with a line of equality showing a clear trend in the
bias
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Figure 8.6: Bland and Altman plot for CDU versus CT in the measurement of
the residual aneurysm size post EVAR
Figure 8.6 is a Bland and Altman plot of the differences against the average of the
two measurements of residual aneurysm size post EVAR. The mean differences
between CDU and CT are plotted against the mean aneurysmal diameter. The
limits of agreement (-0.87-0.75) represents the range within 95% of the
differences would be expected to occur, and were calculated as the mean

1.96

times the standard deviation of the differences. Indicating a 95% confidence level
that the error between the two techniques is within this range. However the LOA
are outside to accepted range of between -0.5 and 0.5.
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8.5 Discussion
These results show an excellent degree of correlation (r = 0.96) between CDU and
CT in measuring the residual aneurysm sac size over time demonstrating that
either imaging modality could be safely utilized to determine an alteration in the
residual aneurysm size during post operative surveillance. The high proportion of
CT scans (37%) were the maximum residual aneurysm diameter was not made
simply highlights the poor awareness of the importance of this measurement by
radiologists. Our results compare favourably to previous results reported by
Raman et al., 2003 who demonstrated a correlation of r = 0.65 and Arko et al who
reported a correlation of r = 0.93. The LOA however was not satisfactory with
95% confidence interval ranging from -0.87- 0.75 which falls outside the accepted
range of between -0.5 and 0.5.
CDU scans were documented as limited in 26 (6%) patients, for reasons such
as bowel gas and body habitus. This figure is lower than other studies which
documented that CDU was limited in up to 25% of scans performed (Elkouri et
al., 2004). This could simply be due to the prolonged fasting time required (> 6
hours) for the CDU scan.
Ultrasound sensitivity was found to be 100% and specificity was found to be
85% for the detection of endoleaks, these values differ somewhat to those reported
in the literature. Sandford and colleagues reported 67% sensitivity and 91%
specificity for CDU versus CT in the detection of endoleaks with a positive
predictive value of between 33-100% and negative predictive value of between
91-100%. The positive predictive value and negative predictive value in this study
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was similar at 32% and 100% respectively. Arko et al in 2004 demonstrated that
CDU had a sensitivity of 81%, a specificity of 95%, a positive predictive value of
94% and a negative predictive value of 90% when compared to CT, However,
they documented that a small number of endoleaks were missed on CDU and
detected on CT. In comparison there were no endoleaks missed on CDU in this
study and detected on CT.
Manning and colleagues, in a series of 132 patients reported values similar to
our own. They documented a 45% positive predictive value and 94% negative
predictive value for CDU when compared to CT for postoperative surveillance
following EVAR. Specificity of CDU for endoleak detection was 67% when
compared with CTA and sensitivity for CDU was 86%, both lower than our own
findings. Their conclusions however were broadly similar to our own, suggesting
CDU as a first line screening tool which allowed selection of a smaller cohort of
patients in whom CT was necessary (Manning et al., 2009).
Long term follow up of patient post EVAR is currently required due to the
unique unforeseen set of complications that may occur with the rapidly advancing
technology involved in is technique. The desired outcome of EVAR is shrinkage
of the residual aneurysm sac without the presence of an endoleak. Despite the
multiple imaging modalities available to carry out this surveillance many
institutions continue to avail of CT angiography despite the risk to patients from
both radiation and contrast related nephrotoxicity also the obvious disadvantage of
cost.
CDU is universally accepted as the method of choice for the surveillance of
patients with small AAA. It has advantages over CT angiography that make it a
281

more desirable imaging modality for the long term surveillance of patients. It has
no risk of radiation exposure and nephrotoxicity as well as the obvious advantage
of being readily avaible, non invasive and being a much cheaper imaging
modality. However, as with all imaging modalities it too has disadvantages, such
that is largely operator dependant and the quality of CDU images is largely
affected by the patient’s body habitus and excess bowel gas.
Noll et al., 2007 report that almost one-third of the cost of postoperative
EVAR was attributable to radiology imaging costs. In a series of 20 patients,
Henao and colleagues in 2006 described how CT failed to recognize three type II
endoleaks seen by contrast-enhanced ultrasound. A study performed by Civitello
and colleagues in 2003 concluded that contrast enhanced CDU is more accurate
than standard CDU for the detection of endoleaks following AAA repair. As our
current scanning protocol has already detected all clinically significant endoleaks
it is difficult to see how patient care would be optimised by the use of contrast
enhanced ultrasound.
Our results suggest that CDU could be employed as the primary
postoperative surveillance tool in patients who have undergone EVAR. Certain
findings could be indications for proceeding to CT such as increase in sac size, the
detection of high velocity flow within the aneurysm sac suggestive of an endoleak,
structural abnormalities in the graft or inability to obtain adequate pictures of the
graft with CDU. The resultant effect of this would be a dramatic reduction in the
number of CT scans being ordered for patients in post op EVAR surveillance
programmes with resultant less exposure to both ionising radiation and
intravenous contrast. As the number of patients in the EVAR programme has
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increased, thus the ongoing demand on CT scanning has risen exponentially.
Figure 8.2 summarised the increase in the number of EVARS performed per year
in the MMUH. Each patient undergoes 3 CT’s in their first year of surveillance
(post surgery, at 6 months and 1 year). Figure 8.7 demonstrates the increase in the
number of new CT’s required each year with the current surveillance programme.
If each patient underwent only 1 CT post surgery this would lead to a drastic
reduction in the number of new CT’s required per year (figure 8.7). The average
cost of a CT scan varies between hospitals. Assuming that each CT scan cost €500
(Lifescan, United Kingdom Screening Services), Figure 8.8 demonstrates the
reduction in expenditure on new CT scans alone per year. The total expenditure on
new CT’s alone to date is approximately €244,500. If the new EVAR patients
underwent just one CT post surgery this would have cost approximately €81,500 a
reduction of €163,000 between 2003 and 2010.
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Figure 8.7: Current CT’s requirement per year and proposed CT
requirement per year

Figure 8.8: Decrease in expenditure on new CT’ required per year
(MMUH Series 2003-2010)
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8.6 Conclusion
Based on the results obtained in this study we propose that CDU replace CT as the
primary long term surveillance imaging modality for patients post EVAR of their
AAA. However, if abnormalities occur on the CDU scan, then further
investigation of the endovascular stent by CT should be performed at the earliest
convenience (figure 8.9).

Figure 8.9: Proposed algorithm for the surveillance of patients post EVAR
Having demonstrated a high degree of correlation between CDU and CT in
measuring aneurysm size prior to undergoing intervention and following
implantation of an endovascular stent. We sought to extend this research to
examine the natural history of aneurysm sac behaviour following EVAR as
measured by CDU presented in the following chapter.
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Chapter 9

Natural History of Aneurysmal Sac Size
Following Endovascular Aneurysm Repair as
Assessed by Colour Duplex Ultrasound
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9.1 Introduction
Regression of the residual aneurysm sac around an implanted aortic graft is
indicative of successful repair, demonstrating exclusion of the aneurysm from the
systemic circulation.
Two large randomised control trials have shown many short term benefits
with EVAR compared to open surgery. The EVAR 1 trial and the DREAM trial
demonstrated a two thirds reduction in the 30 day post procedure mortality in
patients with aneurysms treated by EVAR compared to those undergoing open
repair, with advantages such as reduced blood loss and lower perioperative
morbidity and a shorter hospital stay (Makaroun et al., 2001). However, as EVAR
continues to evolve it is important to identify factors that are predictive of long
term success.
Exclusion of the residual aneurysm sac from the systemic circulation is a
fundamental component of EVAR as persistent arterial pressurisation of the sac
will lead to continued expansion with the risk of eventual rupture and catastrophic
haemorrhage. Regression of the residual aneurysm sac following endovascular
repair is taken as a marker of a successful procedure while continued expansion
implies failure due to the presence of an endoleak or endotension. Multiple
imaging techniques such as digital subtraction angiography (DSA), computed
tomography (CT) and colour duplex ultrasound (CDU) have been employed to
demonstrate morphological characteristics and aneurysm size prior to surgery and
are routinely used to monitor the residual aneurysm sac post repair.
Several authors have reported regression of the residual aneurysm at an
early stage based on measurements made with CT, some suggesting that
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regression is linked to graft type and make (Sternberg et al, 2003). Some have
linked regression to pre repair factors such as aneurysm size and neck thrombus
(Fairman et al., 2006). Wolf in 2000 concluded that aneurysm regression was
unpredictable and the presence of an endoleak did not determine the rate of
regression. The EURO STAR registry indicated that 16% of aneurysms failed to
decrease in size after repair despite the absence of an endoleak on CT (GillingSmith 1999).
Having demonstrated in Chapter 7 and 8 that CDU has an excellent
correlation with CT for measuring aneurysm sac size pre and post endograft
implantation, I sought to define its role in determining the natural history of the
residual aneurysm sac following EVAR. The aneurysm change was calculated as
the difference from the maximum pre operative aneurysm size to the maximum
aneurysm change observed during surveillance following EVAR.
The aneurysm change was calculated and its relationship to pre existing
risk factors, pre operative aneurysm size and the presence or absence of a type 2
endoleak was determined.
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9.2 Patients and Methods
Following approval from the hospital ethics committee, all patients who
underwent elective EVAR from 1st of January 2003 to the 1st of July 2010 (n=145)
in the Mater Misericordiae University Hospital (MMUH) were recruited. Patients
were considered eligible for the study if they had at least two consecutive
measurements of their residual aneurysm sac following graft implantation on
CDU.
There were 122 (84.1%) male and 23 (15.8%) female patients with a mean (
age of 77.1 (

SD)

years. We examined the various risk factors present in each

patient, the presence or absence of an endoleak and the original aneurysm size
prior to repair. Patient demographics and risk factors were retrieved from the
patient’s admission record and included smoking status, diabetes; hypertension,
statin theraphy, a history of coronary artery disease, family history of AAA, and
drug history.
Patients were considered to be diabetic if they were actively being treated for type
1 or 2 diabetes, to be hypertensive if they were being treated with anti
hypertensive’s and to have a history of coronary artery disease if they had
previous cardiac stenting or surgery.
The change in the residual aneurysm sac size on consecutive CDU examinations
was recorded over time. A significant change in aneurysm sac size was taken to be
a change of

0.5cm between consecutive visits (Sternberg et al., 2003, Fairman

et al., 2006 and Rhee et al., 2000). Patients were followed up post operatively until
one of the end points of rupture, death or most recent scan was reached.
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All patients underwent routine post operative surveillance as previously described
in Chapter 8; figure 8.3. The maximum preoperative measurement obtained on
CDU was considered the base line measurement for this study.
Of the 145 patients that underwent EVAR, 106 (73.1%) patients had at least 2
consecutive CDU measurement post device implantation making them eligible for
the study.
Thirty nine (26.9%) patients were excluded due to failure to attend for follow up at
the appropriate times and patients who underwent recent EVAR only had one
available CDU scan for analysis post implantation. The demographics and co
morbidities of the 106 patients included in the study are summarised in figure 9.1.
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Figure 9.1: Patient demographics
Of the 106 patients included in the study the mean (
per person was 4.6

number of CDU scans

scans.

9.2.1 Colour Duplex Ultrasound
All CDU scans were conducted by the same accredited vascular technologist using
a Siemens Sequoia 512 Mountain View system and a curvilinear 6C2 transducer
(Chapter 5.0 figure 5.6), following the standard clinical measurement protocol for
surveillance of patients post EVAR as previously described in Chapter 5.0, section
5.4.4.
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The maximum anterior to posterior (AP) wall measurement and the maximum
transverse wall diameter was documented in each CDU scan and the larger of the
two measurements was used to determine the residual aneurysm size. The
presence or absence of a type 2 endoleak was also documented.

9.3 Statistical Analysis
The patient’s aneurysm change at each point in their surveillance was calculated
(equation 9.1). The percentage aneurysm change at each point in their surveillance
was also calculated (equation 9.2).

Equation 9.1

Equation 9.2
A univariate and multivariate risk factor analysis was performed using statistical
analysis system software (SAS) to determine if any of the pre existing risk factors
assessed prior to graft implantation or the presence of a type 2 endoleak were
predictive of aneurysm change. A statistical difference was defined as a p value of
<0.05 in all cases.
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This analysis was performed for the group as a whole (n =106). A subgroup
analysis was also performed; patients were allocated to subgroups of decreasing
aneurysms, increasing aneurysms and stable aneurysms based on the maximum
aneurysm change observed during their surveillance.
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9.4 Results
9.4.1 Entire Group
All 106 patients with a mean (

age of 75.6 (

were included in

this analysis, 23 (21.6%) female and 83 (78.3%) male patients. The mean (

SD)

cm.

aneurysm size pre surgery was 5.8 (

Table 9.1 summarises the mean aneurysmal change and the mean percentage
aneurysmal change at each time point and the number of patients that had
complete follow up to that time point.
Time Frame

Number

Mean Aneurysmal

Mean Percentage

(Months)

of

Change (cm)

Aneurysmal

Patients

Change (%)

Assessed

0

106

-0.17

-3.0

1

106

-0.24

-4.31

7

77

-0.59

-9.87

12

55

-0.73

-12.4

18

27

-0.92

-15.8

24

10

-0.48

-16.6

36

3

-1.0

-16.6
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48

1

-2.1

-28

Table 9.1: Summary of residual aneurysmal change for the entire patient group
The mean aneurysmal change at 1 month was a decrease of 0.2

equating to a

percentage aneurysm change of 4.3%. At 7 months post surgery the mean
aneurysmal change was a decrease of 0.59cm (9.8%), at 12 months, a decrease of
0.73cm (12.4%). At 18 months, a decrease of 0.92cm (15.8%) and at 36 months, a
decrease of 1.0cm (16.6%). One patient had follow up at 4 years; their mean
aneurysm change at this point was a decrease of 2.1cm, (28%). Figure 9.2
demonstrates the mean percentage change at each time point and the number of
patients who had follow up to that point.
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Figure 9.2: Mean percentage aneurysm change for the entire patient group
9.4.2 Subgroup Analysis
The study population was then sub divided into stable, decreasing and increasing
aneurysms on the basis of the maximum change observed in residual AAA sac
size during postoperative surveillance (Equation 9.2).
Stable aneurysms were defined as having a less than 0.5cm increase or decrease in
aneurysm sac size. Decreasing aneurysms were defined as having a greater than
0.5cm reduction in aneurysm sac size and increasing aneurysms were defined as
aneurysms that increased in size by 0.5cm or greater.
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Figure 9.3: Aneurysm classification
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Group

Increasing

Decreasing

Stable

Aneurysms

Aneurysms

Aneurysms

11 (10.4) %

58 (54.7) %

37 (34.9) %

Mean Age

74.8 (±9.6) years

77 (±6.9) years

Mean pre op

6.4 (±1.3) cm

5.9 (±0.9) cm

Number of
Patients

73 (±7) years
5.6 (±0.6) cm

AAA size

Mean Aneurysm

+1.06(±0.6) cm

-1.3 (±0.7) cm

-0.06 (±0.27)cm

+16.5(±7.9) %

-22.7 (±10.2)%

-1.2(±5.0)%

change

Mean percentage
change

Table 9.2: Summary of residual aneurysm change by subgroup

i.

Increasing Aneurysms
Eleven patients (10.4%) patients had a significant increase in residual aneurysm
size (0.5cm or greater) with a mean age (
patients in this group were male. The mean (
6.4 (

9.6) years. All the

SD) pre operative AAA size was

1.3) cm (range 5.1- 9cm).

The mean (
1.06 (

SD) of 74.8 (

SD) aneurysmal change observed in this group was an increase of

0.56) cm, a percentage (

SD) change of an increase of 16.5 (
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7.9) %.

ii.

Decreasing Aneurysms
There were 58 (54.7%) patients who were found to have a significant decrease in
residual aneurysm size (a decrease of ≥ 0.5cm) with a mean (
(

SD) age of 77

6.9) years. There were 12 (20.6%) female and 46 (79.3%) male patients in this

group.
The mean (

SD) pre operative AAA size was 5.9 (

The mean (

SD) aneurysmal change was a decrease of 1.3 (

mean (

0.9) cm (range 4.8-8.8cm).

SD) percentage change was a decrease of 22.7 (

0.7) cm and the

10.2) %.

Figure 9.4: Mean percentage aneurysm change decreasing aneurysm group
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iii. Stable Aneurysms
Thirty seven patients (34.9%) were found to have no significant alteration in
residual aneurysm size and were therefore termed stable aneurysms. There were 7
(18.9%) female and 30 (81.1%) male patients with a mean (
(

7.0) years. The mean (

SD) age of 73.9

SD) pre operative AAA size was 5.6 (

0.65) cm

(range 5.1- 9cm).
The mean (

SD) aneurysmal change was a decrease of 0.06 (

the percentage change (

SD) was a decrease of 1.2 (

0.27) cm and

5.0) %.

Figure 9.5: Mean percentage aneurysm change stable group
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9.4.2 Risk Factor Analysis
The patient demographics in each subgroup were are summarised in Figure 9.6
and Table 9.3.

Figure 9.6: Patient demographics by subgroup
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Risk Factor

Mean Age

Entire Group

Increasing

Decreasing

Stable

(n = 106)

aneurysms

Aneurysms

Aneurysms

(n = 11)

(n = 58)

(n = 37)

74.8 (±9.6) years

77.9 (±6.9) years

73 (±7) years

75.6 (±7.2) years

Mean Pre op AAA size

5.8 (±0.9) cm

6.4 (±1.3) cm

5.9 (±0.9) cm

5.6 (±0.6) cm

Smoker

61.3 %

45.5 %

63.8 %

62.2 %

Diabetic

72.6 %

54.5 %

72.4 %

81.1 %

Hypertension

56.6 %

63.6 %

60.3 %

51.4 %

Statin Therapy

57.5 %

27.3 %

70.7 %

48.6 %

Coronary Disease

55.7 %

45.5 %

62.1 %

51.4 %

Family History

9.4 %

36.4 %

5.2 %

8.1 %

Warfarin

5.7 %

0%

3.4 %

10.8 %

Endoleak

42.5 %

54.5 %

39.7 %

45.9 %

Table 9.3: Patient demographics by subgroup
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Table 9.3 summarises the distribution of patient demographics in the entire population
and in each subgroup. The increasing aneurysm group demonstrated a lower percentage of
smokers (45.5%) and diabetics (54.5%) than the 62.2% smokers and 81.1% diabetics in
the stable aneurysm group and the 63.8% smokers and 72.4% diabetics in the decreasing
aneurysm group.
There was a higher percentage (70.7%) of patients in the decreasing aneurysm group on
statin therapy compared to the 48.6% in the stable aneurysm group and 27.3% in the
increasing aneurysm group.
The stable aneurysm group demonstrated a lower percentage of patients with hypertension
and coronary artery disease. A higher proportion of the stable aneurysms patients were on
Warfarin (10.8%) compared to the other groups. Family history of AAA was more
prevalent in the increasing aneurysm group (36.4%).
9.5 Statistical Analysis
Univariate and multivariate analysis were performed to assess the influence of various
risk factor variables on aneurysm change. The predicative values assessed in this series
included age, pre operative aneurysm size, smoking status, diabetes, hypertensive, statin
therapy, coronary artery disease, family history of AAA and the presence of a type 2
endoleak.
Univariate and multivariate analysis was performed for the entire patient population and
each subgroup.
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9.5.1 Entire Patient Group (n = 106)
i.Univariate Analysis
Univariate analysis was performed to assess if aneurysm change was influenced by
any one variable.
Predictive Factor

Parameter

Standard

t Value

p Value

Variable

Estimate

Error

Age

-0.42

0.21

-2.02

0.045

Pre operative size

0.54

1.7

0.31

0.76

Smoking status

-0.001

3.2

-0.00

0.99

Diabetes

12.6

2.96

1.42

0.16

Hypertension

-2.48

3.15

-0.79

0.43

Statin therapy

-10.66

2.99

-3.56

0.0006

Coronary artery

-2.35

3.14

-0.75

0.46

Family history of AAA

9.09

5.27

1.72

0.087

Warfarin

3.17

6.76

0.47

0.64

Endoleak

7.2

3.07

2.36

0.01

disease

Table 9.4: Univariate analysis entire patient population

Univariate analysis for the entire population (n=106) determined that an increasing age
(p=0.04) and statin therapy (p = 0.0006) were positively associated with aneurysm
regression. The presence of an endoleak was determined to be inversely related to
aneurysm regression (p= 0.01).
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ii. Multivariate Analysis
Multivariate analysis was performed on the entire patient population to determine if
aneurysm change was influenced by multiple variables or combinations of variables.
Predictive Factor

Parameter

Standard

t value

p value

Variable

Estimate

Error

Age

-0.28

0.20

-1.35

0.17

Pre operative size

0.21

1.6

0.13

0.89

Smoking status

1.5

3.18

0.48

0.63

Diabetes

3.7

3.5

1.05

0.29

Hypertension

1.3

3.2

0.42

0.67

Statin therapy

-11.1

3.5

-3.16

0.002

Coronary artery

0.16

3.11

0.05

0.95

Family history of AAA

4.2

5.22

0.81

0.41

Warfarin

1.4

6.4

0.23

0.82

Endoleak

7.3

2.9

2.47

0.01

disease

Table 9.5: Multivariate analysis entire patient group

Multivariate analysis for the entire patient population (n=106) demonstrated that statin
therapy (p=0.002) was the only risk factor variable positively associated with aneurysm
regression. The presence of a type 2 endoleak was determined to be inversely related to
aneurysm regression (p = 0.01).
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Parameter

Parameter

t value

p value

Estimate

Estimate

Univariate

Multivariate

Univariate

Multivariate

Age

-0.42

-0.28

0.045

0.17

Pre operative size

0.54

0.21

0.76

0.89

Smoking status

-0.001

1.5

0.99

0.63

Diabetes

12.6

3.7

0.16

0.29

Hypertension

-2.48

1.3

0.43

0.67

Statin therapy

-10.66

-11.1

0.0006

0.002

Coronary artery

-2.35

0.16

0.46

0.95

Family history of AAA

9.09

4.2

0.087

0.41

Warfarin

3.17

1.4

0.64

0.82

Endoleak

7.2

7.3

0.01

0.01

Predictive factor

disease

Table 9.6: Comparison of univariate and multivariate analysis for the entire patient group
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9.5.2 Subgroup Analyses
i.Decreasing Aneurysm Group (n=58) Multivariate Analysis

Predictive Variable

Parameter

Standard

t Value

p Value

Estimate

Error

Age

-0.05

0.17

-0.31

0.76

Pre operative size

-1.53

1.3

-1.18

0.25

Smoking status

-1.29

2.60

-0.50

0.62

Diabetes

9.65

2.84

3.39

0.001

Hypertension

-2.67

2.5

-1.06

0.29

Statin therapy

-9.4

2.9

-3.23

0.002

Coronary artery

6.01

2.52

2.38

0.02

-7.90

5.2

-1.5

0.14

6.2

2.4

2.59

0.01

disease
Family history of
AAA
Endoleak

Table 9.7: Multivariate analysis decreasing aneurysm group

Multivariate analysis was performed on patients in the decreasing aneurysm group. A
history of Diabetes (p= 0.001) a history of coronary artery disease (p= 0.02) and the
presence of an endoleak (p = 0.01) were found to be inversely related to aneurysm
regression. Statin therapy (p = 0.002) was found to be positively associated with
aneurysm regression in this group.
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ii. Stable Aneurysm Group (n= 37) Multivariate Analysis
Multivariate analysis on the stable aneurysm group demonstrated no significant results as
there was no significant change (<0.5cm) in aneurysm size in this group.
iii. Increasing Aneurysm Group (n=11) Multivariate Analysis

Predictive Variable

Parameter

Standard

t Value

p Value

Estimate

Error

Age

0.34

0.19

1.73

0.33

Pre operative size

0.22

1.9

0.12

0.92

Smoking status

-13.45

7.9

-1.7

0.34

Diabetes

-7.22

8.17

-0.88

0.53

Hypertension

1.1

5.99

0.20

0.87

Statin therapy

9.7

10.48

0.93

0.52

Coronary artery

-6.8

4.13

-1.65

0.35

-1.55

8.5

-0.18

0.88

Endoleak

7.63

6.79

1.12

0.46

Warfarin

1.4

6.4

0.23

0.82

disease
Family history of
AAA

Table 9.8: Multivariate analysis increasing aneurysm group

Multivariate analysis on the increasing aneurysm group revealed that no variables were
associated with aneurysm change.
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9.6 Discussion
Endovascular aneurysm repair of abdominal aortic aneurysms has become
increasingly employed as the method of choice for repair of abdominal aortic
aneurysms. However, unlike patients who undergo open surgical repair, EVAR
patients are at continued risk of aneurysm rupture if there is incomplete aneurysm
exclusion from systemic circulation. Regression of the residual aneurysm sac is
perhaps the most important observation following EVAR as it implies successful
exclusion of the aneurysm from the systemic circulation.
An alteration in AAA sac size of 0.5cm or more has previously been
described by others (Sternberg et al., 2003, Fairman et al., 2006 and Rhee et al.,
2000) as being significant and thus was the measurement used for the purpose of
defining subgroups for analysis in this study.
Using repeated CDU measurements, we observed a significant (>0.5cm)
decrease in sac size in 54.7% of patients who underwent EVAR. A significant
reduction in residual aneurysm size was noted at 7 months following surgery
(0.59cm), which continued at 12 (0.73cm) and 18 months (0.92cm) but slowed at
2 years (0.48cm). Rhee and colleagues in 2000 reported a similar progressive
decrease in residual aneurysm sac size in a series of 123 patients in the first year
of endograft implantation. Eleven patients (10.4%) demonstrated a significant
(>0.5cm) increase in aneurysm sac size while thirty seven (34.9%) showed no
significant change in size.
Multivariate analysis performed on the entire patient group (n=106)
demonstrated that statin therapy (p=0.002) was the only variable associated with
aneurysm regression following EVAR. Univariate analysis revealed that statin
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therapy (p =0.0006) and an increasing age (p = 0.04) were associated with
aneurysm regression whereas the presence of an endoleak (p = 0.01) was inversely
related to aneurysm change. These results therefore would suggest that stains play
an active role in aneurysm regression.
Further subgroup analysis revealed that diabetes (p = 0.001) the presence of
an endoleak (p =0.05) and a history of coronary artery disease (p = 0.02) were all
inversely related to aneurysm change in the decreasing aneurysm group. Statin
therapy in the decreasing aneurysm group was found to be positively associated
with regression (p = 0.002). There were also no predisposing factors associated
with aneurysm change in either the stable or the increasing aneurysm group.
The mean (±SD) preoperative age in the entire group of 75.6 (±7.2) years
was slightly older than the 73 (±8) years reported by Fairman (2006) and 72 (±0.8)
years described by Rhee (2000). Patients in the increasing aneurysm group had
larger mean diameters pre operatively 6.3cm (±1.3) than the 5.8cm (±0.9) and 5.6
cm (±0.6) seen in the decreasing and stable aneurysm groups respectively and in
the entire group 5.8cm (± 0.9). Preoperative aneurysm size was not found to be
statistically significant following univariate and multivariate analysis on the entire
patient population or following multivariate analysis on any of the subgroups (P=
>0.05 in all cases).
Fairman and colleagues in 2006, in a series of 351 patients examined
aneurysm change at 1, 6 and 12 months post EVAR and the effect of factors such
as graft type, age, gender, smoking status and variables such as pre procedure neck
thrombus on sac shrinkage they monitored regression with repeat CT
measurements. At 1 month none of their independent variables were predictive of
310

sac shrinkage. At 12 months they demonstrated that pre operative AAA size, the
presence of an endoleak, preoperative neck thrombus and gender was indicative of
aneurysm regression. In our series following univariate and multivariate analysis
aneurysm size prior to intervention was not found to be associated with aneurysm
change in any of the groups (p = >0.05 in all cases).
In contrast to Fairmans series, gender was not found to be a predictor of
aneurysm regression in this study with only 12 female patients in the decreasing
group and 7 in the stable group. However, in Fairmans series only 7 % of the
study population were female, in contrast to the 17.9% presented here, which
might explain these findings.
Multivariate analysis in all groups demonstrated no statistical significant
association between age and aneurysm change (p= >0.05 in all cases). Univariate
analysis however, on our entire patient population demonstrated that an increasing
age was positively associated with aneurysm regression (p=0.04).
Our results are comparable to Rhee (2000), who, in a series of 123 patients,
found that significant sac shrinkage occurs at 6 months after graft implantation.
They also demonstrated a steady decrease in residual aneurysm sac from baseline
to 6 months and 12 months.
Wolf and colleagues in 2000 sought to determine the rate of aneurysm
regression after EVAR using repeated CT measurements in a series of 110
patients. They concluded that the rate of aneurysm decrease in individual
aneurysms is unpredictable and the presence of an endoleak is unreliable in
predicting aneurysm change. In contrast, univariate analysis in our series
demonstrated that the presence of a type 2 endoleak was inversely related to
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aneurysm regression (p =0.01) in the entire patient population. Multivariate found
the presence of a type 2 endoleak to be inversely related to aneurysm regression
(p= 0.01) in the entire patient group and the decreasing aneurysm group (p =
0.01). Indicating that the presence of a type 2 endoleak does affect aneurysm
change. Wolf and colleagues pre operative aneurysm diameter was similar to our
own at 5.9

0.84) cm. Their mean aneurysmal decrease for their entire group at

6 months (0.34cm) and 12 months (0.59cm) was also similar to our own at 6
months (0.24cm) and 12 months (0.59cm).
Bobadilla and colleagues in 2010 assessed the effect of warfarin therapy in
the development of type 2 endoleaks after EVAR and concluded that warfarin was
linked to an increased risk of endoleak development. The effect of Warfarin on
aneurysm regression was assessed in this study and demonstrated no statistical
significance (p= 0.64 univariate analysis and p = 0.84 multivariate analysis)
however, as only 5.7% of patients were warfarinised, this series is not sufficiently
powered to assess its effect. There were a higher percentage of patients in the
stable aneurysm group (10.8%) on warfarin therapy than in the decreasing
aneurysm group (3.4%).
Of the 11 patients in the increasing aneurysm group 6 (54.6%) patients had
a documented endoleak during surveillance with 5 (45.5%) ultimately requiring
treatment. Multivariate analysis revealed that the presence of an endoleak (p =
0.46) was not statistically significant. However, the small sample numbers in this
group is a limitation. This study demonstrates a much higher percentage of
aneurysms that failed to decrease significantly (34.9% in the stable aneurysm
group) compared to the EUROSTAR registry which indicated that 16% of
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aneurysms failed to decrease in size after repair despite the absence of an endoleak
on CT (Gilling-Smith 1998).
There are several limitations of this study such as the small sample size, the
retrospective nature of the study and the failure of a proportion of patients to
attend for follow up. Also, despite the multiple variables evaluated in this series,
the effect of endograft type was not taken into account. Sternberg examined
aneurysm sac shrinkage in a series of 169 patients after endovascular aneurysm
repair using repeat CT measurements at 6 months and 12 months using two
different graft types and concluded that aneurysm regression was graft specific.
The presence of graft type was not taken into account in this study as two different
endograft types were employed with ~95% of the endografts being the same type,
therefore making any meaning full analysis of the effect of endograft type biased.
9.7 Conclusion
This study further defines the role of CDU in the postoperative surveillance of
patients who have undergone endovascular repair of an abdominal aortic
aneurysm. Maximum aneurysmal sac reduction occurs in the first year following
EVAR.
Aneurysm change is clearly influenced by treatment of predisposing risk
factors that can be determined prior to undergoing intervention. Our key finding is
that there is a highly significant statistical association with decreasing aneurysms
size following EVAR and patients on statin therapy, suggesting that statins play a
key role in the regression process. However, to suggest that patients with a known
history of hypercholesterolemia be selected for altered follow up based on the
numbers in this series is unreasonable. A larger more prolonged study to examine
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the effect of statin therapy on the mechanics of aneurysm regression should be
undertaken.
This study also demonstrates that the presence of an endoleak is inversely
related to aneurysm change in the entire patient group and the decreasing
aneurysm group following EVAR, indicating that patients with persistent
endoleaks should undergo more rigorous imaging to monitor aneurysm change
and perhaps a more aggressive intervention approach should be employed.
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Chapter 10

The Effect of Endovascular Aortic Stent Graft
Placement on Arterial Stiffness
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10.1 Introduction
Atherosclerotic coronary artery disease is one of the leading causes of death
worldwide and is the leading cause of early and late mortality following
abdominal aortic aneurysm (AAA) repair (Ballard et al., 1998). Early detection of
risk factors associated with increased cardiovascular risk should therefore be of
upmost importance in patients being considered for elective AAA repair. Having
established the role of CDU in pre and post operative surveillance following
EVAR, we sought to identify a role for CDU in assessment of this risk.
Pulse wave velocity (PWV) is a measure of arterial stiffness and an increase
in PWV has been identified as an independent risk factor for increased
cardiovascular morbidity and mortality (Alecu et al., 2008). Aortic pulse wave
velocity is an indicator of the stiffness of large arteries and is an independent
predictor of morbidity and mortality especially in the elderly population (Alecu et
al., 2008). PWV is the time taken for the arterial pulse to propagate from the
common carotid artery (CCA), to either the radial or the femoral artery.
There is a clear link in the literature to support the relationship between
increased PWV and outcomes in groups with other atherosclerotic disorders.
However there is little to support a link between elevated PWV and the outcome
of patients post Endovascular Aneurysm Repair (EVAR). Despite the
improvement in 30 day mortality associated with EVAR, adverse cardiac events
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are still the leading cause of long term mortality following AAA repair (Virgillio
et al., 2006).
There have been several large randomised trials to date which demonstrate an
improved 30 day survival rate for EVAR versus the open aneurysm repair but no
difference in the quality of life at 1 year. All cause mortality rates were similar
between the open group and EVAR group at 4 years, suggesting that the initial
survival benefit associated with the reduction in perioperative mortality does not
persist (EVAR 1 trial and DREAM trial). Schouten et al in 2006 demonstrated that
the major adverse events affecting long term morbidity and mortality following
EVAR were cardiac in origin (Schouten et al., 2006).
According to the Moens Korteweg equation (Equation 10.1) the PWV, which
is related to the square root of the elastic modulus, rises in stiffer arteries (Blacher
et al., 1999).

Equation 10.1: Moens Korteweg Equation

ρb: density of blood
E:

the elastic modulus

hv:

the thickness of the arterial wall

rvi: internal radius of the artery
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The elastic properties of the aorta and the larger arteries in the body are important
due to their need to expand to accommodate large volumes of blood during
systole.
Arterial wall stiffness can be measured non-invasively by measuring the speed of
arterial pressure wave transmission through the arterial tree. It can be measured
using several reference points such the common carotid artery and the femoral
artery by a simple reproducible method using many commercially available
devices.
Measurement of PWV is simple and, unlike other imaging methods for
determination of arterial stiffness, does not require the evaluation of blood
pressure at the site of imaging. It has become widely regarded as the gold standard
method of measuring of arterial stiffness (Jiang et al., 2007). PWV is calculated by
dividing the distance between two measurement points by the transit time delay
from both points and may be described by the following equation (Zhang and
Greenleaf. 2005)

Equation 10.2: PWV Equation
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PWV is usually determined by arterial tonometery using one of two commercially
available systems, the SphygmorCor (AtCor Medical, Sydney, Australia) and the
Complior system (Conlson, Gorges les Genosse, France). PWV uses pressure
sensors that are applied over the carotid and femoral arteries either simultaneously
or sequentially using an electrocardiogram (ECG) as a timing reference to
determine the time delay between the upstroke of the carotid and the femoral pulse
waveforms (Jiang et al., 2007).
Jiang and colleagues in 2007 compared the carotid femoral PWV measured
by tonometery (the SphygmoCor system) with a standard vascular ultrasound
system using a linear transducer and concluded that there was no mean difference
between the mean values of PWV obtained by the two techniques, indicating that
a commercially available ultrasound scanner such as is available in our department
can be used to accurately and reproducibly measure PWV.
Carotid-femoral PWV is a recognisable index of aortic stiffness and has been
proven to be an important predictor of cardiovascular events in many disorders
(Villacorta et al., 2006). This method of measuring aortic PWV has emerged as
the only reliable measure of arterial stiffness that is able to predict outcomes in
individuals with such risk factors (Smith et al., 2005).
PWV can increase with various risk factors such as age; hypertension and
diabetes. There are no accepted normal reference values, however on the basis of
previous prospective morbidity and mortality studies values greater than 12m/sec
are considered elevated (Rajzer et al., 2001). This value varies depending on the
method of measurement used. In 2008 Cosmin Alecu et al., 2008 defined
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reference values for aortic PWV in the elderly using the commercially available
pulse pen device. They used an apparently healthy group of both males and
females aged between 60-75 years. Individuals with hypertension and diabetes
were excluded from the study. They concluded that in this age group a PWV of
below 10m/sec measured with the pulse pen was considered normal. Values above
13m/sec were considered elevated.
The primary aim of this study was to determine if the implantation of an
endovascular aortic graft altered the patients PWV compared to the patients who
underwent the traditional open surgical repair. An increase in PWV following
EVAR could explain the absence in long term survival benefit in patients who had
EVAR of their aneurysms compared to those who survived open surgery.
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10.2 Patients and Methods
Following approval from the hospital ethics committee, commencing on the 1st of
July 2008, 34 patients being worked up for elective repair of their Abdominal
Aortic Aneurysm (AAA) in the Mater Misericordiae University Hospital
(MMUH) gave their consent to have their PWV calculated using a standard
vascular ultrasound system.
Of the total number of patients examined there were 31 (90%) male and 3 (10%)
female patients with an overall mean (

SD) age of 73 (

years.

Fifteen (44.1%) patients underwent open surgical repair with a mean (
of 72 (

SD) age

years and 19 (55.8%) patients underwent EVAR with a mean (

SD) age of 73 (

years. Both groups had their PWV recalculated post

procedure within 4 weeks.
Patient demographics and co morbidities in the two groups are detailed in table
10.1 and figure 10.1.
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Risk Factor

EVAR Patients (%)

Open Repair Patients

(n = 19)

(%)
( n =15)

Male

84.2

100

Female

15.8

0

Smoker

35.3

40

Diabetic

23.5

6.6

Hypertension

41.2

46.6

Hypercholesterolemia

52.9

20.0

Coronary Disease

52.9

13.3

Family History of AAA

11.7

6.6

Aspirin

47.0

53.3

Lipitor

29.4

13.3

Plavix

11.7

13.3

Warfarin

0

6.6

Table 10.1: Patient demographics by group
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Figure 10.1: Patient demographics by group
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10.2.1 Measurement of PWV
All patients were scanned in the vascular laboratory of the MMUH by the same
accreditated vascular technologist. A Phillips IU22 vascular ultrasound system
was used to perform all colour Duplex ultrasound (CDU) measurements utilising a
7-10MHz linear array transducer. All scans were performed in a darkened
temperature controlled room following the clinical measurement protocol as
previously described in Chapter 5, section 5.5.4. All CDU scans were performed
within a week prior to undergoing intervention, and repeated within four weeks
following intervention.
The two reference points used for the purpose of this study were the right common
carotid artery (RCCA) and the right common femoral artery (RCFA). All values
for PWV were calculated as previously described in Chapter 5.0 section 5.5.5.
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10.3 Results
Of the 34 patients included in this study the mean (
undergoing intervention was found to be 9.3 (

SD) PWV prior to
.

Open surgical repair group
Fifteen patients in total underwent open surgical repair. Their mean PWV prior to
undergoing intervention was found to be 9.9 (
mean PWV in this group decreased to 9.7 (
found to be a decrease of 0.2 (

m/sec. After intervention the
m/sec. The mean change was

m/sec. No statistical difference was found

between the PWV pre surgery and post surgery in the open group when the
student paired t- test was performed (p = 0.88).
Endovascular Aneurysm Repair
Nineteen patients underwent EVAR. Their PWV prior to undergoing graft
implantation was found to be 8.8 (
graft the mean (

m/sec. Post implantation of endovascular

PWV in this group of patients increased to 12.2

(

m/sec. The mean change in PWV was found to be an increase of 3.3

(

m/sec. This difference was statistically significant when the student paired

t- test was performed (p=0.001).
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Figure 10.2: Difference in mean PWV pre and post surgery in both groups
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10.4 Discussion
This study demonstrates a clear increase in mean PWV in the group of patients
who underwent EVAR when compared to the open surgical repair group. The
mean post procedure PWV of 9.7 (

m/sec in the open group was

significantly lower than the elevated 12.2 (

m/sec detected in the EVAR

group.
A study carried out by Alecu et al., in 2008 concluded that PWV values
below 10m/sec were considered normal, values between 10-13m/sec borderline
with values greater than 13m/sec being elevated. Rajzer et al., in 2008 considered
12m/sec to be elevated. Taking this into account, prior to undergoing intervention
the mean ( SD) PWV in the open group was 9.9 (
group was 8.8 (

3.1) m/sec and in the EVAR

2.1) m/sec, both within the normal value ranges. After surgery

however, the mean ( SD) PWV in the open surgical group remained within the
normal range at 9.7 ( 4.5) m/sec whereas the mean ( SD) PWV in the EVAR
group was elevated at 12.2 ( 4.5) m/sec. This indicates that patients in the EVAR
group are at a higher cardiovascular risk post operatively, when compared to the
patients in the open surgical group.
PWV is an independent predictor of cardiovascular morbidity and mortality
with age, hypertension and diabetes being the primary determinants of arterial
stiffness (Alecu et al., 2008). Smith et al in 2005 stated that arterial stiffness is
increased by multiple risk factors such as hypertension, and diabetes. Patients that
have diabetes and renal disease have a higher PWV than those without diabetes, a
condition that leads to a higher all cause and cardiovascular mortality in these
patients (Smith et al., 2005). There was no statistical difference noted between the
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risk factor variables in each group (p = 0.05) however, there was a higher
percentage

of

patients

in

the

EVAR

group

with

known

diabetes,

hypercholesterolemia and coronary artery disease. The proportion of patients with
known hypertension was lower in the EVAR group (41.2%) than the open surgical
group (46%). The mean age of patients 73.7 years in the EVAR group, compared
to 72.4 in the open surgical repair group were not significantly different (p =0.9).
All patients in the open surgical group were male and only 15.8% in the EVAR
group were female.
There are limitations with this study, such as the gender distribution and
sample size. There were no female patients in the open surgical group and the
EVAR group only contained 3 (15.8%) female patients. As gender is one of the
risk factors that affect PWV this is a limitation of the study which could only be
remedied with a larger more evenly distributed population. The PWV
measurements were obtained within four weeks post surgery. To assess the
implication of increased PWV on the long term cardiovascular morbidity and
mortality of these patients, a prospective follow up of this population assessing
cardiovascular event rate and mortality would be required.
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10.5 Conclusion
The initial 30 day mortality results following EVAR demonstrate better survival
when compared to open aneurysm repair. This survival rate does not persist when
the patients are followed up long term. The findings of this study demonstrate that
within the 30 days of graft implantation patients that underwent EVAR have a
higher PWV measurement than those who underwent open surgical repair.
An increase in PWV correlates with an increased risk of cardiovascular
morbidity and mortality in patients with atherosclerotic conditions and the
elevation in PWV observed in the EVAR group in this study could equate to an
increased postoperative cardiovascular event rate which could explain the failure
of the initial survival benefit seen with EVAR.
To appropriately evaluate the long term implications of arterial stiffness on
cardiovascular morbidity and mortality following EVAR, a larger scale study with
a longer prospective follow up specifically looking at cardiovascular event rate
and mortality would be required.
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Chapter 11

Conclusions
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Advances in technology and surgical technique have led to the evolution of
endovascular aortic aneurysm repair. The minimally invasive nature of the
procedure coupled with the concerns regarding durability of the repair have forced
a re-evaluation of how aneurysm patients are assessed prior to and following their
surgery.
The aim of this thesis was to investigate the role that Colour Duplex
Ultrasound (CDU) plays in the detection, diagnosis and management of patients
with AAA’s, with particular relevance to those undergoing endovascular
aneurysm repair (EVAR).
Chapter 6 sought to determine the presence and severity of asymptomatic
carotid artery disease (CAD) and peripheral artery disease (PAD) in 389 patients
with AAA to determine if this was a reasonable focus group to screen for occult
CAD and PAD. The incidence of CAD (30.4%) and PAD (45.3%) was found to be
higher in patients with AAA than that documented previously in other similar
screening studies. Therefore, it is reasonable to conclude that patients with AAA
are a group that should be targeted for screening for atherosclerotic disorders in
other vascular territories. Similarly it is logical to suggest screening patients with
CAD and PAD for AAA’s.
The obvious advantages of screening for occult disease are that advances prior
to AAA repair may help anticipate and thus prevent complications which may
arise during, or as a consequence of surgery. More importantly, however, is the
question of whether identification of these conditions alters the long term clinical
outcome for the patient. A larger, more prolonged study of patients with coincidentally diagnosed PAD and CAD as a consequence of screening during AAA
workup, is required to determine what proportion of these patients ultimately
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require intervention for their disease and whether the cardiovascular death rate in
this screened population is different to the population as a whole.
Chapter 7 assessed the accuracy of CDU in measuring maximum aneurysm sac
size in patients with AAA who had not yet undergone intervention. A high degree
of correlation between CDU and the commonly accepted gold standard of
computed tomography (CT) was established.

However, CT scanning is still

necessary prior to undergoing EVAR as numerous measurements of the native
aorto-iliac segment need to be taken. The obvious next study would be to
determine whether or not CDU could be employed as a measurement tool in
patients prior to EVAR selection thus obviating the need for preoperative CT
completely.
Chapter 8 evaluated the role of CDU in the postoperative surveillance of
patients following EVAR, comparing it to the gold standard method of CT. A high
degree of correlation between CDU and CT was demonstrated when measuring
residual aneurysm sac size post EVAR, with a high sensitivity and specificity also
achieved for CDU when compared to CT for the detection of endoleaks. Thus, it is
reasonable to conclude that CDU could safely supplant CT as the primary imaging
modality following EVAR, with just those patients with abnormal or inconclusive
CDU scans requiring a CT. This would produce a sizeable reduction in the number
of surveillance CT scans required with an accompanying reduction in radiation
and contrast exposure, along with a substantial cost saving.
Having established the efficacy of CDU in the postoperative surveillance of
EVAR patients, chapter 9 sought to identify its role in evaluating the residual
aneurysm sac following EVAR. Aneurysm change was assessed and its
relationship to pre existing risk factors and the presence of a type 2 endoleak
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examined. Maximum residual sac reduction was found to occur in the first year
following EVAR. Following univariate and multivariate risk factor analysis,
reduction of the residual aneurysm sac was found to be dependent on risk factors
that could be assessed prior to undergoing intervention. One key observation was
the highly statistical associated observed between patients on statin treatment and
aneurysm regression indicating that statins play a significant role in the regression
process following EVAR. Based on this observation a larger more prospective
study to clearly identify and outline the role that statins play in the regression
process would be recommended.
One potential factor which was not assessed in this series was the influence of
endograft type on sac behaviour following implantation and this is perhaps an area
which should receive further study.
Chapter 10 demonstrated that within 30 days of graft implantation, patients that
underwent EVAR have a higher pulse wave velocity (PWV) measurement than
those patients who underwent open surgical repair. An increase in PWV correlates
with an increase in arterial stiffness and an associated higher risk of cardiovascular
morbidity and mortality in patients with atherosclerotic conditions. This could
explain the absence of a long term survival benefit in patients who underwent
endovascular repair of their aneurysms compared to those who survived open
surgery. The next step in evaluating this finding would entail examining the long
term implications of increased arterial stiffness on cardiovascular morbidity and
mortality following EVAR. A larger scale study with a longer prospective follow
up would be required to compare the postoperative cardiovascular event rate in
patients who underwent EVAR with open repair.
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